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ABSTRACT
The structure of bacteriophage P22 and its precursor particles has
been studied by immunological methods. Rabbits injected with P22 pro-
heads, tail-less phage, or mature phage produced hyperimmune sera that
precipitated all P22 structures tested.
Characterization of the anti-prohead serum by immunoelectrophoresis
showed that it contained antibodies against the scaffolding protein, gp8.
Identification of this antibody class was facilitated by the charac-
teristic immunoelectrophoretic patterns produced by several of the amber
fragments of the gp8 polypeptide. They also showed reactions of par-
tial identity with the full gp8 molecule.
In immunoelectrophoresis experiments, absorption of the anti-
prohead serum with prohead structures resulted in the loss of the gp8
precipitin arc from the immunoelectrophoretic pattern. In experiments
using electron microscopy, antibodies directed primarily against the
scaffolding protein were generated by absorption of the anti-prohead
serum with both phage and 8~ amber mutant lysates. These antibodies
uniformly coated the prohead shell. The combined results suggested
that scaffolding protein in proheads was available for reaction with
antibodies in the external environment. Two interpretations are pos-
sible: either, scaffolding protein is normally accessible throughout
the coat protein lattice, or, it becomes accessible after incubation
of the prohead structure with the antiserum. In fact, incubation of the
proheads with either anti-phage or anti-prohead serum apparently leads
to a migration of the internal density, so that the prohead no longer
excludes the negative stain.
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Anti-phage, anti-prohead, and anti-head sera contained antibodies
against the capsid protein, gp5, as assayed by immunoelectrophoresis of
these three sera after absorption with a 5~ amber mutant lysate. Elec-
tron microscopy experiments using anti-phage and anti-prohead sera
showed that these sera uniformly coated the capsids of phage and pro-
heads. They also bound to P22 spirals, structures composed primarily
of coat protein, that accumulate in the absence of scaffolding protein.
A prohead-specific class of anti-capsid antibodies, generated by suc-
cessive absorption of the anti-prohead serum, first with phage, and
then, with a 5~ amber mutant lysate, continued to coat proheads. The
existence of this antibody class indicated that there was a set of
capsid determinants on proheads which had become altered or unavailable
during virus maturation, so that phage were no longer able to interact
with these anti-capsid antibodies. On the other hand, electron micros-
copy of anti-phage serum that had been absorbed with proheads showed
that it no longer coated phage. Thus, all of the antigenic determi-
nants present on phage also seemed to be present on prohead precursor
structures, suggesting that no new antigenic sites were generated in
the prohead-to-phage transition.
Anti-phage and anti-prohead sera inactivated phage; anti-head
serum, produced in response to tail-less phage, did not. Results from
serum blocking experiments indicated that most of the virus neutralizing
antibodies in the anti-phage and anti-prohead sera were directed against
the tail protein, gp9. As proheads do not contain tail protein, these
antibodies were probably generated against contaminating phage ghosts in
the prohead immunogen preparation. Anti-gp9 antibodies in the two phage-
inactivating sera were also detected by immunoelectrophoresis. In the
electron microscope, phage tails that had been incubated with anti-gp9
antibodies appeared coated.
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INTRODUCTION
The study of viruses developed from their identification as
agents of disease, originally in plants, and later in animals and
humans. Since viruses utilize the synthetic apparatus of their
host cell for their reproduction, antibiotics which act on the
synthetic apparatus are not useful in therapy, since they tend to
be toxic to the host. Immunoprophylaxis remains the most effective
way to control virus diseases (Neurath and Rubin, 1971). The bene-
ficial consequences of the development of vaccines for smallpox,
yellow fever, poliomyelitis, and measles are well known. In the
veterinary field, vaccines for canine distemper, canine hepatitis,
Newcastle Disease virus, hog cholera, and foot-and-mouth disease
virus (the most troublesome disease of farm livestock) have been
used with success (Borek, 1972). With many other viruses, the
prospects of effective vaccines seem less promising because of
antigenic heterogeneity and other problems.
There have been close links between the fields of Virology and
Immunology for a very long time. One might say they were born to-
gether in 1798, when Edward Jenner introduced vaccination with cowpox
to protect against smallpox (Langer, 1976). Implicit in this discovery
were the beginnings of the recognition of contagious viral disease, an
appreciation of cross-reactivity between related viruses and the notion
of active immunization. Almost a century later, Pasteur attenuated
virulent rabies virus by serial passage through a novel host, the
rabbit, thus introducing a method of preparing live virus vaccine which
persists to the present day (Fenner, 1972).
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There are two main approaches available in the treatment of
viral infections. In the preventive approach, active immunization,
as noted previously, makes use of the organism's own immune system.
Vaccines can generally provide high-level immunity with long-lasting
effects, but are of very limited spectrum; essentially, one vaccine,
one virus. In addition, there are substantial problems in the
manufacture of vaccines. Not only are there formidable difficulties
in scaling up preparations, but the cell substrates used to grow
viruses have a substantial probability of containing latent viruses.
Thus, as far as immunization is concerned, it may be of considerable
use to define which viral antigens produce antibodies that will
protect the organism.
A second approach dealing with viral deseases involves chemo-
therapy. As noted earlier, the great success which attended anti-
bacterial chemotherapy since World War II has not been paralleled
for viruses, primarily because of the intimate dependence of viral
replication on host metabolic processes. However, there are viral-
specific processes which may be potential targets for the develop-
ment of chemotherapy, for example, the reactions involved in virus
assembly.
With respect to immunization, there was essentially no lapse
between the general recognition that viruses were built from symmetri-
cally arranged subunits (Crick and Watson, 1956; Caspar and Klug,
1962; Horne and Wildy, 1961) and the realization that isolated subunits
might be used as immunogens (Appleyard, 1961; Wilcox and Ginsberg, 1963).
Although most vaccines currently in use still consist of virus particles
and soluble antigens, it has been demonstrated that not all antigens of
a given virus are needed to induce antibody responses leading to pro-
tection (Kasel, et al., 1964; Davenport, et al., 1964). The useful
proteins present in most vaccines, therefore, represent only a small
proportion of the total macromolecular species. Therefore the use of
vaccines made of purified components have a number of advantages.
Superfluous proteins which may cause undesirable sensitization or toxic
reactions will be eliminated; innoculation of viral nucleic acid will
be avoided which even if lacking infectivity, might retain undesirable
coding potential; hyper-immunizing doses can be used; and vaccine
standardization may be based on chemical as well as biological criteria
(Pereira, 1972). It is possible that such an approach may be taken one
step further with the use of wholly synthetic molecules as immunogens.
This depends on the detailed elucidation of the
antigenic structure of the proteins. Such experiments have been done in
model systems, for example with enzymes (Arncn, 1972).
The main focus of this thesis is the elucidation of the antigenic
structure of a simple bacterial virus, Salmonella phage P22, by exploit-
ing the specificity of the immune response. In using antibodies to
analyze phage structure, I also gathered information on the nature
of the rabbit immune response to P22. As a result of the inherent
complementarity of antigen:antibody studies, information about one
of the reactants provided information on the other. Information
derived from a simple system may not be directly transferable to
more complicated organisms; however, because of the precision of
the phage system, including the well-developed genetics, and detailed
knowledge of protein composition and protein assembly, clear answers
to well-defined questions can be obtained.
Viruses have been described as "vagabond genomes" (Rott, 1965).
As such, viruses have evolved structures specifically designed to meet
the demands characteristic of this life-style. As free agents in the
environment, viruses must protect their genetic complement from degrada-
tion. However, the same structure which protects the nucleic acid must
also serve as its vehicle of transfer. In this capacity, the virus
particle must also function in recognition of, and adsorption to, the
host cell, penetration of the cell envelope, and perhaps, transport of
the nucleic acid to the proper site for its replication. Considering
the complex series of progressive functional states which the relatively
simple virus capsid must assume , I was intrigued as to how such struc-
tures are designed and assembled. This thesis presents the results of
my investigation into the assembly and structure of bacteriophage P22.
The genetics, protein composition, and morphogenesis of P22 have been
defined in detail (Botstein, et al., 1973; King, et al., 1973). In
these experiments, I attempted to discover, using antibodies as probes,
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how the disposition of the proteins in precursor and mature virus
particles are related to their biological functions.
Fraenkel-Conrat and Williams showed in 1955 that tobacco
mosaic virus could be reconstituted from its protein and nucleic
acid components. Thus, it seemed that virus parts contained with-
in themselves blueprints for the construction of the virus. Around
the same time, Crick and Watson (1956) postulated that the protein
coats of viruses were made up of identical subunits. In this way,
shells of considerable size could be coded for by a minimum of gene-
tic material, and constructed in the most error-free manner. In
1962, Caspar and Klug were responsible for a major advance in the
theory of construction of regular viruses. They provided a
geometrical model for the packing of similar subunits into what
they termed "quasi-equivalent" positions on the surface of an ico-
sahedral shell. Such a shell has 20 faces and 12 vertices. Simply
stated, quasi-equivalence allows for a certain bonding flexibility
in identical subunits so that molecules can participate in arrange-
ments having 6-fold local symmetry (on the faces) or 5-fold local
symmetry (at the corners). Recent X-ray diffraction studies by
Harrison and co-workers in tomato bushy stunt virus (Winkler, et al.,
1977) have supported the icosahedral symmetry concept and showed that
quasi-equivalent bonding may be accomplished by subunits containing
rigid domains joined through flexible hinge regions.
As experiments dealing with virus structure became more
sophisticated, however, it became clear that an accurate description
of the mature virus shell was not a sufficient description of its for-
mation. Shortly after the introduction of Caspar and Klug's simple
theory of icosahedral virus structure, Epstein and co-workers (1963)
showed that the formation of the T4 phage head required the products
of a very large number of genes. Subsequently, Laemmli
showed that complex intermediate structures accumulated in cells in-
fected with mutants in these genes (Laemmli, 1970).
As the genetic and structural complexity of the system unfolded,
it became clear that the assembly of the large bacteriophages was not
simply a self-assembly process involving the components of the mature
virion. The functions of a number of accessory proteins seemed also
to be involved. In fact, the study of the disposition of these auxil-
iary proteins during capsid assembly has been highly instructive in
understanding how capsid shells are constructed (Casjens and King,
1975). It appears that all of the large bacteriophages augment the
basic capsid-building capacity of the major head protein by the
strictly ordered addition, processing, or release of auxiliary pro-
teins.
Naively, one might think that there would be a number of ways
to proceed to assemble the mature virion. Three general classes of
packaging models are: 1. The capsid forms around a nucleic acid-
containing core (Kellenberger, et al., 1968); 2. nucleicacid and
the protein subunits combine cooperatively in a step-wise manner to
form the capsid and 3. the nucleic acid is packaged into a pre-formed
capsid, the "headful" encapsidation model (Streisinger, et al., 1967;
Luftig, et al., 1971). In fact, the basic approach to capsid assembly
and DNA packaging is the same for all large viruses containing double-
stranded DNA,Amechanism 3 above: the phages assemble a capsid shell
first, then fill it with DNA. Condensing rigid double-stranded DNA
molecules apparently requires very complex machinery. The precursor
shell seems to be a major component of this machinery.
We therefore see that it is the precursor shell as a DNA
packaging organelle, which must be constructed, and not just a passive
protective shell. The assembly of such precursor shells has turned
out to be quite an extraordinary process. In P22,the assembly of the
major coat protein into a functional shell depends upon a scaffolding
protein which polymerizes with it into a double-shelled structure
containing both proteins (King and Casjens, 1974; Earnshaw
et al., 1976). In concert with DNA packaging, all of the
scaffolding molecules depart from the shell. These molecules complex
again with newly synthesized coat protein to form more proheads.
Before describing the detailed pathway of P22 morphogenesis
I'll briefly review the maturation of phages, T4, Aand T7.
A major unsolved problem in phage assembly is the nucleation
and polymerization of the capsid subunits to form a closed precursor
capsid shell. Do you start at one pole and aggregate continuously to
the other? Or, is it more efficient to build smaller assemblies first,
perhaps the vertices, and then assemble these? Or, does an assembly
core form and the major capsid subunits aggregate around that? Again
there is a pattern common to all of the double-stranded DNA phages.
Each initiates capsid formation with the help of an assembly core
(Showe and Black, 1973) or scaffolding protein (King, et al., 1973)
as with P22, made up of proteins which do not appear in the final
structure.
Simon showed, for example, that cores are actually visible
inside early T4 capsid intermediates by using thin-section analysis
of wild-type infected cells (1972). These core-containing particles
had been described earlier as accumulating in mutant-infected cells
(Laemmli, et al., 1970). Such particles were also found as kinetic
intermediates in pulse-labelled wild-type T4 infected cells (Laemmli
and Favre, 1973). Finally, Bijlenga, et al. (1973) showed that these
core-containing particles, called tau-particles, made at high tempera-
ture in cells infected with a ts mutant in gene 24, were converted to
phage when gp24 was activated by a temperature downshift. In an
important control to this experiment, Bijlenga and co-workers
(Bijlengaet al., 1974) showed that this conversion was conservative,
ruling out that the tau-particles were breaking down and reassembling
during the post-shift period.
Biochemically, attempts to isolate tau-particles failed,
apparently because of the tendency of these particles to adhere to
each other or the membrane. Although it was not possible to analyze
the protein composition of the tau-particles directly, examination of
the behavior of several mutants suggested that the morphological in-
ternal core was composed of several proteins and served as an assembly
core in shell assembly (Showe and Black, 1973). At least four phage
proteins, gp22 and three internal proteins, IPI, IPII and IPIII, were
of
part of the core. In the absenceAthese four proteins, no organized
structures formed.
In phage A , the development of an in vitro DNA packaging system
(Kaiser and Masuda, 1973; Hohn, et al., 1974) allowed one to test
directly whether a particular structure could serve as a precursor to
the mature virus. Morphogenesis of phage A capsids involved pre-
cursor structures distinguishable from the mature phage. The term
"petit X " was used initially to describe the small, empty-looking
particles seen in all negatively stained X lysates except E~ ly-
sates, which lack the major head protein gpE (Murialdo and Siminovitch,
1972; Casjens, et al., 1972). Several types of petit X have been
described, differing in their lysate source and protein composition
(Ray and Murialdo, 1975; Hohn, et al., 1975). Originally it was
thought that these small, head-like particles were aberrant by-pro-
ducts of the assembly pathway. However, experiments using purified
petit A particles as head donors in the in vitro DNA packaging
system showed that one type of petit A , called the prehead, was in-
deed a precursor of the mature phage (Hohn and Hohn, 1974; Kaiser, et
al., 1975).
Although petit K particles looked empty in negative stain,
subsequent thin-section analysis of wild-type and mutant-infected
cells showed a number of core-containing petit X particles. These
studies indicated that the core-containing prohead I petit A was con-
verted to an empty prohead II petit X which had lost its core. The
prohead II particle was subsequently filled with DNA to form the
mature X capsid (Zachary, et al., 1976). The authors observed
core-containing structures in thin sections through every induced
mutant lysogen analyzed with the exception of E~ lysates, which lack
the major coat protein, and Nu3~ lysates. Nu3 inductions produced
misshapen, amorphous structures, which were variable and difficult to
recognize. Furthermore, using analysis of double mutant inductions,
they showed that gpNu3 was required at a very early step in X capsid
morphogenesis. Therefore, these authors concluded thatgpNu3 may be a
scaffolding protein required for the formation of the A prohead.
Protein analysis of various petit X particles supported the
conclusion that gpNu3 was part of an assembly core, as it was present
in core-containing structures and absent in empty particles (Ray and
Murialdo, 1975).
There is also an in vitro DNA packaging system for phage T7
(Kerr and Sadowski, 1974). Core-containing prohead structures have
been purified and been shown to be capable of complementing in vitro
a cell-free extract lacking heads (Roeder and Sadowski, 1977). Elec-
tron microscopic examination of negatively stained mutant cell lysates
showed that no structures were produced in 10~ lysates which lack the
major head protein. However, 9~ lysates also contained no structures,
suggesting that gp9 functioned as a scaffolding protein of prohead
formation. The proheads produced after infection with mutants in
genes 8, 14, 15 and 16, had aberrant protein compositions and lacked
cores when examined in the electron microscope. Although some struc-
ture formation proceeds in the absence of these proteins large numbers
of aberrant spiral-shaped or tubular structures are also observed.
Thus, these proteins may also be involved in the formation of the
assembly core.
The transition from prohead precursor to mature phage particle
is a complicated process in which all the well-studied phages contain-
ing double-stranded DNA undergo a major change in their protein compo-
sition (King, et al., 1973). In phage T4, not only does the major
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coat protein, gp23, get cleaved, but the internal assembly core
proteins, IPI, IPII, IPIII, and gp22, are cleaved as well. While
the gp23 cleavage step appears to occur prior to DNA packaging, the
removal of the assembly core from the T4 precursor particle by pro-
teolytic cleavage appears to be specifically linked to DNA packaging
(Laemmli, et al., 1974). In phage X , gpNu3,which is essential for
prohead formationis totally lost from the particle (Hendrix and
Casjens, 1975) and may be degraded (Ray and Murialdo, 1975). Two
core-related minor proteins, gpB and gpC, are retained in the finished
head but in altered form: gpC fuses with the major head protein, gpE,
and together they are cleaved; gpB is cleaved as well (Casjens and
Hendrix, 1974). The final modification in A head maturation involves
the addition of the second major coat protein, gpD. Present in equal
numbers with the gpE and present on the outside of the head, gpD does
not seem to become part of the head until the head is filled with DNA
(Hohn and Hohn, 1973).
In phage T7, the scaffolding protein, gp9, departs either before
or during DNA packaging, and two other proteins leave the capsid once
DNA packaging is complete (Roeder and Sadowski, 1977).
A consistent feature of these pathways is the mutual exclusion
of the unaltered scaffolding protein and the DNA: there is
no case in which both have been found to be present simultaneously
within the capsid. There are several possible explanations for this:
The core proteins may function exclusively in capsid initiation and
coat protein aggregation. Once this function was complete, they would
no longer be required and may simply be removed to make room for the
DNA. This hypothesis seems insufficient to explain the behavior
of the core proteinsin T4 and A , because altered forms of at least
some of the core proteins remain inside the mature head. The hy-
pothesis gains somewhat more validity in the case of T7 (and in P22,
as we shall see) where the scaffolding protein is completely removed.
Alternatively, the virus may make efficient use of scaffolding pro-
teins as active parts of the machinery involved in the condensation
of the DNA. Laemmli (1975) has suggested such a role for a fragment
of one of the core proteins, gp22, in T4 DNA packaging.
Bacteriophage P22 Assembly
P22 is a lysogenic phage of Salmonella typhimurium. It was
discovered by Zinder and Lederberg (1952), who found that it trans-
ferred bacterial genes from one host to another. Morphologically,
it is relatively simple. The mature phage head is isometric, about
60 nm in diameter (Lenk, et al., 1975) with a small tail at one
vertex (Israel, et al., 1967). It contains one double-stranded DNA
molecule (molecular weight, 27 x 106) which is circularly permuted
and terminally repetitious (Rhoades, et al., 1968). The growth and
DNA metabolism of infected cells has been studied in detail by Botstein
and Levine (1968). The overall sequence of events in DNA packaging
has been described by Tye and co-workers (1974). They have shown con-
clusively, by examining the distribution of mature chromosome ends,
that Streisinger's headful packaging model is operating in P22 DNA
packaging (Streisinger, et al., 1964, 1967).
Amber mutations defining 14 late cistrons have been isolated
and mapped by Botstein, Chan and Waddell (1972) and Poteete and King
13.
(1977). Twelve of these cistrons specify proteins involved in
particle assembly, (the other two control lysis). The morpho-
genetic genes are clustered together on the chromosome, and they
are further grouped according to their specific functions in particle
assembly. This is shown in Figure 1. Genes 5 and 8 specify proteins
directly involved in the construction of the capsid shell. The gene
5 product is the major coat protein while the gene 8 product is the
scaffolding protein absent from mature phage. Genes 1, 2, and 3,
code for proteins which are necessary for the packaging of the DNA
into the precursor shell. Genes 4, 10 and 26 are responsible for
the production of proteins which stabilize phage heads newly-filled
with DNA. Genes 7, 16 and 20 specify proteins which are incorporated
into the capsid at its inception, but which are not necessary for head
formation; they appear to function later in the phage lifecycle, in
the injection of DNA into the host cell (Hoffman and Levine, 1975;
Poteete and King, 1977; R. Griffin Shea, unpublished experiments).
Gene 9 is separated from the rest of the morphogenetic genes and codes
for the baseplate protein (Israel, et al., 1967). The remaining two
genes, 13 and 19, are involved in cell lysis.
I have summarized the defective phenotypes of the mutants in the
morphogenetic genes in Table 1. I have paid particular attention to
the state of the baseplate protein in the mutant-infected lysates, as
this will be important in the discussion of the experimental results in
Chapter I of this thesis.
The late mutants of P22 have been examined in detail by Botstein,
King and their colleagues (Botstein, et al., 1973; King, et al., 1973;
14.
Figure 1
Map of the Morphogenetic Region of the P22 Chromosome
Gene sizes have been drawn proportional to the molecular
weights of their polypeptide chains. The region to the left
of gene 9 contains genes functioning in superinfection exclusion
and control of lysogeny. The map is based on data from Botstein,
et al. (1971) with additions from Poteete and King (1977).
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TABLE 1
Defective Phenotypes of Mutant Lysates
Lysate Function of Missing Gene Product Major Capsid Structure Form of Tail Spike
Protein
Cell lysis
Major coat protein
Scaffolding protein present only
in proheads
Minor structural protein of pro-
heads and phage, required for
DNA packaging
Non-structural protein, required
for DNA packaging
May be a minor phage structural
protein, required for DNA
packaging
DNA injection
DNA injection
"3
Head completion
(neck?)
_ _ _ _ _ 1 _ _ _ _ _ _ _ _ _ _ _ _ _
Infectious phage particle
Spirals, aberrant shells
Proheads (only)
Proheads (only)
Proheads (only)
13- 19-
5-
8-
1-
2~
3~
7~
16~
20
4-
10'
phage-
E h
Empty heads
On particle, soluble
Soluble
Soluble
Soluble
Soluble
Soluble
On particle,
probably also
soluble
Soluble
Non-infectious,
like particles
TABLE 1 (Contd.)
Defective Phenotypes of Mutant Lysates
1 Defective phenotypes taken from Botstein, et al. (1973).
Lysate Function of Missing Gene Product Major Capsid Structure Form of Tail Spike
Protein
26~ Head completion Empty heads Soluble
9- Tail spike Heads
18.
Poteete and King, 1977). The phenotypes of these mutants have been
characterized in terms of the extent of DNA maturation, the pro-
duction of head-related structures as seen in the electron micro-
scope, and the protein compositionsof infected cell lysates and the
structural intermediates purified from them. The genes specifying
all of the known P22 morphogenetic proteins have been identified.
Conversely, the proteins corresponding to the known P22 morphogenetic
genes have also been identified. Using the accumulated observations
from these genetic, biochemical and electron microscopic analyses,
the investigators have been able to define precisely, (though not yet
understand completely) all of the steps in the assembly of the parti-
cle which are specified by phage genes. The pathway of P22 phage assem-
bly is presented in Figure 2.
As illustrated in the figure, the products of genes 5 and 8
assemble to form the prohead precursor structure, the earliest struc-
tural intermediate which can be seen in infected cells (King, et al.,
1973; Lenk, et al., 1975). Pulse-chase experiments using wild-type
infected cells indicated that the proheads were precursor particles
(King, et al., 1973). The prohead intermediates in the pulse-chase
experiments were indistinguishable from proheads accumulating in 2~
and 3- mutant infected cells. In fact, the proheads accumulating at
high temperatures in an infection using a reversible 3-ts mutant were
shown to be precursors to phage. After activation of gp3 by tempera-
ture downshift, radioactive label was transferred from the prohead
precursors into phage. Temperature shift experiments were also done
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(19a follows)
Figure 2
P22 Morphogenetic Pathway
This diagram shows the intermediate structures and gene
controlled steps in the assembly of infectious bacteriophage P22
particles. Gene products are designated 'gp' followed by the
number of the gene. The major coat protein gp5 polymerizes with
the scaffolding protein gp8 and four minor protein species to
form the precursor prohead. With the function of the gene 2 and 3
products, the prohead encapsidates a headful of DNA from the
replicating concatemeric DNA (Tye, Huberman, and Botstein,1974).
All of the gene 8 product exits in this process and then recycles.
Three gene products add to the unstable newly filled heads converting
them to stable mature heads. In the absence of these steps the
bracketed particle loses its DNA, yielding empty heads (not shown).
Also not shown are the aberrant spiral and shell structures which
form when the scaffolding protein is removed by mutation. The
molecular weights shown are for the single polypeptide chains.
The active form of some of the precursor proteins may be as multimers.
This figure summarizes results from Botstein, Waddell and King(1973),
King, Lenk, and Botstein (1973), King and Casjens (1974), and Poteete
and King (1977).
functions DNA
gp2, gp3
gplO
Ap gp26 W gp99P54g T T
gp 1, gp16, 9p2 gpp8
gp8 -
MAJOR (2
6 . . .. . . . . . . . . . . .55,0 q p9 76,0002 p2. gp?6 23,000
gpl 9 . . . . ... gpl 94,000
.pI6 . gpl6... .....gpI6..... gp l6 67,000
MINOR p2. . gp20 ...... gp20.. . .. gp20 50,000
p7 .... ..... ........... gp 7 - --.-.-.-. gp7. - - gp 7 18,000
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using 2~ and 3- ts mutants (Lenk, et al., 1975). In these experiments,
the production of phage from proheads accumulated at high temperature
was assayed by electron microscopic examination of ultra thin sections
of infected cells at various times after temperature downshift. With
time after the temperature shift, in concert with increasing viable
phage titer, the proheads were converted to DNA-filled particles.
With the recent development of an in vitro DNA packaging system in
P22 (V. Jarvik, S. Gottesman, and D. Botstein; A. Poteete and D.
Botstein, manuscript in preparation) it has been possible to test
the precursor nature of the prohead particles directly. In agreement
with the earlier in vivo results, wild-type, 2~ and 3~ proheads have
been shown to be head donors in a cell-free DNA packaging system.
Proheads from a 1~ infection, though morphologically normal, are in-
active. The gene 1 protein is present in proheads from wild-type in-
fected cells, and in the proheads accumulating in 2-13~ infected cells.
As indicated in Figure 1, three minor proteins are also present
in proheads, gp7, gpl6, and gp20. These proteins, though assembled
early, are not required for the assembly of morphologically normal
phage particles; however, these phage-like particles are non-infectious.
The proteins probably function in DNA injection during the subsequent
infection cycle (Hoffman and Levine, 1975; Poteete and King, 1977;
R. Griffin Shea, unpublished experiments).
The P22 prohead precursor shell loses its scaffolding protein
prior to, or during, the packaging of DNA. Unlike the other phages dis-
cussed, the scaffolding protein is released uncleaved from the particle
(King and Casjens, 1974). In fact, the scaffolding protein is re-
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cycled and used in multiple rounds of prohead assembly.
Thus it operates catalytically in prohead assembly within the
cell even though the prohead can be isolated as a stable structure.
The products of gene 1, 2, and 3, are required for DNA packaging,
though their functions in this process are not well understood
(Botstein, et al., 1973; King, et al., 1973). Given that proheads
are precursors to DNA encapsulation and cutting, the products of
genes 1, 2, and 3, must mediate this process because lysates de-
fective in these genes accumulate proheads and uncut DNA. The
product of gene 1 is a structural component of proheads, empty
heads and phage, although, as noted above, inactive proheads, are
formed in its absence. The product of gene 2 is not associated with
any of the particles in phage-infected cells. Very little is known
about its role in DNA packaging; however, DNA packaging in vitro is
gp2-dependent and purification of the protein is underway using DNA
(A. Poteete, personal communication),
packaging activity as an assay, The product of gene 3 is variably
found associated with empty heads and phage (unpublished experiments).
There is some indication that gp3 may be directly involved in DNA
cleavage. There is slow solubilization of the concatemeric DNA
which accumulates in 5-, 8-, 1- and 2- infections, but not in 3~ in-
fections (Botstein, et al., 1973). In addition, Raj and co-workers
(1975) have found that phage mutants giving high frequencies of
generalized transducing particles map in gene 3, supporting this idea.
Continuing along the pathway, once DNA has been incorporated into
the particle, it remains stably packaged only after the action of the
products of genes 4, 10, and 26. Electron microscopic observation of
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negatively stained preparations of particles from 4-, 10-, and 26~
mutant infections show that the heads are the size and shape of
phage particles but they are empty (Botstein, et al., 1973); how-
ever, examination of ultrathin sections of cells infected with
these mutants show that a substantial number of particles are filled
with DNA inside the cell (Lenk, et al., 1975; Poteete and King, 1977).
Thus, the empty heads derived from 4-, 10-, and 26- infections were
derived from particles initially full of DNA, but the DNA was sub-
stantially lost after cell lysis. The products of genes 4, 10, and
26 are not required for the cutting of the DNA (Botstein, et al.,
1973; Poteete and King, 1977). The products of all three genes
appear to be structural components of the phage, although gplO is
hard to detect because the gplO band is obscured by the coat protein
band in SDS-gels (King, et al., 1976). Empty heads lack scaffolding
protein (King, et al., 1973). The unstably packaged heads that
accumulate in 4-, 10- and 26- infections can be rescued to a limited
extent by in vitro complementation with an extract containing these
gene products (Botstein, et al., 1973; Poteete and King, 1977). The
empty heads in a 26~ infection often show tails; 4~ and 10- empty
heads do not show tails.
Once DNA has been stably packaged, the particles show a distinct,
short, cylindrical neck structure with a single fiber projecting from
it (Yamamoto and Anderson, 1961; Botstein, et al., 1973). It is
possible that the products of genes 4 or 10 and possibly 26, are
situated in the neck region. Full heads showing this neck and fiber
structure accumulate in cells infected with mutants of gene 9, the
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tail protein cistron. They are stable and very similar to complete
phage particles, except that they lack the gene 9 baseplate protein.
The last step in P22 morphogenesis is the addition of this protein to
the phage head (Israel et al., 1967). When tail parts are limiting,
only about 3 tail parts/phage are required to form an infectious
particle (Israel et al., 1967). In addition to its structural role in
forming the P22 baseplate, the product of gene 9 also has enzymatic
activity. It acts as a specific endoglycosidase (Israel et al., 1972)
in cleaving the 0-antigen, an important constituent of the outer mem-
brane of gram-negative organisms (Wright and Kanegasaki, 1971; Iwashita
and Kanegasaki, 1975; Takeda et al., 1975), and this process has been
implicated in adsorption of the bacteriophage to the host cell (McConnell,
1976). Iwashita and Kanegasaki (1976) have purified P22 baseplate pro-
tein using its glycosidase activity as an assay. Recently, P. Berget
and A. Poteete have purified the product of gene 9 of phage P22 using
its tailing activity as an assay (unpublished experiments). Prepara-
tions of this material were used in the experiments of Chapters I and
II.
As regards DNA maturation during head assembly, Botstein and co-
workers (1973) showed that uncut, concatemeric DNA accumulated in cells
infected with mutants blocked at or before the prohead assembly step.
This includes 1-, 2-, 3~, 5~, and 8~ lysates. Therefore, the cutting
of the DNA apparently requires that head assembly proceed to the point
of encapsulation of the DNA. The actual entry of the DNA into the pre-
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cursor shells is probably coupled to the exit of the scaffolding pro-
tein since all phage structures containing DNA, or which have con-
tained DNA at some point in their history, lack the scaffolding pro-
tein (Casjens and King, 1974). P22 solves the problem of head
assembly in a unique way. The scaffolding protein is released un-
cleaved from the precursor shell and is then re-used in several
subsequent prohead assembly reactions. This was shown by pulse-
chase experiments in which the radioactivity in labeled coat protein
molecules chased out of the proheads, out of empty heads, and into
phage. On the other hand the amount of radioactive scaffolding pro-
tein in proheads did not decrease during the chase (Casjens and King,
1974; King and Casjens, 1974).
The recycling of the scaffolding protein means that it must be
released functionally unaltered from the prohead precursor shell.
Thus, the disposition of the scaffolding protein is of a very different
nature than that of the disposable assembly core proteins which are
proteolytically processed in T4 and ) head morphogenesis. We might
ask, then, how the coat protein and the scaffolding protein interact,
both during assembly and in the prohead structure. I will discuss
in some detail the states of these proteins in 5~ and 8~ lysates as
these lysates have been used extensively in experiments throughout
this thesis.
Proper shell formation by coat protein subunits is entirely
dependent upon their association with the scaffolding protein (King,
et al., 1973). Cells infected with amber mutants in gene 8 synthesize
substantial amounts of gp5 coat protein but it cannot assemble
efficiently into closed shells. Instead, three major types of coat
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protein aggregates form slowly: spherical shells of the diameter of
proheads; smaller spherical shells approximately 2/3 the prohead
diameter; and spiral structures, which look as though one edge of
the growing shell has missed the opposite edge and continued poly-
merizing (Lenk, et al., 1975). Tubular forms of P22 have never
been observed suggesting that the coat protein itself has considerable
form-determining specificity (King, et al., 1973). Low-speed centri-
fugation of radioactively labelled 8~ lysates indicates that about
one-half of the coat protein present in an 8~ lysate associates with
the membrane fraction.
What about the scaffolding protein? Does it show a tendency
to form a shell in the absence of the coat protein? Apparently not.
Electron microscopic studies examining either negatively stained 5~
infected cell lysates (King, et al., 1973) or ultra thin sections
of 5~ infected cells (Lenk, et al., 1975) have failed to reveal
any kind of particles in these cells. Sucrose gradient analysis of
labelled 5~ infected cell extracts similarly fail to show any large
aggregates of gp8 (Casjens and King, 1974). Therefore, it appears
that the scaffolding protein must be activated for assembly by
interaction with the coat protein. A mechanism for head assembly
consistent with these observations is the formation of an initial
complex between coat protein and scaffolding protein, and their sub-
sequent co-polymerization.
It is not clear to what extent the scaffolding protein and the
coat protein subunits continue to interact with one another in the
prohead. Although the preceding data suggest that the scaffolding
protein itself has little tendency to form a shell, several indepen-
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dent experiments investigating the fine structure of proheads
suggest that, in association with the coat protein, gp8 forms a
shell within the outer gp5-containing shell. Negatively stained
proheads appear as spherical structures with scalloped edges con-
taining organized internal material (Botstein, et al., 1973). The
images of proheads in thin sections also suggest the presence of an
inner ball or shell (Lenk, et al., 1975). Conditions were found in
which treatment of the proheads with detergent released the internal
core material. The resultant empty shells were composed entirely of
gp5, the coat protein. All of the gp8 was solubilized by this treat-
ment, indicating that it inight form the inner shell (Casiens
and King, 1974). The structure of proheads was also studied using
low angle X-ray diffraction of particles in solution (Earnshaw, et
al., 1976). These studies show that proheads have a smaller radius
than phage and contain considerable density at an inner radius. The
simplest model to account for these observations is one in which the
gp8 forms a thick shell within the outer coat protein shell. As ex-
pected, X-ray analysis also shows that treatment of the proheads with
SDS detergent, which releases gp8, causes the loss of the inner material.
In addition, the scattering experiments yielded information on the pack-
ing of the coat subunits in proheads and phage. Results indicate that
there is no gross reorganization of the coat subunits; rather the whole
lattice is expanded by about 10% during maturation.
Thus, the electron micrscopic and X-ray evidence suggest that the
bulk of the scaffolding protein is on the inside of the head. Analysis
of the protein composition of proheads indicates that there are about
250 molecules of scaffolding protein for every 420 molecules of the
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coat protein. Of course, this poses the problem of how 250 molecules
of a protein of 42,000 daltons molecular weight get out of the pro-
head during phage assembly. This question is specifically addressed
in the experiments of Chapter III. The experiments presented in this
thesis are based on the generation of antibodies directed against the
genetically defined P22 antigens. Such a combination of immunology
and genetics can be very powerful in the elucidation of fine struc-
ture. In 1965, Edgar and Lielausis developed a method to examine the
role of various gene products in the synthesis of phage T4 antigens.
Crude amber mutant lysates, which generally lack the product of a single
gene, were tested for their ability to block the phage-neutralizing
activity of anti-T4 phage serum. In the phage system, the titering of
plaque-forming units is a very sensitive method for the detection of
infectious particles. Thus, the methodology that they developed in
the serum blocking experiments provided a very sensitive assay for the
genetic identification of the phage target antigens of the neutralizing
antibodies. The rationale of this approach and a set of theroretical
serum blocking curves are presented in section of Materials and Methods.
(This section should be read before considering the experimental results
of serum blocking experiments using anti-P22 sera, which are presented
in Chapter I).
In 1970, Yanagida and Ahmad-Zadeh extended the combined genetic
and immunological approach to the localization of gene products on the
phage structure. In these experiments,absorption of the serum with
crude amber mutant lysates was used to generate monospecific sera.
These sera were then incubated with phage or phage precursor structures,
and the particles were examined for visible antibody binding in the
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electron microscope. In this procedure, the binding of antibodies
directed against known phage proteins to specific sites on the phage
localize the gene product to that position on the structure. In
later experiments, Yanagida (1972) fully characterized the anti-T4
sera he obtained by the technique of immunoelectrophoresis. In
specifying the total phage-specific antibody composition of the
serum, Yanagida was able to interpret the absence of binding by a
component antibody class, as evidence that the target antigen was
not exposed on the particle suface. I utilize similar experimental
approaches in Chapters II and III to analyze the antigenic structure
of bacteriophage P22.
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MATERIALS AND METHODS
(a) Bacterial Strains
Bacterial host strains for P22 phage are from the collection of
D. Botstein and are derivatives of Salmonella typhimurium LT2. Strain
DB7004 is permissive for amber mutants and was used for plating and
stock-making. Strain DB7000 was used as the restrictive host for
amber mutants and was used to make non-permissive amber mutant ly-
sates. These strains are described in Susskind, et al. (1974).
(b) Phage Strains
The P22 phage mutants are from the collection of D. Botstein
and have been described previously (Botstein, et al., 1972, 1973;
Poteete and King, 1977). Representative amber alleles for each gene
were as follows: gene 1, amNlO; gene 2, amH200; gene 3, amN6; gene 5,
amNll4; gene 8, amH202, amH1348, amN123; gene 9, amN108, amH1014,
amE1017, amN110; gene 10, amN107; gene 13, amHlOl; gene 16, amN121;
gene 20, amN20; gene 26, amH204; and gene 7, amH1375.
Each phage strain also contains the clear plaque mutation cl7 to
ensure entry into the lytic growth cycle upon infection, except for
amH104 (gene 9), which carries the clear plaque mutation c25 . In gen-
eral, the experiments were done with double amber mutants which contain,
in addition to the allele of interest, an amber mutation in gene 13,
amHlOl. Absence of the gene 13 product prevents natural cell lysis
(though the cell contains lysozyme, the gene 19 product) and phage pro-
duction continues past the normal lysis time. After shaking with chloroform
(CHCl3 ), 13~ infected cells lyse rapidly releasing a large burst of phage
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or phage proteins.
When recombinant phage strains were constructed (Botstein, et
al., 1973) each allele in a multiply marked recombinant was checked
by recombination or spot complementation against strains carrying the
parental allele.
(c) Preparation of Phage Stocks
Phage stocks were prepared by the following methods: plate stock
method - 2 x 105 phage were mixed in soft top agar with approximately
2 x 107 DB7004 (su+) bacteria and were spread on an LB agar plate. The
plate was incubated at 300C for 7-9 hours, and the soft top agar was
then removed from the plate and suspended in several ml of DF. Agar
and bacterial debris were removed by centrifugation at 6900 x g for
twenty minutes. Liquid stock method - A single plaque was suspended
in 25 ml of LB broth to which 0.5 ml of an overnight bacterial culture
of DB7004 was added. The infected culture was aerated vigorously at 250C
for 6-8 hours. Bacterial debris was removed by centrifugation at 6900 x
g for ten minutes, and the phage were pelleted by centrifugation at
35,000 x g for 90 minutes and resuspended in 2 ml buffered saline. In
experiments requiring large numbers of particles, secondary phage stocks
were used to infect large volumes of cells. These stocks were pre-
pared by growing I liter of DB7004 cells to about 2-4 x 108 cells/ml in
LB. Phage stocks prepared by either of the above two methods were used
to infect the cells at a multiplicity of about 7 phage/cell. The in-
fected cells were aerated vigorously at 370C until lysis (1-2 hours).
Chloroform was added and the cells were incubated on ice for several
minutes. Bacterial debris was removed by centrifuging the suspension
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at 6900 x g for 20 minutes. The supernatant fraction was decanted
for use as a secondary phage stock.
(d) Media and Chemicals
LB broth (Kikuchi and King, 1975) was used for growing bacteria
and phage stocks. LB bottom and soft agar (Adams, 1959) were used
for plating. Dilution fluid (DF) contains 1 g trypton (Difco) and
7 g NaCl per liter. Minimal medium for radioactive labeling experi-
ments was made up from a filtered solution containing per liter:
5.8 g Na2HPO4 ; 3.0 g KH2PO4; 0.24 g MgSO 4 ; 1.0 g NH4Cl; and 0.5 g
NaCl. The solution also contained 50,ug/ml leucine which is required
for growth of the auxotrophic strain, DB7000, used in these experiments.
A freshly prepared 40% (w/v) glucose solution, also filtered, was
diluted 1:100 into the minimal medium just prior to use. Buffered
saline (BS) is described by Chan and Botstein (1972). Stock TM buffer
is IM Trizma base (reagent grade, Sigma Chemical Co.) and 10-1 M MgSO4
brought to pH 7.5 with HCl acid. This is diluted 1:100 for use as TM
buffer. Immuno buffer is made by a 1:50 dilution of stock TM into
0.85% NaCl. High resolution buffer (Gelman Instrument Co., No. 51104)
at pH 8.8 was used as running buffer in immunoelectrophoresis experi-
ments. Agarose (Electrophoresis grade) was obtained from Sigma Chemical
Co. A 1% agarose solution, made up in 1:4 diluted high resolution
buffer, was used as the gel matrix in immunoelectrophoresis.
Crystalline bovine pancratic DNase I, DN-Cl, was obtained from
Sigma Chemical Co. CHC13, A.C.S. grade was obtained from Fisher
Scientific Co. Sodium azide was obtained from J.T. Baker Chemical Co.
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Naphthol blue black (Amido Black 1OB; Buffalo Black NBR), used for
staining immunoprecipitates in immunoelectrophoresis ,was obtained
from Sigma Chemical Co. Antifoam A emulsion, from Sigma Chemical
Co., was used to prevent foaming in lysate preparations involving I
liter or more of cell cultures. 14C-labeled amino acids mixture
(0.1 mCi/ml) was obtained from New England Nuclear Corporation
(NEC-445). Complete Freund's adjuvant was obtained from Difco
Laboratories. Reagents for polyacrylamide gel electrophoresis were
as described in Kikucki and King (1975).
(e) Preparation of Rabbit Antiserum
Hyperimmune sera, termed anti-phage, anti-prohead and anti-head
serum, were obtained by injection of P22 phage, prohead and tail- head
structures, respectively, into white, virgin female New Zealand
rabbits. Immunogens at approximately 1013 particles/ml were emulsi-
fied with an equal volume of complete Freund's adjuvant. A volume
of 0.5 ml of the emulsion was injected between the toes into each foot-
pad and subcutaneously into the back, a total of 2.5 ml of each pre-
paration per rabbit. In general, the rabbits were bled from the ear
vein for three consecutive days, approximately every three weeks, as
outlined in the accompanying table. The volume of blood withdrawn
over a three day period was approximately 120 ml.
The rabbit which produced the anti-head serum was approximately
six months old. The rabbits which produced anti-phage serum and anti-
prohead serum had been injected previously at least once the year be-
fore with P22 phage and proheads, respectively, by S. Casjens. In this
previous procedure, approximately 5 x 1011 particles in buffer were in-
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TABLE 2
INJECTION AND BLEEDING SCHEDULE
Injection Bleeding Antiserum Pool
Designation
1974 1975
12/30 1/13 - 1/15 1
2/3 - 2/5 4
2/24 - 2/26 7
3/17 - 3/19 8
6/9 - 6/11 9
7/29 - 7/31 12
1976 1976
3/9 3/30 - 4/1 14
4/23 - 4/25 15
5/17 - 5/19 16
6/14 - 6/16 17
m
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jected subcutaneously into the back 2-3 times a week for three weeks.
After a period of three weeks or more, 5 x 1011 particles were again
injected subcutaneously.
(f) Preparation of Immunogens (In collaboration with W. Earnshaw)
(i) Prohead Preparation for First Injection
An overnight culture of DB7000 (su~) cells was diluted 100-
fold into 12 liters of LB broth and grown with vigorous aeration at
370C to approximately 2 x 108 cells/ml. Three hundred ml of 2~13~
phage in LB at 10 phage/ml were added to give a multiplicity of
about 10 phage/cell. Cells infected with mutants defective in gene
2 are blocked in DNA packaging; proheads are the only class of parti-
cles accumulating in these cells. The infected cells were harvested
three hours later by continuous centrifugation in a refrigerated
Sharples centrifuge. The cell pellet was resuspended in approxi-
mately 15-30 ml TM buffer. Several drops of CHCl3 were added and
the solution vortexed vigorously. Cell lysis was evidenced by the
extreme viscosity of the chloroformed mixture. A total of 1.5 mg
DNase I was added and the solution was vortexed and kept on ice until
the viscosity was significantly reduced. Cell debris was removed by
centrifugation at 6900 x g for 15 minutes.
The supernatant fractions were pooled and layered onto 15 ml
of 15% sucrose over a CsCl shelf ( = 1.6 gm/ml) of 1.5 ml and centri-
fuged in an SW 27.1 rotor at 25,000 rev/min for 4 hours at 200C. An
opaque band was collected from the shelf and dialysed overnight
against TM buffer.
This material was centrifuged through a 15 ml 10-30% sucrose
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gradient over al.5 ml CsCl shelf (f = 1.6 gm/ml) at 25,000 rev/min
for 2.5 hours at 150C in an SW 27.1 rotor. A clear blue diffuse band
above the CsCl shelf was collected and dialysed overnight against TM
buffer. This solution contained approximately 1013 proheads as
roughly determined by electron microscopy. The prohead preparation is
shown in Figure 3.
(ii) Phage and Tail- Head Preparation for First Injection
Two aliquots of an overnight culture of DB7000 (su~) cells
were diluted 100-fold into each of two 12 liter batches of LB, and
grown with vigorous aeration to 2 x 108 cells/ml at 370C. To one
culture, 300 ml of wild-type 13~ phage at 8 x 1010 phage/ml were
added (moi = 10); to the other, 270 ml of 9-13~ phage at 1011 phage/
ml (moi = 12). Cells infected with mutants of gene 9 accumulate com-
plete phage heads, lacking only the gene 9 tail protein. The infec-
tions continued for 3 hours and 15 minutes.
The infected cells were pelleted by Sharples continuous centri-
fugation, first the 9~13~ preparation, and then the wild-type 13~ in-
fected cells. The pellets were resuspended in 15-30 ml of TM buffer.
The cells were lysed with several drops of CHCl3 added with vigorous
vortexing. A total of 0.75 mg of DNase I was added and the mixture
stood on ice, with intermittent vortexing, for several minutes.
The preparations remained somewhat viscous and the material was
centrifuged several times at 6900 x g for 20 minutes. The accumulated
pellets were re-extracted 4 times. Several aliquots ofl.5 ml each of
the pooled supernatant fractions were layered on top of15 ml of 30%
sucrose with al.5ml CsCl shelf ( e= 1.6 gm/ml).
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Figure 3
Proheads Purified from Cells Infected with an Amber
Mutant Defective in Gene 2
The proheads were purified as described in section f, i.
Since these particles were isolated by sucrose gradient
centrifugation, without a density fractionation, they are con-
taminated with higher levels of host material than were the DNA-
containing particles. The arrow points to a phage ghost, pre-
sumbly from the infecting phage used to prepare the infected
cells from which the proheads were purified. These represented
about 1% (3/283) of the particles seen in electron micrographs
of this preparation. Another arrow points to what appears to
be an isolated tail structure, probably the result of the
breakdown of a phage ghost.
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These were centrifuged at 25,000 rev/min for 2.5 hours at 150C
in an SW 27.1 rotor. A very sharp bluish-white band appeared in the
area of the CsCl shelf from both the wild-type 13~ and 9~13~ super-
natant materials. These bands were collected, and in the case of
wild-type 13~ phage, titered. The concentration of wild-type 13- phage
in the pooled bands was 2 x 1014 phage/ml. The solutions from the
bands were dialysed overnight against TM buffer. Electron microscopic
examination showed both wild-type 13- phage and 9~13~ head preparations
to be free of large contaminating material as shown in Figures 4 and 5,
respectively, and to be in the approximate concentration range of 1014
particles/ml. These solutions were diluted 1:10 in BS before emulsi-
fication with Freund's adjuvant for use as immunogens.
(iii) Particles for Second Injection
Sucrose gradient purified proheads at approximately 1013 particles/
ml were provided by W. Earnshaw. The tail~ heads were from the original
preparation described above. The solution had been stored at 40C in
azide for several months. The material was dialysed overnight against
two changes of 3000 volumes of TM buffer. A 1:10 dilution of this
material served as the immunogen. Wild-type 13~ phage, which had been
purified through a CsCl gradient were provided by Dr. P. Berget. These
were diluted in TM buffer to 1013 phage/ml.
(g) Neutralization Curves
Wild-type c,7 phage were diluted in LB to 2 x 108 phage/ml. For
the first neutralization experiment, anti-phage, anti-prohead, and anti-
head serum were all diluted 500-fold in LB. In the second neutraliza-
tion experiment, anti-phage and anti-prohead serum were diluted in LB
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Figure 4
Phage Particles Used for Preparation of Anti-phage Serum
The particles were prepared as described in section
f, ii.
ICM
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Figure 5
Tail-less Heads Purified from Cells Infected with an
Amber Mutant of Gene 9
These particles were prepared as described in section
f, ii. A small neck structure and protruding fiber can be
seen on some of the particles. A contaminating prohead can
be seen in the field. These represented about 6% (24/400)
of the particles seen in the electron micrographs of this pre-
paration.
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to a k value of 0.1 min~1. The phage and antiserum dilutions were
warmed to 370C prior to mixing. Incubations were started by mixing
2 ml of the phage solution with 2 ml of the appropriate antiserum.
An LB broth control, containing no anti-serum was also mixed with
phage to measure phage stability over the reaction period. The
phage titer remaining after incubation with the antiserum was
measured every 5-10 minutes. The initial rate of inactivation (k)
POwas calculated according to the equation P_= e-kt, p0
equals the initial phage titer, P represents the surviving phage,
and t equals time. The reactions were stopped by 100-fold dilution
into DF.
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(h) Serum Blocking Experiments
(i) Protocol I
1. Lysate Preparation
The lysates were prepared by infecting DB7000 (su~) cells
at 2 x 108 cells/ml in LB broth with phage at multiplicities of 10
phage/cell. The infected cells were incubated with vigorous aeration
for 2 1/2 hours at 370C, lysed with chloroform, and diluted in broth
for use as lysate samples.
2. Serum Blocking Procedure
Two-fold serial dilutions of the lysates were made in
broth in volumes large enough for use in several experiments. The
antisera were diluted so as to kill 95% of the tester phage in 2 hours
if no blocking of the serum occurred. In the serum blocking assay, one
ml of diluted lysate was mixed with one ml of antiserum at the approp-
riate dilution and the mixture was incubated overnight at 48 0C. To
assay the neutralizing antibody remaining after absorption, tester phage
were added to a final concentration of about 107 phage/ml in the mixture.
The samples were incubated for a further two hours at 480C and titered
to measure survival of the tester phage. In each experiment, controls
were included to determine the amount of tester phage added, the k value
of the unabsorbed serum, and the effect of lysate alone on the phage.
The results of the serum blocking assay are presented as percentage
serum blocked (1-kfinal/kinitial) calculated as described by Edgar
and Lielausis (1965).
(ii) Protocol II
1. Lysate Preparation
DB7000 cells were grown to 2 x 108 cells/ml in LB broth at
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300C and infected with phage at a multiplicity of 5 phage/cell. The
infected cells were incubated with vigorous aeration at 300C for 1
hour. At that time they were concentrated 10-fold, and lysed by
shaking with chloroform. The resulting lysate was centrifuged at
10,000 rev/min for 10 minutes in the cold to remove large debris and
unlysed cells. The resulting supernatant fraction served as the lysate
sample for serum blocking experiments.
2. Serum Blocking Procedure
The protocol was as described above except that the temper-
ature of incubation was reduced to 470C and the serum was used at a
slightly higher k (0.04 min-1 ) to yield a surviving phage fraction of
about 1% after a 2 hour incubation.
(iii) Preparation of Purified Particles
1. Preparation of Wild-type 13~, 9~13~ and 2~13~ Lysates
DB7000 (su-) cells were grown to 6 x 108 cells/ml in one
liter of LB broth at 370C. The cells were infected with 500 ml of
phage solution containing 4.5 x 1012 total phage to give a final
multiplicity of about 10 phage/cell. The infected cells were in-
cubated with vigorous aeration at 370C for 2 1/2 hours. The cells
were centrifuged at 7500 rev/min for 20 minutes and resuspended in
approximately 15 ml of TM buffer plus 50 Mg/ml DNase. Chloroform
was added to lyse the cells and the mixture was incubated at 40C for
1/2 hour before being frozen at -800C. The burst size of the wild-
type lysate before concentration was 750 phage/input cell.
2. Particle Purification
The frozen lysate samples were passed through several cycles of
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cooling and warming to promote cell lysis. A small aliquot of CHC13
was added during this procedure as well. The extract was centri-
fuged at 8000 rev/min in a Sorvall SS-34 rotor for 20 minutes. The
supernatant fraction was decanted and clarified by centrifugation as
above.
(a) Purification of Wild-type Particles and Tail- Heads
The supernatant fractions from the wild-type and tail- lysates
were centrifuged at 15,000 rev/min in a Sorvall SS-34 rotor for 80
minutes to pellet phage and tail~ heads. The particles were resus-
pended in approximately 12 ml of TM buffer and applied in 2 ml ali-
quots to a CsCl step gradient containing 1 ml of CsCl at each of
three densities, 1.3, 1.5, and 1.7 gm/ml. The gradient was centri-
fuged at 45,000 rev/min at 150C for 30 minutes in a Beckman SW 50.1
rotor. The phage and head particles formed an opaque blue band at
a position about 2/3 of the distance to the bottom of the centrifuge
tube. These bands were collected by side puncture of the tube and
dialyzed in the same flask against two changes of 400 volumes of TM
buffer. The phage were titered and were found to be at a concen-
tration of 9.2 x 1013 phage/ml. The optical density of the tail- heads
was measured at 260 nm. Using a conversion factor equating 1 0.D. unit
to 5 x 1011 particles/ml, the concentration of the heads was 1.2 x 1014
heads/ml.
(b) Purification of the Proheads
Aliquots of 1.5-3.0 ml of the clarified 2~13~ lysate were layered
onto 12 ml of a 15-30% sucrose gradient over a shelf of 3 ml of 60%
M
47.
sucrose solution. All sucrose solutions were made in TM buffer. The
proheads were centrifuged at 25,000 rev/min for 2 1/2 hours at 150C.
The proheads formed a light blue band approximately half-way down the
centrifuge tube. The proheads were collected from the gradient by
side puncture and dialyzed against 2 changes of 200 volumes of TM
buffer. By SDS-gel analysis, the proheads were at a concentration of
approximately 2.5 x 1013 proheads/ml).
(c) In Vitro Constitution of Phage Particles and Their
Puri fi cation
In the in vitro constitution of phage, 1.5 ml of purified P22
heads in TM buffer at a concentration of 1.2 x 1014 heads/ml were
added to 0.6 ml of a solution of purified gp9 containing 6 x 1014 phage
equivalent units of tails. This mixture contains about a 3-fold excess
of tails. The mixture was incubated for 1 hour at 370C. The mixture was
diluted with an equal volume of TM buffer and an aliquot of 0.1 ml was
removed for titering. The remainder of the solution was layered onto
two CsC1 gradients and purified as were the phage and head particles in
section a. The titer of the 1:2 dilution of the reaction mixture was
6.1 x 1013 phage/ml, one-half the concentration of the tail- heads used
in the reaction. The titer of the in vitro phage after dialysis was
1.1 x 1014 phage/ml.
(iv) Antiserum Preparation
All of the antisera used in the serum blocking experiments were
from the earliest pool of bleedings (Series 1), and were not absorbed
with Salmonella.
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(v) Tailing Assay
The tailing activity of lysates used in serum blocking experi-
ments was measured. The source of heads was gp9 particles, prepared
and purified as described in the preceding sections, h (iii) 1 and h
(iii) 2a. The lysates were prepared as in Section h, Protocol II,
and included wild-type 13~, 5-13~, and 2~13~ lysates. For the tailing
assay, the lysates were centrifuged at 15,000 rev/min in a Sorvall SS-34
rotor for 90 minutes to remove endogenous phage which would contribute
to the titer derived from phage produced specifically after tail addition;
these lysates were not centrifuged prior to their use in the serum block-
ing experiments. Purified gp9 (P. Berget and A. Poteete, unpublished
experiments) at a concentration of 1 x 10l phage equivalents/ml in LB
was included as a positive control. The samples to be assayed for tail
donor activity were diluted through eight 3-fold serial dilutions. For
the first point in each assay, an aliquot of 0.5 ml of the tail donor,
undiluted, was mixed with 1.0 ml of the purified heads at a concentra-
tion of 3 x 1010 phage equivalents/ml in LB. For the remainder of the
points, one ml of each serial 3-fold dilution of the tail donors was
mixed with 2 ml purified head preparation. The reaction mixes were in-
cubated for one hour at 370C and then put on ice. The number of phage
formed in vitro was titered.
The number of phage equivalents of tails present in each tail
donor was estimated according to the procedure of Israel, et al.,(1967).
The logarithm of the phage titer at each tail donor dilution was
plotted against the logarithm of the corresponding dilution. As long
as tails are in excess, the number of plaque-forming units/ml remains
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constant, and the curve maintains a plateau level. Eventually,
dilution reduces the number of tails to equivalence with the number
of heads present in the reaction mix. With increasing donor dilutions,
the log of the phage titer drops abruptly, with a slope of 3.3 accord-
ing to Israel, et al Therefore, a line having a slope of 3.3 was
fitted to the data points. For each tail donor, the number of phage
equivalents of tails added was equated to the number of heads at
the equivalence points where the break in the curve occurred. The
number of phage equivalents of tails present in the undiluted sample
was calculated from this value.
(vi) Theoretical Serum Blocking Curves
Serum blocking curves provide a basis for determining whether
a lysate contains, relative to a control lysate, smaller (or greater)
quantities of an antigen, fewer (or more) species of an antigen, or
"altered" antigens. Theoretical serum blocking curves illustrating
these possibilities are presented in Diagram 1. Curve A is produced
by control lysates. At low dilutions of lysate, all phage-neutralizing
antibodies are removed by the targets present in the lysate. As the
lysate is diluted, the number of target sites is reduced below that
concentration necessary to saturate the antibodies, and the level of
serum blocking falls. The percentage serum blocked decreases mono-
tonically with increasing lysate dilution until finally, no serum
blocking is detected. Curve B is produced when all antigens are
present, but in concentrations greater than those present in control
lysates. For example, lysates which block 50% of the serum at 2-12
lysate dilution (4,096-fold dilute) contain target antigens in 4-fold
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greater concentration than lysates which block 50% of the serum at
2-10 dilution (1,024-fold dilute). Therefore, differences in the
concentrations of serum blocking antigens generate horizontal dis-
placements of the curves. Curve C is produced by lysates which lack
all target antigens, and therefore, cannot block any portion of the
antiserum. Curve D is produced by lysates lacking a class of target
antigens against which 50% of the phage-neutralizing antibodies are
directed. Therefore, the vertical displacements of the curves reflect
differences in the antigenic composition of the lysates; that is, the
plateau levels of the curves define classes of target antigens which
are absent from the lysates. Curve E is produced by lysates which
contain "altered" antigens, but in which no classes of target antigens
are missing. Because these antigens are in some way altered, their
dilution results in a rate of decrease in serum blocking ability
different from that of the antigens in the control lysate. No such
class of lysates was found in these experiments; all serum blocking
curves showed similar shapes.
Experimental error in the data does not contribute equally to
the scatter in the points at both ends of the serum blocking curves.
At low dilutions of the lysates, experimental error is less significant.
For example, at 90% serum blocking levels, an error of 5% in the
determination of the residual phage-neutralizing activity of the serum
(k final/k initial) results in an uncertainty of + 0.5% in the percen-
tage serum blocked. At 10% serum blocking, the same error leads to an
uncertainty of + 4.5%. Therefore, there is generally more scatter in
the data points at low levels of serum blocking activity.
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(i) Immunoelectrophoresis Experiments
(i) Preparation of Antigens for Immunoelectrophoresis
The source of the antigens used in the immunoelectrophoresis
experiments are categorized in Table 3 according to batch numbers.
The detailed description of their preparation is as follows:
1. Preparation of Concentrated Lysates
All lysate batches for immunoelectrophoresis were prepared
in the same way. A 1/100 dilution of a DB7000 (su~) overnight was
grown in LB at 370C with aeration to 4 x 108 cells/ml and put on ice,
with the aeration continuing. Samples of P22 amber mutants contain-
ing 2 x 10l total phage were added to 100 ml LB medium and warmed
to 37 C. A volume of 100 ml of the DB7000 cell suspension was poured
into the warmed phage solution and the culture was aerated vigorously.
The infection was stopped at 120' by chilling the cells on ice with
aeration for approximately 15-30 minutes. The infected cells were
centrifuged at 3,000 x g for 11 minutes. The cell pellet was resus-
pended in 0.5 ml immuno-buffer, containing 2.5 mg/ml DNase I solution,
and frozen at -800C.
Before immunoelectrophoresis, the suspensions were thawed at
room temperature. Ten ml of DNase at 5 mg/ml was added to each extract
before electrophoresis. These extracts, approximately 100-fold con-
centrated, were frozen and thawed several times for use as antigen
preparations in immunoelectrophoresis.
2. Preparation of Purified Particles
(a) Phage and Tail~ heads
Batch 1: The phage and tail~ heads designated as Batch 1
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Table 3
Particles and Lysates Used as Antigens in
Immunoelectrophoresis Experiments
Figure Purified Componentsl Batch Lysates (13~1 Batch
17a-20a
20b
20c
21a
21b & c
22a
22b
23 a-c
24a
24b
25a
25b
(8/2/75)phage
proheads
gp9
6 x 1014 phage
equivalents
phage
gp9
phage
wild-type
5-
5 9-
2~
5~
5-9-
5~
8~-
5
5 ~9-
8~
5~
3~8~amH1348
3~8~amNi 23
3-8~iiiH202
5~
3~8~amH202
3~8~amH1348
3~8-amN123
8~
5-
5-9-
3~8~amH202
3-8-imH1348
3~8-amN123
wild-type
3~
(6/12/75)
2 (5/17/76)
2
1
1
2
2
2
2
2
2
2
(5/7/76)
8 (P. Berget
and A.
Poteete)
1
8
53.
Table 3 (Contd.)
Particles and Lysates Used as Antigens
in Immunoelectrophoresis Experiments
r P2Figure Purified Components Batch Lysates (13~) Batch
25c phage (7.7 x 10120/ml)
proheads
phage
spirals
phage
tail~ heads
phage
empty heads
1~16-20~ proheads
proheads
phage
tail~ heads
proheads
empty heads
5~
3~5~8~amN123
3~8~amNI23
3-5-
2
5 (7/12/76
lysates pre-
pared for
electron
microscopy
2 (5/12/76)
3 (provided
by W. Earn-
shaw)
2
4 (provided
by W. Earn-
shaw)
5 (from W.
Earnshaw)
6
7 (7/13/76)
1
1I1
26a
26b-c
27a
27b
28a
28b
29
30
31a-c
wild-type
8-amH202
8-amHl 348
8~amN123
wild-type
8-
3~
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Table 3 (Contd.)
Particles and Lysates Used as Antigens
in Immunoelectrophoresis Experiments
Purified Components 1 Batch Lysates(13~)
32a-f 8
wild-type I
Batch
Particle purification described in Materials and Methods, Section (i)
i. 2.
Lysate preparation described in Materials and Methods, Section (i)
i. 1.
Figure
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are from the immunogen preparation described in Materials and Methods,
Section (f), (ii). These particles were diluted 10-fold in TM buffer
and re-purified by centrifugation through a CsCl density step gradient.
Twelve ml of sample were layered over a gradient containing 1.6 ml
each of CsCl at densities of 1.7 gm/ml, and 1.5 gm/ml, and 2.8 ml of
CsCl at a density of 1.3 gm/ml. The gradients were centrifuged in a
Beckman SW27.1 rotor at 25,000 rev/min for 3 hours at 150C. Bluish-
colored bands appeared about 85% of the way down the tube. These
were collected by side puncture. The pooled purified phage and pooled
purified tail heads were dialyzed against two changes of 2,000 ml of
TM buffer.
Batch 2: Wild-type lysate preparation: An overnight culture
of DB7000 (su~) cells was diluted 100-fold into 1 liter of LB broth
at 390C and grown with vigorous aeration to 2 x 108 cells/ml. The
temperature was shifted to 370C prior to infection with a small volume
(approximately 5 ml) of wild-type phage calculated to give a multiplicity
of infection of 10 phage/cell. The infection continued for 2 hours with
vigorous aeration. The infected cell culture was aerated on ice for an
additional hour. The infected cells were pelleted by centrifugation in
the cold at 5,250 rev/min for 10 minutes in a Sorvall GSA rotor. The
pellets were resuspended in 5 ml cold TM buffer. DNase was added to a
concentration of 2 pg/ml. The resuspended cells were frozen at -800C
for several weeks.
The suspension was thawed at room temperature and then kept on
ice. DNase was added again at same concentration as above. Shortly
thereafter, 3 drops of CHCl3 was added and the sample was vortexed
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vigorously. This step was repeated. The lysate remained on ice for
an additional 10 minutes. Then, the material was centrifuged at
10,000 rev/min for 10 minutes. The initial separation was not too
good; some cellular material was decanted with the supernatant liquid.
The pellet was extracted a second time in the same manner as above.
The supernatant fractions were pooled and centrifuged again at 10,000
rev/min in a Sorvall SS-34 and the supernatant fraction was used as
the starting material in the purification procedure.
Phage purification: The supernatant fraction was applied in 2 ml
aliquots to a CsCl density step gradient containing 1 ml of CsCl at
each of three densities, 1.3, 1.5 and 1.7 gm/ml. The gradient was
centrifuged at 45,000 rev/min for 30 minutes at 150C in a Beckman SW 50.1
rotor. Bluish-white bands, approximately 2/3 to 3/5 of the distance
down the centrifuge tube, were collected by side puncture. The pooled
bands were dialyzed against two changes of 200 volumes of TM buffer.
The final, purified phage titer was 7.7 x 1012 phage/ml.
(b) Proheads
Batch 1: The proheads designated as Batch 1 are from the immunogen
preparation described in Materials and Methods, Section (f), (i). Ali-
quots of 4 ml of these proheads were re-purified through a sucrose
gradient containing steps of 7 ml each, ranging from 5% to 40% sucrose
in 5% increments. The gradients were centrifuged in a Beckman SW25
rotor at 22,000 rev/min for 4 hours at 150C. Bluish-colored bands,
approximately 3/4 of the distance down the centrifuge tube, were
collected by side puncture. The pooled material was dialyzed against
two changes of 200 volumes of TM buffer.
57.
Batch 6: The 1~16~20~ proheads used in these experiments
were prepared in collaboration with Dr. S. Casjens. Their prepara-
tion is described in W. Earnshaw, et al., 1976.
Batch 7: 2~13~ lysate preparation: An overnight culture of
DB7000 (su~) cells was diluted 100-fold into 1 liter of LB broth at
370C and grown with vigorous aeration to 3 x 108 cells/ml. A volume
of 280 ml of 2-13~ phage at 1012 phage/ml in pre-warmed LB were
added to give a multiplicity of 4 phage/input cell. The infection
proceeded for 2 hours at which time the infected cells were chilled
on ice with aeration for 10 minutes. The infected cells were
pelleted by centrifugation at 7,000 rev/min for 10 minutes in a
Sorvall GSA rotor. The pellets were resuspended in TM buffer.
DNase was added to a concentration of 25 Ag/ml. The final volume
of the cell suspension was 10.7 ml, so that the cells were about 100-
fold concentrated. The concentrate was frozen at -800C.
Prohead Purification: The frozen cell suspension was thawed
at room temperature and then kept on ice. Six drops of CHCl3 were
added with vortexing. The lysate was incubated on ice for 10
minutes before centrifugation at 10,000 rev/min for 10 minutes in a
Sorvall SS-34 rotor. The supernatant fraction was decanted and centri-
fuged again as above. This material was layered in 1 ml aliquots on
top of 17 ml of a 15-30% sucrose gradient and centrifuged at 25,000
rev/min for 2 1/2 hours in an SW 27.1 rotor. Bluish bands, approxi-
mately half-way down the tube were collected by side puncture. The
pooled bands were dialyzed against two changes of 200 volumes of TM
buffer.
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(ii) Preparation of Antisera for Immunoelectrophoresis
1. Absorption with Uninfected Salmonella Cells
The antisera used in the immunoelectrophoresis experiments
were absorbed with whole, uninfected Salmonella typhimurium to remove
anti-Salmonella antibodies. The cells were concentrated 200-fold
prior to mixing with the sera; then, the mixtures were incubated over-
night in the cold, followed by centrifugation at speeds of 8,000 -
10,000 rev/min for 10-15 minutes. This centrifugation removes not
only immune precipitate which has formed, but also any unreacted
bacterial cells which pellet at these speeds. The clarified super-
natant fractions were used as antiserum samples and are referred to
as "whole" antisera. The dilutions of the sera during absorption
were negligible.
In general, Salmonella absorption removed 3-4 precipitin arcs
from the immunoelectrophoretic patterns of P22 lysates.
2. Preparation of Partially Purified Anti-prohead Serum
Anti-prohead serum from series 15 was partially purified
and concentrated two-fold by ammonium sulfate precipitation (0-40%
saturation at 00C). Portions of the solid ammonium sulfate (from
Schwartz/Mann Co.) were added to 65 ml of the serum at intervals with
constant stirring over a 15-20 minute time period. After addition of
the ammonium sulfate was complete, the mixture was stirred in the cold
(00C) for 1 hour. The mixture which contained a substantial amount of
precipitate, was centrifuged at 10,000 rev/min for 10 minutes in a
Sorvall SS-34 rotor. The supernatant fraction was discarded. The pellet
resuspended poorly in 4 ml of immuno buffer (probably because it was too
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concentrated) and the suspension was stored overnight in the cold (40C).
It was then dialyzed overnight in the cold against two changes of 600
volumes of immuno buffer containing 0.002 M sodium azide. Virtually
complete solubilization occurred during the first dialysis procedure.
The dialysate was centrifuged at 10,000 rev/min for 10 minutes in a
Sorvall SS-34 rotor. The final volume of the supernatant fraction was
30 ml. This 2-fold concentrated, partially purified serum served as
the starting material in all experiments using anti-prohead serum from
series 15. These included the immunoelectrophoresis experiments of
Chapter II,
and the electron microscopy experiments of Chapter III.
(iii) Imunoelectrophoresis Procedure
Six glass microscope slides were placed in a polystyrene frame
(Gelman Instruments, Immunoelectrophoresis Frame, No. 51447) which
holds 6 slides, 3 slides in each of 2 sides. Approximately 13 ml of
melted 1% agarose was added to each side, covering the three slides
and the exposed part of each frame. Troughs and holes were cut into
the agarose by an apparatus from Gelman Instrument Co. (No. 51449).
Concentrated lysates or purified particles, prepared for use in immuno-
electrophoresis as described above, were placed in the antigen wells
using volumes between 1 and 2 ml. Electrophoresis was carried out in
high resolution buffer, pH 8.8 (Gelman Instrument Co., No. 51104) at
10-15 milliamperes, until marker hemoglobin reached a distance of
approximately 1 cm from the antigen well. Electrophoresis times ranged
from 1-2 1/2 hours. After electrophoresis, the agarose gel in the
trough was removed and 100 pl of anti-P22 serum was added. After over-
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night incubation at room temperature in a humidity chamber, agarose
gels with developed precipitin bands were washed three times, 4-8
hours each, in immuno buffer plus 0.2% sodium azide. The final wash
was in double-distilled water for at least four hours. The gels were
covered with lint-free paper (Gelman Instrument Co.) and dried by
evaporation overnight. After drying, the paper was removed, and the
slides were stained in 1.5% amido black in 10% HAc. The destaining
solution is a methanol: water: acetic acid mix in the ratio of 4.5:
4.5:1. After 5 minutes of staining, rinsing solution was added, the
slides gently shaken, and the destaining solution poured off. This
procedure was repeated until the obvious blue color was gone. For
the final destaining, the slides were immersed in destaining solution
for one hour. The slides were dried by evaporation, standing several
hours at room temperature.
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(j) Electron Microscopy Experiments
i. Particle purification
1. Wild-type phage and tail-less heads
The wild-type 13~ phage used in the absorption experiments
included three different preparations of CsCl purified phage. One
preparation, containing 7.7 x 1012 phage/ml is described in
Materials and Methods, Section i,2,a. Another preparation was pro-
vided by Dr. P. Berget and contained 1.9 x 1013 phage/ml. The third
preparation and a preparation of tail-less heads were prepared in
parallel as follows: for each infection, 1 liter of DB7000 cells was
grown with aeration to 2 x 108 cells/ml at 370C in LB. One ml of
either wild-type 13~ phage or 9~13~ phage at 1.6 x 1012 phage/ml
was added to each culture to give a multiplicity of infection of
about 8 phage/cell. The infection continued for 2 1/2 hours and was
then aerated while cooling on ice for 20 minutes. The infected cells
from each culture were centrifuged at 7000 rev/min in a Sorvall GSA
rotor for 10 minutes. The supernatant fractions were discarded and
the cell pellets resuspended in 6 ml of TM buffer. The final volume of
each suspension was 14 ml to which DNase was added to a final concen-
tration of 7 Ag/ml. The lysate suspensions were frozen at -800C.
The lysates were thawed at room temperature and put on ice.
Three drops of CHCl3 were added as well as two additional 10l ali-
quots of a DNase solution at a concentration of 1 mg/ml DNase. The
suspensions were vortexed vigorously and incubated on ice for 10-20
minutes. Cell debris was removed by centrifugation at 10,000 rev/min
for 20 minutes in a Sorvall SS-34 rotor at 40C. There was poor separa-
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tion of pellet and supernatant fractions so the supernatant fractions
were centrifuged twice again as above. Aliquots of 2 ml each of the
supernatant fractions were layered onto CsCl step gradients containing
1 ml steps of CsC1 at densities of 1.3, 1.5 and 1.7 g/cc. The
gradients were centrifuged at 45,000 rev/min in a Beckman SW50.1 rotor
for 30 minutes at 150C. The phage and heads formed bluish-white bands
about 60% of the way down the centrifuge tubes. The bands were
collected by side puncture. The wild-type 13~ phage bands were pooled,
as were the 9-13- head bands, and these were dialyzed overnight against
two changes of 1,000 volumes of immuno buffer. The titer of the
dialyzed wild-type 13 phage was 6 x 1013 phage/ml.
2. Proheads
One liter of DB7000 cells were grown with aeration to
3 x 108 cells/ml at 390C in LB, and then cooled on ice with aeration
for 10 minutes. The cells were warmed to 370C and a 2~13~ phage
stock, containing 1 x 1012 total phage in 280 ml of LB, was added to
give a multiplicity of infection of about 4 phage/cell. The infec-
tion continued for 2 hours. The infected cells were then cooled on
ice with aeration for 10 minutes and centrifuged at 7,000 rev/min for
10 minutes. The supernatant fraction was decanted and the pellets
resuspended in TM buffer containing 25 pg/ml DNase to a final volume
of 10.7 ml. The suspension was frozen at -80"C.
The lysates were thawed at room temperature and then kept on
ice. Six drops of CHCl3 were added and the suspension was vortexed.
The lysates were incubated for 10 minutes on ice and then centrifuged
at 10,000 rev/min in a Sorvall GSA rotor for 10 minutes. The super-
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natant fraction was removed and centrifuged again as above. Two
ml aliquots of the supernatant fraction were added to 17 ml of a
15-30% sucrose gradient. The gradients were centrifuged at 25,000
rev/min for 2 1/2 hours at 150C in an SW27.1 Beckman rotor. The
prohead bands, running about half-way down the centrifuge tube, were
collected by side puncture and pooled. The proheads were not dia-
lyzed.
3. T4 phage
T4 phage (rIIv/t~) which had been purified through two
CsCl gradients and dialyzed were provided by Dr.P. Berget. These
were purified through a third CsCl gradient in a procedure similar
to that described for the wild-type P22 phage and tail-less heads
in Section i,l.
ii. Serum absorption
In general, the sera were absorbed by the addition of
small aliquots of antigen, between 0.1 and 0.2 ml. every 10 minutes
or so at 480C. Control sera were absorbed in parallel using TM
buffer. After 1-2 ml of antigen were added in this way, the serum
was incubated at 40C for at least one hour, and often overnight.
The resultant immune precipitates, and in the case of Salmonella
absorption, the unreacted whole cells, were pelleted by centrifugation
at 10,000 rev/min in a Sorvall SS-34 rotor for 10 minutes at 40C. This
procedure was repeated using the supernatant fraction until antigen
addition no longer resulted in visible immune precipitate formation.
At this point, one more addition of a small volume of antigen, usually
0.5 ml or so, was added to ensure complete serum absorption. This
final absorption mixture was treated as above. The extent of serum
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absorption was checked in each final supernatant fraction by immuno-
electrophoresis of the absorbed serum with the absorbing antigen.
1. Prohead absorption of anti-phage serum
Anti-phage serum was from series 1, the earliest pool of
bleedings, which was also used in the serum blocking experiments.
The serum was absorbed, as described above, first with a 200-fold
concentrated preparation of uninfected Salmonella cells. Complete
absorption of the serum required approximately 6 x 1010 cells/ml
serum. Then, a 1/5 dilution of the Salmonella-absorbed anti-phage
serum in TM buffer was absorbed, as above, with the purified pro-
heads described in section 2. In all, the serum was diluted 18-fold
to give a final k value of 280 min- at 370C. As a very rough esti-
mate, full absorption of the anti-phage serum at a k of about 5,000
min-1 required about 7 x 1014 proheads/ml of serum.
2. Phage absorption of anti-prohead serum
The anti-prohead serum was from series 15 and had been
partially purified and concentrated (2-fold) by ammonium sulfate
precipitation as described in section i, ii, 2. The anti-prohead
serum was first absorbed with uninfected Salmonella cells as described
above. As in the case of anti-phage serum, complete absorption of the
serum required about 6 x 1010 cells/ml serum.
The Salmonella-absorbed anti-prohead serum was then absorbed
with the CsC1 purified phage from each of the three preparations described
in section j, i, 1. Absorption of the serum to the point where antigen
addition no longer resulted in immune precipitation was accomplished
through six separate cycles of phage addition in the manner described
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above. At the conclusion of this absorption series, the serum was
22-fold diluted and used in some of the immunoelectrophoresis
experiments as phage-absorbed anti-prohead serum (06). A final
small aliquot of purified phage was added to the serum, and this
was processed to yield the final phage-absorbed serum (07) used in
the electron microscopy and several immunoelectrophoresis experiments.
iii. Lysate preparation
The following lysates were prepared for use in absorbing
the phage-absorbed anti-prohead serum described above: 3~13~,
3~5~13-, 3~8-13- and 3~5-8-13-. A wild-type lysate was also pre-
pared in parallel to monitor the infection.
DB7000 cells were grown with aeration to about 5 x 108 cells/
ml in 1,500 ml LB at 340C. The culture was chilled on ice with
aeration for 2 hours prior to infection. A total of 6 x 1011
phage of the appropriate genotype were added to 160 ml LB and in-
cubated at 300C. The infection was initiated by adding 160 ml
of the bacterial culture to the phage solution. The infected cells
were aerated vigorously for 3 hours and 10 minutes, and then chilled
for 10 minutes on ice. The infected cells were centrifuged at 7,000
rev.min in a Sorvall GSA rotor for 10 minutes at 40C. The super-
natant liquid was decanted and the cells were resuspended in 1.5 ml
TM buffer containing 20 ug/ml DNase. The lysates, approximately 100-
fold concentrated were frozen at -800C. The burst of phage from
the wild-type lysate was 1,700 phage/cell.
The lysates were thawed for 2 hours on ice. Four drops of CHCl3
was added to each lysate with vortexing. The lysate was incubated on
ice for 45 minutes with intermittent vortexing. Cellular debris was
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removed by centrifugation of the lysates at 10,000 rev/min in a
Sorvall SS-34 rotor for 30 minutes. The supernatant fractions
were decanted and their antigenic composition was determined by
immunoelectrophoresis.
iv. Lysate absorption of the serum
A 0.7 ml aliquot of each lysate described in the pre-
ceding section was diluted in TM buffer to 4.5 ml total volume.
Four aliquots of 0.6 ml of the phage-absorbed serum described in
section ii, 2 were each diluted to 1.5 ml with TM buffer. The
four pools of diluted serum were warmed to 480C and one ml ali-
quots of the appropriate diluted lysate was added to each pool
every 10 minutes. Immuno-precipitates formed immediately. At
the completion of the additions, the mixtures were incubated for
an additional hour at 480C and then stored overnight at 40C. The
precipitates were pelleted by centrifugation of the lysate-absorbed
sera at 10,000 rev/min for 30 minutes at 40C. The supernatant
fractions were clarified as in the following section, and used in
the electron microscopy experiments.
Initially, there was not enough residual antibody activity
in these lysate-absorbed sera to produce a sufficient level of
coating even in the case of the positive control. Therefore, the
sera were concentrated 10-fold by ammonium sulfate precipitation
as described in section i, ii, 2. In this procedure, the ammonium
sulfate pellet from 4.5 ml of each absorbed serum was resuspended
in 0.3 ml TM buffer and dialyzed. The dialysate, which was centri-
fuged at 10,000 rev/min for 10 minutes at 40C in a Sorvall SS-34
rotor, was diluted to a final volume of 0.45 ml in TM buffer. These
10-fold concentrated supernatant fractions were used as the lysate-
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absorbed sera in the electron microscopy experiments.
v. Antiserum clarification
In the electron microscopy procedure to be described, antigen
samples are absorbed to electron microscope grids prior to their incu-
bation with the antiserum. This means that antiserum components are
also absorbing to the grid during the incubation period. In an effort
to reduce the background material in all of the sera, though particularly
in antisera which had been incubated with concentrated lysates, I cen-
trifuged the absorbed sera and their controls at speeds sufficient to
remove ribosome-sized particles. The sera were centrifuged at 45,000
rev/min for 4 hours at 150C in a Beckman SW50.1 rotor. Even in the
control sera, some material was pelleted. The supernatant fractions
were carefully decanted and used as clarified sera in the electron
microscopy experiments.
Vi. The antigen mixture
The antigen sample in the electron microscopy experiments
consisted of a mixture of purified structures including P22 phage,
tail-less heads, proheads, spirals and T4 phage. The P22 phage
from one of the three preparations described in section j, i, 1.
The tail-less heads are described in the same section. The proheads
are described in section i, 2. T4 phage were provided by Dr. P. Berget
and are described in section i, 3. Spirals were provided by W. Earnshaw
and are described in Earnshaw, et al., 1976.
The structures were diluted in TM buffer to about 5 x 1011
particles/ml and were mixed together in equal volumes. The initial
concentrations of the particles and the amounts added were adjusted
empirically as the experiments progressed to provide the proper distri-
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bution of particles on the grids.
Vii. Electron microscopy procedure
A drop of sample was applied to a carbon-coated copper
electron microscope grid (200 A ). The sample was absorbed to the
grid for 30-45 seconds and and washed off with two drops of double
distilled water. If the sample was to be reacted with antiserum,
the grid was inverted onto a drop of antiserum placed on a para-
film sheet. The samples were incubated with the antiserum for 30
minutes except in the case of whole and phage-absorbed anti-prohead
serum which were incubated for 15 minutes. At the end of the incu-
bation period, the grid was removed from the antiserum drop, washed
with two drops of double-distilled water, and stained according to
the standard negative staining procedures used for samples not
reacted with antiserum. The grid with absorbed sample was washed
with one drop of 2% uranyl acetate and incubated for 30 seconds with
a second drop. This was washed off with a single drop of 0.1% uranyl
acetate. The excess moisture was removed by touching a piece of torn
filter paper to the edge of the drop. The samples were examined in a
JELCO-100B electron microscope. Micrographs were taken on Kodak
Electron Image Plates at an instrumental magnification of about 45,000 x,
or 80,000 x at 80 kV.
The particles had a tendency to desorb from the grids during
antiserum incubation which was counteracted if the antiserum contained
antibodies specifically against the structures. In one experiment, I
compared the amount of desorption which occurred during 10 and 15 minute
incubation times. Although desorption was approximately the same for the
two samples, antibody binding was not. It seems that antibody binding is
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not linear with time. In the sample incubated for 10 minutes, there
was no detectable antibody binding; at 15 minutes, antibody binding
was clearly present. In a separate experiment, the level of antibody
binding did not detectably increase between 15 and 30 minutes.
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Chapter I: Characterization of the Phage-neutralizing Activity
of Sera Prepared against Phage P22 and its Precursor
Particles
A. Phage Neutralization Curves
Antibodies specific to P22 structures were generated by inject-
ing rabbits with preparations of P22 phage, proheads and tail- heads.
The sera produced were collected at various intervals in order to ob-
tain samples of antibody classes which might be present only trans-
iently. Also, the rabbits were injected more than once so that the
response of antibody species that may have been only weakly present
initially might be enhanced. Characterization of the antisera, as
described below, showed these precautions to be unnecessary: though
the antibody titer rose and fell in intensity over time, no transient
antibody classes were detected; booster injection served solely to in-
crease the response of antibody classes that were detectable in the
earliest bleedings.
Several pools of antisera were characterized by their ability to
kill phage. In these experiments, phage and antisera are incubated
together at high dilution so that phage killing by the antisera repre-
sents direct inactivation rather than a reduction in titer due to
phage agglutination. Representative killing curves for anti-phage,
anti-prohead, and anti-head sera are shown in Figure 6. In this
experiment, all three sera have been diluted by the same factor to
directly compare their relative killing power. Anti-phage and anti-
prohead serum kill phage rapidly, with anti-phage serum being about
five times more potent a killing agent than the anti-prohead serum.
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Figure 6
Inactivation of Phage P22 by Anti-phage, Anti-prohead
and Anti-head Serum
Aliquots of P22 13~ c17 tester phage at 2 x 108 phage/ml were
mixed with equal volumes of 500-fold dilutions of anti-phage serum
(-x-x-), anti-prohead serum (-U-U-), and anti-head serum
(-A-A-), in broth at 370C. A control sample (-o-o-) was incu-
bated with broth only. All samples were pre-warmed at 370C before
mixing. Aliquots were withdrawn and diluted 100-fold immediately
to stop the reaction, prior to plating for surviving phage. The
surviving phage produce a range of plaque sizes, ranging from min-
ute to normal-sized plaques. At times of incubation longer than
those shown (90 minutes to 2 hours), the phage titer of the mix-
ture containing anti-head serum decreased with multi-hit kinetics.
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Anti-head serum, which was generated against phage which lacked the
tail protein, gp9, did not kill phage at a rate detectable in the
first hour of incubation. At later times, the phage titer decreased
reflecting aggregation by the serum as will be described in Chapter
II.
The kinetics of the phage-killing activity of anti-phage and
anti-prohead serum were examined in more detail in the experiment
shown in Figure 7. The two antisera have been further diluted so as
to kill phage at a slower rate. The dilutions were chosen so as to
yield the same final k value for the two sera. Under these conditions,
the curves are exponential from zero time indicating that one hit is
sufficient to inactivate the phage. The kinetics of phage inacti-
vation are exponential down to 10-2 phage survival; between 10-2 and
10-3 phage survival, the rate begins to decrease for both sera. The
initial first order rate constants for phage inactivation of the un-
diluted antisera (K) at 370C calculated from thesedata are 2,150 min-I
for anti-phage serum and 450 min-l for the anti-prohead serum.
B. Identification of the Targets of the Neutralizing Activity of
Anti-phage Serum
Phage structural proteins may be deleted systematically from in-
fected cells by infecting with amber mutants defective in the
appropriate genes. This aspect of a well-characterized phage system
provides a method for the genetic identification of the phage struc-
tural proteins which form the target of the phage-neutralizing bodies.
In these experiments, serial dilutions of amber mutant lysates, which
lack known phage proteins, are incubated with dilute antiserum for a
time sufficient for antibody-antigen binding reactions to go to comple-
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Figure 7
Kinetics of Inactivation of Phage P22 by Anti-
Phage and Anti-prohead Serum
Aliquots of P22 tester phage at 2 x 108 phage/ml were
mixed with equal volumes of anti-phage serum (-x-x-) and anti-
prohead serum (-u -r-) which had been diluted 21,000-fold and
4,200-fold, respectively, to give approximately the same final
k values. A control sample (-o-o-) was incubated with broth
only. Phage and antiserum samples (pre-warmed) were incubated
at 370C. The reactions were stopped by 100-fold dilutions prior
to plating for surviving phage.
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tion. The residual neutralizing activity of the serum is then
measured by determining the rate of inactivation of subsequently
added tester phage. The results of such experiments are expressed
as the percentage of the neutralizing activity of the serum which is
blocked by incubation with the lysate samples. I expect an amber
mutant lysate to fail to completely block the serum's phage-
neutralizing ability if the amber mutation occurs in a gene whose
product is part of the neutralization target.
The final assay in these experiments is phage killing; thus,
serum blocking power experiments detect only those antibodies which
kill the phage on complexing with it. Data from serum blocking experi-
ments are limited in that they provide a measure of the concentration
of only those antigens which react with the phage-killing antibodies
in the serum; the assay does not detect classes of antigenic phage
proteins which bind antibodies, but whose combination with antibodies
does not lead directly to phage inactivation. These antibodies are
characterized in a later section.
Serum blocking power assays were done using anti-phage and anti-
prohead sera, as these sera contain phage-neutralizing antibodies.
1) Serum blocking experiments with lysates lacking specific
phage gene products
All P22 amber mutant lysates fell into one of four serum blocking
categories. The first category is defined by the behavior of a wild-
type lysate, which is shown as a reference curve in each panel of
Figure 8. Incubation of anti-phage serum with a wild-type lysate, which
contains all P22 structural proteins, completely blocks the ability of
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Figure 8
Blocking of the Phage-inactivating Activity of Anti-
Phage Serum by P22 Amber Mutant Lysates
Lysates were prepared and serum blocking curves determined
as described in Materials and Methods, Section h, using Protocol
I. The k of the anti-phage serum was 0.025 min-1 at 480C. The
burst size of the wild-type lysate was 880 phage/input cell.
Panel a shows the blocking of anti-phage serum by a wild-
type lysate (-o-o-) and a lysate which lacks the baseplate pro-
tein, 9~13~ lysate (-ug-n-). The serum blocking curve of the
wild-type lysate is replotted in panels b and c for reference.
Panel b shows blocking of anti-phage serum by a lysate which is
blocked in DNA packaging and accumulates proheads, 2 13~ lysate
(-x-x-). Panel b also shows the blocking of anti-phage serum
by a lysate which lacks one of the head completion proteins and
which accumulates empty heads, 26~13~ lysate (-U -UI-). Panel c
shows the serum blocking activity of two lysates which do not
form appreciable numbers of structures and which contain several
P22 structural proteins in soluble form. A 5-13~ lysate (-U-U-)
lacks the major capsid protein. An 8~13~ lysate (-x-x) lacks the
scaffolding protein and accumulates low levels of aberrant struc-
tures.
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the neutralizing antibodies to kill phage. In a plot of percentage
serum blocked against lysate dilution, the wild-type lysate generates
a curve which starts around 100% serum blocked. The value stays close
to 100% until dilution of the lysate reduces the amount of target anti-
gen to a concentration below that capable of saturating the serum. At
this point, the amount of serum blocking protein falls monotonically
with lysate dilution, until finally no serum blocking antigen is
detectable.
The second class of serum blocking curves is represented by the
behavior of lysates made with amber mutants defective in gene 9, as
shown in panel a of Figure 8. Such lysates lack gp9, the tail protein.
Though the lysate shows considerable blocking activity at very high
lysate concentrations, it contains less than 1% of the concentration
of serum blocking protein in the control lysate. The serum blocking
power at low dilutions of the lysate may be accounted for by the input
phage particles used to generate the 9-13- lysate. Failure of the 9-13~
amber mutant lysate to block a large percentage of the neutralizing
activity of the serum suggests that it is missing most, if not all, of
the target antigen classes. Therefore, the bulk of the inactivating
antibodies in the anti-phage serum appears to be directed against the
tail protein, gp9.
This hypothesis is supported by the behavior of all other P22
amber mutant lysates, each of which contains gp9 tail protein at con-
centrations equal to, or greater than, the wild-type level. Panel b
of Figure 8 contains results representative of the third class of serum
blocking curves. This category consists of amber mutant lysates which
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contain fully potent serum blocking antigen in concentrations
greater than that present in the wild-type lysate. Members of this
category include amber mutant lysates in which assembly is blocked
at the prohead stage. The behavior of a 2~13~ amber mutant lysate,
which produces only proheads, is plotted in panel b of Figure 8.
Initially, the curve of a 2~13~ amber mutant lysate parallels that of
a wild-type lysate, blocking 100% of the serum. However, the serum
blocking antigen in a 2~13~ amber mutant lysate is more concentrated
than the serum blocking antigen in a wild-type lysate. Quantitatively,
the 2-13- amber mutant lysate in this experiment appears to contain
about eight times as much target antigen as the wild-type standard
lysate. Table 5, to be discussed, shows directly that gp9 is over-
produced in a non-permissive infection with a 2-13~ amber mutant
phage. Thus, the presence of increased concentrations of serum
blocking protein in lysates known to overproduce gp9 is consistent
with the conclusion that the tail protein, gp9, is responsible for
the bulk of the serum blocking protein present in lysates.
Panel b of Figure 8 also includes a plot of the data from the
incubation of anti-phage serum with a 26~13~ amber mutant lysate. This
lysate is one of a class of amber mutant lysates which contains, in
addition to proheads, empty head structures into which DNA has been
unstably packaged. The curve shows a high degree of similarity with
that of a 2~13~ amber mutant lysate. This suggests, as discussed
above, that gp9 is overproduced in 26~13~ amber mutant infections.
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The final class of serum blocking power behavior is exhibited
by lysates prepared from amber mutants defective in genes 5 and 8.
The common feature of these two lysates, which distinguishes them from
all other P22 amber mutant lysates, is the absence of structure for-
mation. A 5~ amber mutant lysate lacks gp5, the capsid protein. An
8~ amber mutant lysate lacks gp8, the scaffolding protein, which dir-
ects the proper assembly of gp5 into a capsid shell. A plot of the
serum blocking activity of a 5~13~ and an 8~13- lysate is shown in
panel c of Figure 8. The curves at high lysate concentration block
100% of the serum because of the presence of input phage which were
used to make the mutant lysates. With increasing dilution, a plateau
level seems to occur in which 80-90% of the serum is blocked, leaving
approximately 15% of the antibodies active. Furthermore, the serum
blocking protein in these lysates, though lacking an antigenic species,
appears to be present in concentrations higher than that which exists
in a wild-type lysate, and more nearly equivalent to the concentration
of serum blocking protein present in prohead-producing lysates. The
5~13~ and 8~13~ amber mutant lysates in this experiment may be diluted
about eight times more than a comparable wild-type lysate before
dilution reduces the amount of target antigen to levels no longer
sufficient to saturate the neutralizing antibodies. The data in
Table 5, to be discussed,show that gp9 is over-produced in a 5~13~
amber mutant lysate. SDS-gel experiments (unpublished experiments)
show the same phenomenon for both 5-13~ and 8~13- amber mutant lysates.
Thus, the data from this final class of lysates are consistent with the
hypothesis that the bulk of the phage-neutralizing antibodies in anti-
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phage serum are directed against gp9, the tail protein. The data
also identify a minority class of about 15% of the phage-inactivating
antibodies which are directed against an antigenic determinant which
is absent from 5~13~ and 8~13~ lysates.
We can probably exclude the gene 8 product itself as the target
antigen of the 15% class of phage-neutralizing antibodies: the final
assay in serum blocking power experiments is phage killing. Gene
product 8, the scaffolding protein, is a catalytic structural protein
which is not incorporated into the final assembled phage structure
(King, et al., 1973). As such, gp8 itself cannot be part of the tar-
get antigen on the phage. This implies that the 8~ mutation exerts
its influence indirectly in the serum blocking power assay by affecting
the assembly of the target antigen. The serum blocking behavior of an
8~ amber mutant lysate is perhaps most easily interpreted as evidence
of a structure-dependent antigen, i.e., a protein of the phage which is
capable of binding antibodies against itself only when it exists as
part of an organized structure. In an attempt to identify the target
protein of the minority class of killing antibody, lysates made from
amber mutants defective in each gene involved in phage assembly have
been tested in serum blocking experiments with anti-phage serum. All
remaining amber mutant lysates fell into either the first or third serum
blocking power categories, that is, containing all species of target
antigens at wild-type, or greater than wild-type, concentrations,
respectively. Lysates defective in any of three genes, genes 16, 20
or 7, show wild-type serum blocking behavior, thereby falling into
category I. These lysates produce non-infectious particles which are
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morphologically identical to phage. The data for a 16~13~ amber
mutant lysate are shown in Figure 9. Figure 9a also shows, for
comparison, curves obtained by repeating the serum blocking assay
for the 5~13~ and 8~13~ amber mutant lysates used previously in
Figure 8. Data for a 20~13~ mutant lysate are in Figure 10, and
for a 7~ amber mutant lysate, in Figure 12. All exhibit serum
blocking power behavior very similar to that of a wild-type lysate.
Two lysates which also fall into this category - 10- and 4~ - pro-
duce tail-less heads which have lost their DNA. Such lysates usually
have wild-type levels of gp9 tail protein ( unpublished
experiments ). The serum blocking activity of a 10~13~ amber mutant
lysate is shown in Figure 9b and the behavior of a 4~13~ amber mutant
lysate in Figure 11.
The remaining prohead-producing lysates fall into category III
of serum blocking behavior; all the serum blocking antigens are pre-
sent at greater than wild-type concentrations. The behavior of a 1~13~
amber mutant lysate is shown in Figure 9b; the serum blocking activity of
a 3~13~ amber mutant lysate in Figure 11. These lysates accumulate pro-
heads and unassembled gp9.
Figure 12 graphs the results of an experiment investigating the
role of gene 13 in antibody inactivation. Gene 13 product is required
for bacterial cell lysis at the termination of phage infection,
although it is not responsible for lysozyme production which is under
the control of gene 19. It has not been identified on SDS gels and may
or may not be a component of phage particles. Four 13+ lysates - 7~,
9~,2~ and 5- amber mutant lysates - were chosen to represent the first,
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Figure 9
Blocking of Anti-phage Serum by l~, 10~ and 16~
Amber Mutant Lysates
The lysates were prepared and the serum blocking experiment
done as in Materials and Methods, Section h, Protocol I. The anti-
phage serum in this experiment had a k at 480C of 0.02 min~1.
Panel a shows the blocking serum activity of a lysate which
lacks one of the proteins involved in DNA injection. A 16~13~ ly-
sate (-o-o-) produces phage-like particles which are non-infectious.
The serum blocking experiment included as a reference the 5~13~ ly-
sate (-u-u-) and the 2~13~ lysate (-x-x-) used in the experiment
of Figure 8. Panel b shows the serum blocking activity of a lysate
defective in head completion which accumulates empty heads, 10~13
lysate (-x-x-), and a lysate defective in DNA packaging which
accumulates proheads, 1~13~ lysate (-ri-u-). The 16~13~ curve has
been re-plotted for comparison.
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Figure 10
Blocking of Anti-phage Serum by a Lysate Lacking the
Gene 20 Product
Lysates were prepared and serum blocking curves determined
as described in Materials and Methods, Section h, using Protocol
II. The 13 control lysate (-o-o-) and the 20~13~ lysate (-x-x-)
were prepared in parallel. The antiserum had a k of 0.04 min~I
at 470C.
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Figure 11
Blocking of Anti-phage Serum by Lysates Lacking Gene
2 Product, Gene 3 Product or Gene 4 Product
Lysates were prepared and serum blocking curves determined
as described in Materials and Methods, Section h, using Protocol
II. The lysates included 13~ control lysate (-o-o-), 2~13~
lysate (-x-x-), 3-13- lysate (-0-i-), and 4~13~ lysate
(-<)- 0-). The wild-type 13~ lysate had a titer of 4.8 x 1011
0/ml. The k of the anti-phage serum at 470C is 0.04 min-1.
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second, third and fourth categories of serum blocking activities,
respectively, as had been determined by previous experiments using
13~ amber mutant lysates. The serum blocking curves described for
the 13+ lysates, shown in Figure 12, are very similar in nature to
those obtained for lysates of the same class which were 13~. These
data indicate that the gene 13 product has no role in determining
the antigenicity of the phage with respect to neutralizing anti-
bodies. The data presented above eliminate all known minor phage
proteins involved in assembly (with the exception of gp9) as targets
of any portion of the neutralizing fraction of antibodies present in
anti-phage serum.
In light of the gp5- and structure-dependence of the minority
target antigen, the simplest hypothesis assigns some organized state
of gp5, such as that which exists in phage or prohead structures, as
the target antigen. Further relevant information on this question
follows in the discussion of serum blocking power experiments using
anti-phage serum in which purified structures serve as blocking agents.
Results from these experiments contradict this simple interpretation
of the lysate blocking data; rather, they suggest a complicated
behavior for the target antigen of the minority fraction of the phage-
neutralizing antibodies in the anti-phage serum.
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Figure 12
Serum Blocking Curves With 13+ Lysates
Lysates were prepared with mutants defining each of the
four serum blocking categories described previously, but all
carrying the 13+ allele. The 9~ lysate (-A -,A-), 7~ lysate
(-0- 0-), 2- lysate (-x-x-), and 5~ lysate (-D--0 -) gave
curves similar to their 13~ counterparts.
Lysates were prepared from su~ cells at 2 x 108 cells/ml,
infected at a multiplicity of 10 phage/cell and incubated at
300C for 60 minutes. The burst size of a control wild-type 13+
lysate, prepared in parallel, was 490 phage per input cell. The
serum blocking assay was as described in Materials and Methods,
Section h, Protocol I. The anti-phage serum had a k of 0.02 min~
at 480C.
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2) Serum blocking activity of the amber fragments of gp9
It is difficult to determine whether 9 amber lysates block some
small fraction of the phage-neutralizing activity of anti-phage serum
(see Figures 8 and 12). The 9~ amber mutant chosen for the previous
experiments produces the shortest gp9 amber fragment of several amber
mutants mapping in gene 9. As larger amber fragments may contain a
number of antigenic determinants, I examined several 9~ amber mutant
lysates for their serum blocking activity.
Four amber mutant alleles of gene 9 were used to generate 9
amber mutant lysates for serum blocking experiments. Two of the
amber mutants map very close to the same site; however, they are not
identical as they show unique patterns of suppression on several
different amber suppressing hosts (P. Berget, unpublished experiments).
SDS-gel electrophoresis experiments, using similar lysates, provide
data on the molecular weight of the amber fragments in the lysates. A
9~amN110 lysate, which was used in previous serum blocking power
experiments, contains the smallest gp9 amber fragment at a molecular
weight of 7,000 daltons, 9% of the total mass of the polypeptide. A
9-amE1017 lysate contains a much larger fragment, with a molecular
weight of 50,000 daltons, 66% of the mass of the complete polypeptide.
Finally, lysates made from the two amber mutants which map very close
together, 9~amN108 and 9~amH1014 contain 9~ amber fragments of similar
molecular weight, approximately 59,000 daltons in molecular weight,
which is 78% of the total mass of the gp9 molecule. The amber fragment
from a 9~amN108 lysate is slightly smaller than the amber fragment from
a 9~amH1014 lysate (C. Hall and J. King, unpublished experiments). The
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relative lengths of these polypeptides are consistent with the data
which exist on the relative ordering of the alleles by genetic
mapping techniques (K. Lew, thesis results).
The results of the serum blocking experiments using these four
9~ amber mutant lysates are graphed in Figure 13. Though the lysates
contain four different size amber fragments, none shows increased
serum blocking ability.
3) Serum blocking experiments with purified particles and tail
protein
In an effort to refine the characterization of the anti-phage
serum, serum blocking experiments were done with components which
were purified from amber mutant lysates. In these experiments, the
purified structures include wild-type phage, 9~ tail-less heads, 2~
proheads, purified gp9 (P. Berget and A. Poteete, unpublished experi-
ments), and phage which were purified after their formation in vitro
by the addition of purified gp9 to purified 9~ tail-less particles.
The results of serum blocking power experiments with these purified
components are shown in Figure 14.
The data from the serum blocking behavior of purified wild-
type phage particles are graphed in each panel of Figure 14 as a
reference curve. As expected, purified phage block the anti-phage
serum 100%. This plateau level is maintained until dilution lowers
the concentration of target antigen below saturating amounts. With
dilution beyond this point, serum blocking power decreases monotoni-
cally with dilution, until, finally, no serum blocking activity is
detectable.
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Figure 13
Blocking of Anti-phage Serum by gp9 Amber Fragments
The lysates were prepared from DB7000 su~ cells in LB, in-
fected at a multiplicity of 5 phage/cell, and incubated at 300C
for 60 minutes. The serum blocking procedure is described in
Materials and Methods, section h, protocol II. The k of the anti-
phage serum was 0.085 min~1 .
The 9 amber mutant lysates contain different-sized amber
fragments. The 9~amNlO lysate (-A-A-), used in previous experi-
ments, contains the smallest gp9 amber fragment. The 9-amE1017 ly-
sate (- 0-0-) contains a gp9 amber fragment of intermediate molec-
ular weight. The 9~amN108 (- (- Q-) and 9~amH1014 (-x-x-) lysates
contain larger amber fragments of approximately the same size. A
16~13~ lysate (-o-o-) serves as a reference curve.
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Figure 14
Blocking of Anti-phage Serum by Purified
Particles and Tail Protein
The serum blocking assay was done as in Materials and
Methods, Section g, Protocol II. The k of the anti-phage serum
was 0.04 min~1. The preparation and purification of these parti-
cles are described in Materials and Methods, Section h, iii.
Panel a shows the serum blocking activity of purified phage
(-o-o-), purified tail~ heads (- A-A -) and purified proheads
(-x-x-). The viable titer of the phage at the first data point is
4.6 x 1012 phage/ml. The titer of the tail~ heads, is approximately
5 x 1012 heads/ml. The titer of the proheads was estimated by
comparison of the proheads with the phage and heads above on SDS-
gels. The titer of the proheads at the first data point is
approximately 2 x 1012 proheads/ml. The serum blocking curve of
purified phage is re-plotted in panels b and c for reference.
Panel b shows the serum blocking activity of purified phage
particles (-0-0-) generated in vitro by the addition of purified
gp9 to purified tail- heads, as described in Materials and Methods,
Section h, iii, 2c. The titer of the phage at the first data
point is 2.7 x 1012 phage/ml.
Panel c shows the serum blocking activity of purified gp9
(-vi-o-), provided by P. Berget and A. Poteete. The titer of tails,
at the first data point is 5 x 1012 phage equivalents/ml.
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The serum blocking power data for 9~ particles are also graphed
in panel a of Figure 14. These particles, which lack the tail pro-
tein, gp9, are at approximately the same concentration as the puri-
fied wild-type phage in this experiment, as determined both by 0.D-260
measurements and by the titer of viable phage produced after tail
addition. Despite their similar particle concentration, 9~ have only
about 2% of the concentration of the serum blocking protein of the
wild-type phage, as measured at the point where 50% of the serum is
blocked. This substantiates the identification of the gp9 tail
protein as the main target of the neutralizing antibodies. The back-
ground level of blocking probably represents input particles used for
the infection. SDS-gel electrophoresis of the 9~ particles, at a con-
centration of 2.5 x 1012 particles/ml, did not reveal contaminating
gp9 in the preparation, although levels less than about 10% would not be
detected by this method. If these phage-density particles account for
the low level of fully potent serum blocking protein present in the 9-
particle preparation, only about 0.0001% of them are viable phage. The
viable phage present could account for only 30% serum blocking at the
first data point. The remaining residual serum blocking antigen in
this preparation is probably due to non-viable particles which contain
less than the three equivalents of gp9 required for infectivity. Note
that in the range of 210-212-fold dilution, the 9~ particles block 0%
of the neutralizing activity of the serum. In the same range of con-
centration, the wild-type particles block 100% of the phage-inactivating
antibodies. If 9- particles displayed the antigenic determinants miss-
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ing from 5~ and 8~ lysates (Figures 8c and 12) we would expect them
to block 15-20% of the serum. They do not; the curve goes to zero.
The lack of serum blocking by the head particles indicates that the
target antigen of the minor neutralizing antibody species is not
located or is not available on phage heads.
Therefore, all of the phage-neutralizing antibodies in the
anti-phage serum are apparently directed against antigenic deter-
minants which are gp9-dependent. In the simplest interpretation
of the results, all phage-neutralizing antibodies in the anti-phage
serum are directed against the tail protein itself, gp9, though a
subset may react only with the assembled state.
Particles which lack gp9 may be tailed to form viable phage
by the in vitro addition of purified gp9. Immunologically, this
same operation may be expected to provide the target antigen which
is missing from tail-less heads, thereby generating full serum
blocking power in the 9~ particle preparation. Panel b of Figure
15 shows the resultant shift in the serum blocking curve of 9~ parti-
cles after the addition of purified gp9. The serum blocking power of
phage generated in vitro (and subsequently purified) compared with
that of purified phage generated in vivo is virtually identical. This
provides independent evidence that gp9 may be the sole agent respon-
sible for blocking all of the phage-inactivating antibodies in anti-
phage serum. Although the in vitro derived phage are, by viable titer,
two-fold less concentrated than the in vivo phage, they show similar
amounts of serum blocking. SDS-gel analysis (data not shown) indi-
cates that the in vitro preparation of phage, formed in the presence
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of excess gp9, contains roughly three times as much gp9 as the
wild-type phage preparation, which accounts for their higher
concentration of serum blocking protein.
Additional information of the characterization of the
neutralizing antibodies in anti-phage serum is provided by the serum
blocking behavior of purified proheads, which is included in panel a
of Figure 14. SDS-gel analysis indicated that the proheads are
about four times less concentrated than the 9~ particles. Therefore,
proheads and tail~ heads are similarly poor blocking agents against
anti-phage serum.
The small amount of gp9 which seems to be present in the pro-
head preparation, as indicated by the serum blocking data, was not
detectable on SDS-gels by protein staining. The tail protein was
probably contributed by empty phage heads which came from the
original input phage population which was used to generate the pro-
head-producing lysate. Empty heads sediment similarly to proheads
(King, et al., 1973) and proheads purified through a sucrose
gradient, particularly in preparative scale purification procedures,
are contaminated by the low levels of empty heads present in the input
phage stocks.
Final proof for the hypothesis that gp9 is the target antigen
of the majority of the phage-inactivating antibodies in anti-phage
serum is shown in panel c of Figure 14. The purification of gp9 from
a 5-13- amber mutant lysate by biochemical methods (P. Berget and
A. Poteete, unpublished results) provides the putative target antigen
in a form which is approximately 95% pure. The purified gp9 was in-
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cubated with the anti-phage serum and tested for its ability to
block the phage-killing antibodies. As the results in panel c
of Figure 14 show, purified gp9 blocks 85% of the phage-
neutralizing antibodies present in anti-phage serum. The direct
conclusion from these data is, therefore, that gp9 itself, as puri-
fied from a 5-13~ amber mutant lysate, is the target of 85% of the
phage-killing antibodies present in anti-phage serum.
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C. The Neutralizing Activity of Anti-prohead Serum
(1) The serum blocking activity of purified components
Anti-prohead serum kills P22 phage at a rate about five
times slower than anti-phage serum. However, the shape of the two
killing curves are very similar. In order to determine the target
of the neutralizing activity of anti-prohead serum, I did serum
blocking experiments with purified particles, as described previously.
The same preparations of particles used with the anti-phage serum
were used to block the anti-prohead serum. The results are shown in
Figure 15.
The serum blocking curve of wild-type phage is plotted in each
panel. As expected, the phage block 100% of the neutralizing species.
The concentration of phage which blocks 50% of the neutralizing
species in anti-prohead serum is very similar to that which blocks
50% of the anti-phage serum, at equivalent k values. This suggests
that the neutralizing antibodies in both sera are very similar.
The serum blocking curve of purified proheads, at approximately
the same concentration as the phage, is shown in panel a. As the
serum was originally made against proheads, I was somewhat surprised
that the proheads were very ineffective antigens against the neutrali-
zing antibodies. This suggested that a species of immunogen present
at very low concentration in the preparation was, nevertheless, responsi-
ble for the induction of a large fraction of the antibodies capable of
killing phage. The most likely contaminants are phage ghosts. These de-
rive from the input particles used to make the lysate from which the pro-
heads were isolated. Empty heads sediment similarly to proheads and are
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Figure 15
Blocking of Anti-prohead Serum by Purified
Particles and Tail Protein
The serum blocking assay and purified components are as
described in the Legend to Figure 14. The k of the anti-pro-
head serum was 0.07 min-1 .
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not easily fractionated by the procedure (King, et al., 1973).
Tail~ heads also showed virtually no serum blocking activity, as
shown in panel a. This result indicates that the tail protein
is the target of the neutralizing activity in anti-prohead serum, as
well as in anti-phage serum. This can be seen more clearly in panel
c, which shows blocking by purified gp9. The purified protein blocks
more than 85% of the neutralizing species in the anti-prohead serum,
similar to its blocking behavior against anti-phage serum.
The central panel shows that assembling the purified gp9 onto
tail-less particles regenerates full serum blocking activity. Thus, all
of the serum blocking activity of phage particles is gp9-dependent.
The serum blocking curves resulting from the incubation of puri-
fied components with anti-prohead serum are practically superimposable
on those obtained using anti-phage serum. Consequently, the two sets
of experimental data generate the same conclusions as to the nature of
the phage-killing antibodies in both sera. Despite the fact that the
prohead immunogen preparation contain Atail protein only as a con-
taminant, at least 85% of the phage-neutralizing antibodies in both
anti-phage and anti-prohead sera are directed against the tail
protein, gp9. The similarity in the serum blocking data may indicate
that the minority antibody fractions of the two sera are directed against
the same target, as well. The most likely target antigen for this anti-
body fraction is gp5, the capsid protein, as previously discussed for
the anti-phage serum.
(2) Blocking of anti-prohead serum by P22 amber mutant lysates
Anti-prohead serum and anti-phage serum behaved almost identically
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in response to serum blocking by purified components. In order to
examine whether the analogous behavior of the two sera extended to
interactions with crude lysates, I did additional serum blocking
experiments using several P22 amber mutant lysates to block the
anti-prohead serum.
The results of one such experiment are shown in Figure 16. The
serum blocking curve for a wild-type lysate, shown in panel a, and
re-plotted in panels b and c for reference, is particularly striking.
At high lysate concentrations, the lysate blocks all of the phage-
neutralizing antibodies in the anti-prohead serum. With increasing
lysate dilution, the percentage serum blocked starts to fall;
however, at intermediate lysate dilutions, this trend reverses itself,
and increasing lysate dilution leads to increased serum blocking.
Finally, at very high lysate dilutions, this effect ceases, and serum
blocking by the lysate decreases monotonically with dilution. The
serum blocking curve of a 2- lysate, shown in panel b, exhibits a very
similar shape, except that the target antigen appears to be present in
higher concentration.
A 9~ lysate, shown in panel a, has no detectable serum blocking
activity. In fact, the serum blocking curve may show negative values.
Panel a also shows the serum blocking curve of a 5~9- amber mutant
lysate. This curve is very similar to that of the 9~ lysate.
Only a 5~ lysate, shown in panel c, shows a constant, positive
level of serum blocking activity of about 85%. Presumably, the soluble
tail protein present in this lysate accounts for its serum blocking
activity.
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Figure 16
Blocking of Anti-prohead Serum by P22 Amber Mutant Lysates
The lysates were prepared from DB7000 su~ cells in LB, in-
fected at a multiplicity of 5 phage/cell and incubated for 60
minutes at 300C. The wild-type burst was 300 phage/input cell.
All lysates are 13~. The serum blocking protocol is described
in Materials and Methods, Section h, Protocol II. The k of the
anti-prohead serum was 0.06 min-1 .
Panel a shows serum blocking curves for wild-type lysate
(-o-o-), 9~ lysate (-0- 0-) and 5~9~ lysate (-&-L-). The wild-
type curve is re-plotted in each panel for reference.
Panel b shows the serum blocking curve of a 2 lysate
(-x-x-).
Panel c shows the serum blocking of a 5~ lysate (-u-rn-).
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Discussion - Serum Blocking
The Neutralizing Activity of Anti-phage Serum
The experiments with purified phage and phage precursors clearly
show that the gp9 tail protein is the major target of the neutrali-
zing antibody present in anti-P22 serum. Purified phage block all of the
neutralizing antibody present in the serum. Deletion of a single protein
species, gp9, from the phage particles removes all their serum blocking
power. Addition of purified gp9 to tail-less particles, which alone do
not block any fraction of the neutralizing antibody, restores full serum
blocking activity. Therefore, antigens are composed of or depend
upon the gp9 tail protein.
However, purified gp9 blocks only 85% of the neutralizing antibody
species, not 100% as might be expected. This discrepancy might be
accounted for if some of the antigenicity of the complete phage particle
represented the assembled six-fold form of the tail protein and was not
displayed by soluble tail subunits. Unfortunately, experiments with
defective lysates are only partially consistent with the model. Lysates
prepared with amber mutants of gene 9 did not block any substantial
fraction of the serum, confiming that the major target is the gene 9
product. In addition, 5~ and 8~ lysates, which are blocked in shell
assembly and accumulate the unassembled tail subunits block 85% of
the neutralizing species, just like the purified protein. However,
lysates blocked in DNA packaging - 1~, 2~, or 3~ - which also contain
only the unassembled form of the tail subunits, block 100% in con-
tradiction with the model. These lysates accumulate organized pro-
heads, in contrast to the 5~ and 8~ lysates.
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The lysate experiments suggest that the residual 15% of the
neutralizing activity is directed against an antigen which only exists
on an organized shell. Since the defective lysates containing
proheads block all of the serum, the minor target could be a minor
protein of the prohead. These include, gpl, gp7, gpl6, and gp20.
However, lysates made with mutants defective in each of these genes
still block all of the killing antibody of the serum. This eliminates
the minor proteins as candidates for the minor antigenic target. Only
lysates defective in coat or scaffolding protein synthesis fail to block
all of the killing species.
The scaffolding protein, gp8, is not a structural protein of
the mature phage (Botstein, et al., 1973). Therefore, it cannot be a
part of the target of killing antibody. This leaves as the best
candidate for the target of the minor killing antibody species, the
organized form of gp5, the major coat protein. If this is the case,
proheads or tail-less heads should block 15% of the neutralizing
species of the serum. The data shown in Figures 14 and 15 indicate
that this was not the case; these particles had no detectable serum
blocking power. The relevant observations are summarized below:
Component Serum Blocking Component Serum Blocking
tail heads 0% proheads 0%
soluble tails soluble tails
(5- lysate) 85% (5- lysate) 85%
phage (tail~ heads 100% 2~ lysate 100%
+ soluble tails). (proheads + soluble
tails)
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These data point out the paradox which exists: the serum blocking
activity of antigens in combination is greater than the sum of the
serum blocking activities of the antigens alone. No simple model can
account for this behavior. The non-additivity of the serum blocking
activities implies a complicated situation in which events affecting
serum blocking do not occur independently. Perhaps, the serum blocking
activities of the antigens reflect a non-additive interaction of their
complementary antibodies. One possible model which explains the data
is as follows: Experiments in the following chapters will show that
anti-phage serum contains large quantities of precipitating anti-capsid
antibodies. Given sufficient time, these antibodies will lead to a
loss of phage titer in serum blocking experiments, because the phage
will become aggregated into complexes which will titer as a single
plaque forming unit. Alternatively, there may exist a killing class
of anti-gp5 antibodies which requires several hits before inactivation
results. These two classes of antibodies are indistinguishable and
both lead to multiple hit kinetics. In the presence of anti-gp9
antibodies, these anti-capsid antibodies will not detectably contribute
to the overall rate of phage-neutralization: in a vast majority of the
cases, the phage will be killed by a single anti-gp9 antibody before
enough anti-gp5 antibodies can bind to kill the phage; as a result,
anti-capsid antibodies bound to dead phage are undetectable. It is
only in the absence of anti-gp9 antibodies that phage-neutralization by
the anti-capsid antibodies may be measured.
The key observations are summarized in Table 4. These can be
explained by the above model as follows. The killing activity of whole
Table 4
Characterization of the Phage-neutralizing Activity of
Anti-phage Serum Using Non-additive Antibody Interactions
Antigen Antibodies Absorbed Antibody Composition Serum
of Absorbed Serum Blocking
Anti-capsid Anti-tail
Phage + + No phage-neutralizing 100%
antibodies
Tail-heads + - Anti-tail 0%
Proheads + - Anti-tail 0%
Soluble gp9 - + Anti-capsid 85%
Wild-type + + No phage-neutralizing 100%
lysate antibodies
9~ lysate + - Anti-tail 0%
5~ lysate - + Anti-capsid 85%
8~ lysate - + Anti-capsid 85%
All other + + No phage-neutralizing 100%
P22 lysates antibodies
tested
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serum is due to antibodies against the tail protein. If these
antibodies and the anti-capsid antibodies are removed by absorption,
there is no residual killing activity. If only the anti-capsid
antibodies are removed, the serum remains just as active as the whole
serum. However, if the antibody class against the tail is
absorbed out, leaving the anti-capsid antibodies active, one then
detects a low level of inactivation whose apparent k is 15% of the
starting serum. Thus, when the whole serum is blocked by preparations
lacking organized capsids, such as 5~ or 8~ lysates, or purified gp9,
only 85% of the k of the serum is blocked. Actually all of the anti-
body species normally detectable in the serum were blocked, but the
absorption effectively unmasked the multi-hit and anti-capsid antibodies.
In fact, the numbers are somwhat misleading. The 15% figure was
calculated from the survival of the tester phage after 2 hours incuba-
tion, assuming exponential inactivation. This was reasonable, since
the starting serum displayed exponential inactivation. However, given
that the residual inactivation was due to a multi-hit process, this
apparent k is not comparable with that determined from exponential
inactivation.
I attempted to prepare serum specifically absorbed with gp9,
to characterize the residual antibody species in more detail. As a
control, one sample was absorbed with 9~ particles. This absorption
should leave behind all of the anti-gp9 antibodies,the dominant killing
species. The resulting serum retained had an apparent k of about 120%
the starting titer. However, the sample absorbed with 5~ lysate had a
residual k value much lower than the 15% I had expected. However,
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at that time I did not understand that the residual killing activity
inactivated phage in a multi-hit fashion. In titering the absorbed
serum, I measured the rate of inactivation as a function of time from
0-60 minutes. There was little inactivation over this period. How-
ever, the conditions of the two experiments were not identical. In
the standard serum blocking assay, a single time point was taken
after 120 minute incubation with tester phage. Presumably, had I
extended the incubation period for the absorbed serum to 120 minutes,
I would have detected a residual neutralizing species.
The results of the serum blocking experiments using 8 lysates
suggest that only a fraction of the antibodies directed against the
coat protein have neutralizing activity. Electron microscopy experi-
ments described in Chapter III showed that 8~ lysates contained
aggregates of coat protein which bound anti-phage antibodies. How-
ever, these structures were unable to absorb the neutralizing anti-
capsid species. Thus, they represent only a subset of the total anti-
coat protein antibodies.
The Neutralizing Activity of Anti-prohead Serum
The blocking of anti-prohead serum by purified components
was similar to the blocking of anti-phage serum by purified components.
This suggested that both sera inactivate infectious phage by similar
mechanisms. Thus, one might have thought that the phage-neutralizing
antibodies in anti-prohead serum would consist of anti-gp9 antibodies
which inactivate with single-hit kinetics, and anti-capsid antibodies
which display multi-hit inactivation.
However, this relatively simple model is not sufficient to ex-
plain the blocking of anti-prohead serum by P22 mutant lysates. The
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complex shapes of those curves indicates that the serum also contains
antibodies which inhibit inactivation. The differential absorption
of the inhibiting versus the inactivating antibodies then generates
the complex blocking curves.
A model which accounts for the results is as follows: Assume
that, in addition to the anti-tail neutralizing species and anti-
capsid neutralizing species, the serum contains non-neutralizing anti-
capsid antibodies which compete for the targets of the neutralizing
anti-capsid species. When these antibodies bind to phage, they
prevent the killing species from binding and inhibit phage inactiva-
tion. (As will become clearer later, this probably stems from the
fact that the synthesis of most of the antibodies in the serum were
induced by proheads. However, the inactivating species were probably
induced by low levels of contaminating empty heads. When the whole
serum is incubated with phage particles, the anti-prohead species
react with sites close to the target sites for inactivation).
Lysates contain high levels of tail protein which block
the anti-tail antibodies over a wide concentration span. The
residual 15% inactivation by serum incubated with relatively high
lysate concentrations is due to the anti-capsid species. Diagram 2
shows schematically what happens. At high lysate concentration all
antigens are in excess, and all antibody species are absorbed. As
the particle concentration decreases, one class of antigenic sites
become limiting, and a class of neutralizing anti-capsid antibodies,
directed against these targets, remains after absorption. For
example, the killing anti-capsid antibodies may be bound only in the
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Diagram 2: Schematic Illustration of the Blocking of
Anti-prohead Serum by a Wild-type Lysate
The symbols below the graph describe the state of the absorb-
ing antigens and the neutralizing antibodies after overnight incu-
bation with samples of lysate dilutions. The hexagonal symbols
( ) represent the phage in the lysate; the short dashes ( /-" ),
the soluble gp9. The antibody species of interest, which include
anti-gp9 antibodies (0), killing anti-capsid antibodies (o), and
inhibiting antibodies (e) which interfere with phage neutralization
by the killing anti-capsid antibodies, are either bound to the
particles or remain free in solution, as indicated. Only free anti-
bodies are active in neutralizing tester phage which are added after
the binding reactions have gone to completion.
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vicinity of the tail while targets for the non-neutralizing anti-
bodies may be distributed over the entire capsid surface. Accord-
ing to this model, at lysate dilutions of 16-128 fold on the wild-
type curve in Figure 16, or in Region 2 of Diagram 2, neutralizing
anti-capsid antibodies are free in the absorbed serum while the
interfering antibodies are bound. When tester phage are added,
the free neutralizing antibodies in the absorbed serum do not have
to compete for sites on the tester phage, and they kill phage at a
rate even faster than when they are present in whole serum. There-
fore in the initial part of the wild-type curve, increasing lysate
dilution leaves more and more killing anti-capsid antibodies free
in the serum.
Eventually, however, increasing the dilution of the antigens
causes the number of binding sites for the inhibiting anti-capsid
antibodies to become limiting (Region 3, Diagram 2). Beyond this
point, more and more inhibiting anti-capsid antibodies remain in
the serum after absorption. These inhibit the killing anti-capsid
antibodies, and the rate of phage-killing decreases. This is re-
flected by the portion of the wild-type curve, from 128-512 fold in
Figure 16, or Region 4 in Diagram 2, in which decreasing antigen
concentration results in decreased serum neutralizing activity after
absorption.
This trend continues until dilution of the lysate beyond 500-
fold in Figure 16, or Region 5 in Diagram 2, finally reduces the
concentration of the soluble gp9 in the lysate to a level where all
of the anti-gp9 antibodies can no longer be absorbed (Region 6,
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Diagram 2). Once anti-gp9 antibodies exist free in the absorbed
serum, they are the primary antibody species responsible for phage-
killing because they kill with single-hit kinetics. Thus, the final
portion of the wild-type curve reflects the concentration of the anti-
gp9 antibodies which are free in the absorbed serum. Lysate dilution
increases the concentration of free anti-gp9 antibodies until, finally,
all species of antibodies are free, and the percentage serum blocked
falls to zero (Region 7, Diagram 2).
This model also accounts for the serum blocking behavior of the
other P22 lysates tested. Prohead-containing lysates - 1~, 2~, and 3~ -
and empty head-containing lysates - 4~, 10~ and 26~ - and lysates con-
taining phage-like particles - 7~, 16~ and 20~ - contain organized
capsid shells which presumably absorb the anti-capsid antibodies in
more or less the same fashion as the phage particles. Therefore, the
initial and intermediate portions of the serum blocking curves of these
lysates are similar to those of the wild-type lysate. The anti-gp9
antibodies are absorbed by the soluble gp9 which is present in these
lysates until high lysate dilution reduces the concentration of soluble
gp9 to less than saturating amounts. Thus, the latter portions of the
serum blocking curves of these lysates are also similar to the wild-
type curve, except that the serum blocking curves of the prohead-
containing lysates, which overproduce gp9, extend over a wider range
of lysate dilutions.
With 5~ and 8~ lysates, none or very few of the anti-capsid
antibodies are removed from the serum whereas all of the anti-gp9 anti-
bodies should be removed. Therefore, 5~ and 8~ lysate-absorbed sera
presumably contain the full complement of the killing and non-killing
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anti-capsid antibodies. Thus, they provide an estimate of the rate of
phage-killing by the minority fraction of the antibodies as it exists
in whole serum.
I expected the residual rate of phage-killing by 9~ lysate-
absorbed anti-prohead serum to be indistinguishable from the rate
of phage-killing by the whole serum, because anti-gp9 antibodies
would be solely responsible for phage-inactivation in both sera.
Although the results are in general agreement with this prediction,
it appears that negative values of serum blocking are actually ob-
tained at several lysate dilutions. Apparently, at these lysate
concentrations, high concentrations of neutralizing anti-capsid
antibodies are free in the serum in the absence of significant
concentrations of inhibiting antibodies. Under these conditions
the contribution to phage-killing by the uninhibited anti-capsid
antibodies becomes measurable. Eventually, at higher lysate dilutions,
the inhibiting antibodies are free in solution, and the serum blocking
level returns to zero.
The serum blocking curves of the wild-type or 2 lysates
against anti-prohead serum may be duplicated by mixing purified
phage, or purified proheads, respectively, with purified gp9 (D. Smith,
R. Griffin Shea, and J. King, unpublished experiments). These results
confirm that the curves are generated by interactions solely between
these structures and gp9.
Attempts to absorb anti-prohead serum with lysates or purified
components were unsuccessful (D. Smith and J. King, unpublished
experiments). The residual k values of the absorbed sera were so low
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that further characterization of the sera was impossible. Although,
the reasons for the inability to regain substantial neutralizing
not
activity are I clear, it is possible that the high concentrations of
serum and of the lysates or purified components used for absorption
produces effects not present in the dilute conditions of the serum
blocking experiments.
Note that the anti-prohead serum can be thought of as the rabbit's
response to two classes of immunogens: 1. proheads, which induce a high
concentration of precipitating antibodies, including anti-gp5 and anti-
gp8 antibodies, as will be shown in the following chapters; and 2. contam-
inating empty heads with tails (from the infecting phage used to generate
the proheads) which induce anti-gp9 antibodies. These empty phage pre-
sumably also induce anti-capsid antibody that slowly inactivates phage,
as described for the anti-phage serum. However, the proheads in the pre-
paration seem to have induced an additional class of anti-gp5 antibodies
which may well compete for similar sites, or interfere sterically with
the binding of this killing anti-capsid fraction. These interfering
species apparently were not generated by the injection of phage particles,
as there is no indication of an inhibiting antibody class in the anti-
phage serum. I will show evidence in Chapters II and III that the popu-
lation of antigenic coat protein sites on proheads contains determinants
not present on phage, a result consistent with this model.
D. Comparison of the Level of Serum Blocking Activity with Concentration
of Tail Parts
Comparison of the serum blocking curves of wild-type lysates with
those of purified phage reveals a consistent feature: the lysates always
display substantially more serum blocking antigen than can be accounted
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for by the number of phage in the lysates. For example, using purified
phage, as in Figure 15, 2.4 x 109 phage/ml are required to block
50% of the anti-prohead serum. Using a wild-type lysate, as in
Figure 16, only 1.5 x 108 phage/ml are sufficient to block an
equivalent amount of serum. (The values were normalized for the
difference in the k values of the two sera). Thus, phage alone can-
not account for the serum blocking activity of the lysate.
Previous SDS-gel electrophoresis experiments using radio-
actively labelled P22 lysates showed that tail protein is heavily
overproduced relative to wild-type levels in all lysates in which
DNA is not packaged - 5~, 8-, 1-, 2- and 3- (S. Casjens and J. King,
unpublished experiments). However, the results of the serum block-
ing experiments suggest that, even in the wild-type lysate, amounts of
gp9 are produced in excess of that needed to tail the phage which are
present.
In order to examine this possibility, I compared the serum
blocking activity and the concentration of soluble tail parts in wild-
type, 5~, and 2~ lysates. Serum blocking curves, similar to those
which have been presented were obtained (data not shown). The concen-
tration of functional tail subunits in these same lysates was measured
by assaying their ability to convert tail-less heads to viable phage
(Israel, et al., 1967). First, phage and phage-sized particles were
removed from the lysates by high-speed centrifugation so that only
soluble tail parts remained. Then, serial dilutions of the lysates
were incubated with a constant number of purified heads, and the numbers
of viable phage produced were measured. The dependence of phage forma-
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tion on lysate dilution (gp9 concentration) had the third power
character described by Israel, et al. This indicated that all three
lysates contained unassembled tail subunits. A summary of the
results is shown in Table 5. Also included for comparison are similar
data for purified gp9 and two samples of purified phage, one produced
in vivo; the other, in vitro.
The results from the tailing assay of the wild-type lysate shows
that, as expected, a considerable amount of excess soluble gp9 is
produced. Comparing the tail parts/ml with the phage/ml in this ly-
sate, soluble gp9 is present in almost 3-fold excess over that which
would be needed to put 6 tail parts on every phage present in the ly-
sate. In addition, in agreement with the radioactive labelling experi-
ments mentioned previously, the number of tail parts/ml in 5~ and 2~
lysates is about 5-fold higher than in the wild-type lysate.
If we now compare the number of tail parts at 50% serum block-
ing for the three lysates, the values are similar for both sera. (The
value for the 2 lysate using anti-prohead serum was uncharacteristi-
cally high in this experiment). This is consistent with the
neutralizing activities of the two sera being very much alike.
A significant difference appears to exist between the serum
blocking activity of soluble gp9, whether purified or as it exists in
lysates, and gp9 which has been assembled into tail structures. For
example, the soluble tail subunits in the purified gp9 preparation
are 6-9 times more effective in blocking the sera than tail protein
present in the tails of phage made in vivo. This is also true of
phage made in vitro by mixing the gp9 preparation with tail-less heads.
Table 5
Comparison of Serum Blocking Activity with Concentration of Tail Parts
Anti-phage Serum3  Anti-prohead Serum4
Preparation Viable Tail Parts/ml Fold Dilution Tail Parts/ml Fold Dilution Tail Parts/ml
Titer at 50% Serum at 50% Sergm at 50% Serum at 50% Serum
(phage/ml) Blocking Blocking Blocking Blocking
Purified 9.2 x 1012 5.5 x 1013 5,714 9.6 x 109  4,096 1.3 x 1010
phage
Purified 5.4 x 1012 3.2 x 1013 5,714 5.6 x 109  4,096 7.8 x 109
in vitro
phage
Purified - 5.9 x 1011 585 1.5 x 109 405 1.5 x 109
gp9 6
Wild-type 4.8 x 1010 5.9 x 1011 288 3.0 x 109  204 2.9 x 109
lysate
5~ lysate - 3.3 x 1012 - 319 4.0 x 109
2- lysate - 2.9 x 1012 1,638 2.7 x 109  409 7.3 x 109
I Determined for lysates as described in Materials and Methods, Section h, iv. For purified viable
phage, we multiplied the viable phage titer by six.
2 The phage-sized particles were centrifuged out of these lysates prior to
3 Data taken from experiment in Figure 14.
the tailing reaction.
Table 5 (Contd.)
Comparison of Serum Blocking Activity with Concentration of Tail Parts
4 Data taken from experiment in Figure 15.
5 These values have been multiplied by the ritio of the k of the anti-prohead serum (0.07 min-)
to that of the anti-phage serum (0.04 min~ ) to adjust for the difference in the concentration
of the two sera.
6 Provided by P. Berget and A. Poteete.
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In this case, it takes 3 1/2 to 5 times as many assembled phage tail
parts to block the sera as it does phage equivalents of the same pre-
paration of soluble tail protein. Actually, the discrepancies are
probably larger than those indicated here because the estimates for the
number of tail parts in the phage preparations do not include tails
present on non-infectious particles.
There are two possible explanations for why soluble gp9 appears
to be a more active serum blocking species than assembled tail parts.
First, there may be tail protein in the lysates and in the purified
gp9 preparation which is not active in tailing but which is, neverthe-
less, antigenic. A second explanation is that free tail subunits have
more antigenic sites available than subunits bound to phage. This
seems likely because assembly of the tail may involve subunit-subunit
interactions which mask determinants on the unassembled proteins.
The neutralization of P22 phage by anti-phage serum is caused
primarily by the reaction of anti-gp9 antibodies with the tail
protein, with one hit sufficient to cause inactivation. None of the
minor proteins of the phage appearsto be target of inactivation.
Antibodies against determinants only present in the assembled shell
also inactivate phage, but with multi-hit kinetics. The target of
this antibody is unknown, but perhaps certain capsid sites at the site
of head-tail attachment play a role in the infectious process.
As expected from the above, antibody induced by tail-less heads
do not directly neutralize phage at any substantial rate.
Serum prepared against proheads does inactivate phage. The
neutralizing antibody species are similar to those in anti-phage serum;
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anti-tail antibodies which inactivate with single hit kinetics, and
anti-capsid antibodies which inactivate with multi hit kinetics. In
addition, the serum contains a species which inhibits the latter anti-
body. The data indicate that the neutralizing antibodies were induced
by low levels of contaminating empty phage particles present in the
prohead preparation. The targets of the neutralizing antibodies may
represent particularly potent immunogens.
The inactivation by anti-tail protein may act either at the level
of a sorption to the host cell, or at later stages of the infectious
process (Israel, et al., 1972). In general, the inactivation resembles
that of bacteriophage lambda and T4, where the neutralizing antibodies
are also directed against the absorption organelles.
I had expected to identify a class of antibodies directed
against the fiber that projects from the P22 tail plate. This looks
morphologically like an attachment organelle. Either (1) the fiber
is coded for by an unknown gene, and is therefore present in all mutant
lysates or (2) it is not essential for phage infection or (3) it is not
an effective immunogen.
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Chapter II: Investigation of the Total Specific Antibody Composition
of Anti-P22 Sera by Immunoelectrophoresis
In the preceding Chapter, I described the inactivation of phage
P22 by anti-phage and anti-prohead sera. I then utilized serum
blocking experiments to characterize the species of antibody which
were responsible for the neutralizing activity of the sera. This
phage-neutralizing fraction of the antibodies may represent only a
small subset of the total antibody population directed against P22
structures. For example, the sera may contain anti-phage antibodies
which bind to the surface of the phage but which do not inactivate
it. In addition, sera made against proheads or tail~ heads may con-
tain antibodies which bind exclusively to these structures but not to
mature phage.
In this section I employ immunoelectrophoresis experiments to
define antibodies in the sera which react with P22 proteins, but which
may not directly inactivate phage particles.
A. Characterization of Precipitating Antibodies by the Technique of
Immunoelectrophoresis
Antibodies which are capable of forming a precipitin network
with P22 antigens can be detected by immunoelectrophoresis, whether
or not they inactivate phage directly. Immunoelectrophoresis
is a two-stage process. In the first step, macromolecular species in
the antigen sample are fractionated by electrophoresis through a
buffered agarose matrix. The separation of the antigens depends both
on their net charge and on their hydrodrynamic properties. Species that
are uncharged under the conditions of electrophoresis, or that are too
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large to migrate through the agarose, remain in the sample well. In
the second step of the procedure, antibody is added to troughs cut
parallel to, but well separated from, the track of electrophoretic
separation. The slide is incubated, allowing antibody and antigen
to diffuse in the absence of electrophoresis. At positions where
antibodies meet their target antigens, immune precipitates form.
These have the form of an arc, since the antigens during electro-
phoresis were distributed in spherical or ellipsoidal zones. The
precipitation arcs are visible directly in the agarose gel between
the antibody trough and the antigen track. In these experiments, un-
reacted proteins are removed by simple washing. The immune precipi-
tates, which remain fixed in the gel during washing, are then stained
using a conventional protein stain.
Immunoelectrophoresis requires both antibody and antigens in
much higher concentrations than were used in the phage inactivation
and serum blocking experiments. The antisera were diluted only 2-15
fold before addition to the slides in all experiments not dealing
specifically with the effects of antiserum dilution on immune precipi-
tation. Purified structures were used as antigens at concentrations
in the range of 1012-1014 particles/ml. When lysates served as the
antigen sample, the infected cells were concentrated 200-fold prior
to lysis for use as antigens.
All the antisera used in the immunoelectrophoresis experiments
have been absorbed with whole, uninfected Salmonella typhimurium (DB7000)
to remove anti-Salmonella antibodies. These antibodies arise due to con-
tamination of the original particles injected into the rabbits with highly
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immunogenic Salmonella cell envelope and flagellar debris.
In many experiments antisera have been absorbed with phage or
phage-precursor particles in order to generate sera specific to an
antigen or a set of antigens on a particular structure. For example,
incubation of anti-prohead serum with phage, under conditions of anti-
gen excess, leaves behind antibodies specific for determinants pre-
sent on proheads but absent from phage.
The amber mutants of P22 were exploited in two ways in the
immunoelectrophoresis experiments. Although there may be multiple
antigenic species in a virus particle, these are all associated with
a single, physically-diffusing species which generates a single
precipitin band. If, however, we prevent particle assembly by in-
fecting with an amber mutant of the coat or scaffolding protein gene,
we increase the chances of structural proteins accumulating as soluble
species. I hoped that this would allow me to detect minor structural
protein antigens of the phage, if they existed.
In addition, I have used amber mutant lysates to absorb the
sera. These lysates lack, in general, only the product of the mutant
gene. Therefore, sera absorbed with lysates prepared with an amber
mutant in a particular gene should contain antibody directed solely
against the product of that mutant gene (Edgar and Lielausis, 1965).
This is somewhat of a simplification. The antigenicity of some
structural proteins may depend upon their organizational state, as
suggested in Chapter I. For example, 5 lysates which lack coat
protein subunits also lack organized shell structures. If minor
particle proteins are antigenic only as structural components of a
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capsid shell, they will not be precipitated from a 5~ lysate.
The absorption experiments were done in the following way: un-
diluted sera were mixed with concentrated lysates or high titers of
purified particles, and incubated overnight in the cold. These absorbed
sera were used in immunoelectrophoresis experiments after low-speed cen-
trifugation. The ratios of antiserum to antigen used in these absorptions
were determined in pilot immunoelectrophoresis experiments. In all cases,
the extent to which the antiserum had been absorbed was checked by immuno-
el ectrophoresis.
In general, experiments using absorbed antisera are presented in the
following manner: whole antiserum is added to one antiserum trough, absor-
bed serum to the other. The outer flanking antigen wells contain the
absorbing antigen. In this arrangement, the reaction of absorbed serum
with the absorbing antigen may be compared directly with the normal pat-
tern obtained from the reaction of whole serum with the same antigen. This
set-up provides the control reactions necessary to gauge the extent to
which the serum has been absorbed. Finally, an antigen of interest is
added to the central well. In this position, the behavior of a single
sample of antigen may be compared against both unabsorbed and absorbed serum
simultaneously.
B. Immunoelectrophoresis of Structure-containing Lysates and Purified
Structures
1. Anti-phage serum
Despite the large size of P22 structures (approximately 50 million
daltons), phage and precursor particles migrate appreciable distances from
the antigen well during electrophoresis. The immunoelectrophoretic behavior
of P22 phage and proheads against anti-phage serum is shown in Figure 17a.
Purified wild-type phage have been added to the upper antigen well, and
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Figure 17
Identification of P22 Antigenic Structures Using
Anti-phage Serum
For all immunoelectrophoresis experiments: the immuno-
electrophoresis procedures are as described in Materials and
Methods, Section j; the antigen samples are described in
Materials and Methods, Table 3; the antiserum samples are from
pools as described in Materials and Methods, Table 2. Volumes
of antigen added are between 1.5 and 2.0 ml; of antiserum,
100 ml. The figures are presented so that the anode is to the
right.
Every antiserum, unless otherwise indicated, has been absor-
bed with whole uninfected Salmonella cells, strain DB7000, concen-
trated 200-fold. The dilutions in these procedures, described in
Materials and Methods, Section j, i, were negligible. Salmonella
absorption removed 3-4 precipitin arcs from the immunoelectro-
phoretic patterns of P22 lysates.
(a) Undiluted anti-phage serum is from series 7. (b) and
(c) Anti-phage serum from series 7 was diluted 1:10 and 0.2 ml of
5~ lysate from batch 1 (see Materials and Methods, Table 3) was
added. The mixture was incubated at 370C for approximately 30
minutes and was stored overnight in the cold. The absorbed serum
was centrifuged at 15,000 rev/min for 2 hours in an SS-34 Sorvall
rotor. Aliquots of the supernatant fraction were added to the
antiserum troughs as indicated. Whole anti-phage serum from series
7 was diluted 1:10 to roughly match the concentration of the absorbed
sera.
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The pattern in the center of panel a is referred to as a
"double-humped precipitin arc". Moving from the cathode to the
anode, the precipitate has two distinct arcs, one very dense,
one considerably lighter, which fuse to give a double-humped
appearance. Phage are present in the inner more dense arc,
while the proheads, present in the lower concentration are pre-
sent in the arc to the right at the electrophoretically more
negative position. Because the same serum is diffusing in from
both troughs, the precipitate is symmetrical about its long axis,
resulting in what will be termed mirror image precipitin arcs.
Absorption of the serum with a 5~ lysate is complete as
shown in panel c. The gp9 precipitin arc, present in the reaction
of whole serum with the 5~ lysate (lower section) is missing from
the reaction of the absorbed serum with the same 5~ lysate (upper
section). The anti-gp5 antibodies in the absorbed serum continue
to precipitate the phage and prohead structures.
a)
phage
wild-tpe
lysa Le
proheads
b)
phage
tail' heads
C)
5 lysate
wild-t pe
lysae
5- lysate
anti-phage
antiamphage
anti-phage
5~ lys.- absorbed
anti-phage
5 lys.-absorbed
anti-phage
anti-phage
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purified proheads to the lower antigen well. Anti-phage serum filled both
antiserum troughs. Phage and proheads migrate from the antigen well to
the anode with the proheads moving faster than the phage. Immunoelectro-
phoresis of a wild-type lysate, in the central well of Figure 17a, with
anti-phage serum results in a dense, slowly-diffusing, precipitin arc.
It appears to be double-humped along its length (moving from the antigen
well to the anode) because the structures, though antigenically related,
electrophorese differently. The dense inner arc of the doublet, closest
to the antigen well, migrates to the same position as purified phage; the
outer arc shows immunoelectrophoretic behavior similar to the purified
proheads. Therefore, the immunoelectrophoretic pattern of a wild-type
lysate against anti-phage serum appears to be due to phage particles and
prohead precursor structures which are present in the wild-type lysate.
Anti-phage serum has been shown by serum blocking experiments to
contain anti-gp9 antibodies. Reaction of the anti-gp9 antibodies,
subunits
present in the anti-phage serum, with the tail A of phage particles
may be expected to contribute to the precipitation of phage particles.
However, as proheads do not contain tails, prohead precipitation by
the anti-phage serum must be the result of a reaction between anti-
phage antibodies and some other antigen present on the proheads. The
most likely antibodies responsible for prohead precipitation are anti-
coat protein antibodies. The precipitation of phage by anti-phage serum
is also probably not merely a result of anti-gp9: gp9 interactions, but
anti-capsid: gp5 interactions as well.
The presence of anti-capsid antibodies is suggested by pre-
cipitation experiments with tail-less heads. These particles are
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efficiently precipitated by anti-phage serum, as shown in Figure 17b.
As these particles completely lack the gp9 tail protein, this
precipitation cannot be due to the anti-gp9 antibodies in the serum,
and must be due to another antibody species.
The non-essential role of the tail in the precipitin re-
action is further demonstrated by removing anti-gp9 antibodies from
the serum. To do this, I absorbed the anti-phage serum with a 5~ ly-
sate, which lacks coat protein, but which contains large amounts of
tail protein, as shown in the serum blocking experiments. Figure
17c shows an immunoelectrophoresis experiment using this 5~ lysate-
absorbed serum. This serum should contain only anti-capsid antibodies.
The absorbing lysate has been added to the upper and lower antigen
wells. Anti-phage serum fills the lower trough; the 5- lysate-
absorbed serum fills the upper trough. The absence of precipitin
bands in the upper region shows that the serum is fully absorbed. As
will be discussed further below, the reaction of whole sera with 5~
lysate, in the lower region of Figure 17c, results in a single faint
precipitin arc, which represents precipitation of soluble tail
protein by anti-gp9 antibodies.
The central well of Figure 17c held wild-type lysate. The re-
action with the whole anti-phage serum shows the typical double-
humped precipitin arc, due to the precipitation of proheads and phage
from the lysate. The 5- lysate-absorbed serum, which is most likely
composed of specific anti-coat protein antibodies, shows a very
similar precipitation pattern. Thus, the precipitation of both phage
and proheads does not depend on the presence of anti-tail antibodies.
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In Figure 17b, this same 5- lysate-absorbed antiserum, present in the
lower antiserum trough, also precipitates tail~ heads. As will be
shown directly by immunoprecipitation experiments described below,
these precipitations are due to anti-coat protein antibody.
2. Anti-prohead serum
In preparing antibody against proheads, I was interested
in two general questions: 1) Could I detect proteins in proheads which
were not present or not antigenic in phage, such as the scaffolding
protein, or other minor proteins? 2) Did antibody prepared against
the precursor proheads efficiently precipitate phage? (This ques-
tion may be of interest with respect to the general problem of
vaccine production).
The reaction of anti-prohead serum with phage and proheads is
shown in Figure 18a. Purified phage were added to the top well,
purified proheads to the bottom well, and wild-type lysate to the
center well. Anti-prohead serum was in both troughs. The reactions
of the serum with the structures are very similar to the patterns
found with anti-phage serum. The lysate shows the typical double-
humped precipitin arcs due to proheads and phage particles. In addition,
the anti-prohead serum reacts with a soluble protein in the wild-type
lysate producing a precipitin arc between the antigen well and the
structure-related precipitin arcs. As will be shown below, this is
due to precipitation of soluble gp8 by anti-gp8 antibodies present in
the anti-prohead serum.
The serum blocking experiments described in Chapter I showed that
anti-prohead serum contained anti-gp9 antibodies at
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Figure 18
Immunoelectrophoresis of P22 Proheads and Phage Using Anti-
prohead Serum
(a) Undiluted anti-prohead serum is from series 7.
(b) Anti-prohead serum from series 7 was absorbed with a 5~
lysate as described in the legend to Figure 17b. Whole anti-
prohead serum has been diluted 1:10.
The pattern in the center of (a) is composed of pre-
cipitin arcs containing phage and proheads, flanked in pre-
cipitin arcs representing a soluble component by the lysate.
Absorption of the sera with 5~ lysate, as in panel b, most
likely leaves only anti-gp5 antibodies. These still precipitate
the structures present in the wild-type lysate, but not the solu-
ble component, gp8.
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about 20% the level found in anti-phage serum. In order to determine
if the precipitation of mature phage by anti-prohead serum was caused
by anti-gp9 antibodies, I absorbed the anti-prohead serum with 5 ly-
sate to remove anti-gp9 and anti-gp8 antibodies. The reactions of
the absorbed and whole antisera with 5~ lysate and wild-type lysate
are shown in Figure 18b. Samples of 5~ lysate were added to the outer
wells. The whole serum was added to the lower trough and the 5
lysate-absorbed serum to the upper trough. The precipitin arc present
in the bottom reaction is absent from the top, indicating that the
serum is fully absorbed. No structures are present since the lysate
is missing the major coat protein. The only antibodies remaining
should be directed against the coat protein or structure-dependent anti-
gens.
Examination of the central section of the slide shows clearly
that the 5~ lysate-absorbed anti-prohead sera still efficiently pre-
cipitates both proheads and phage from a wild-type lysate. Thus, anti-
capsid antibodies are most likely responsible for particle precipitation
by anti-prohead serum.
3. Anti-head serum
P22 heads are identical to P22 phage except that they lack
the tail protein, gp9. Consequently, though anti-head serum probably
did not contain anti-gp9 antibodies, it might otherwise have been quite
similar to anti-phage serum. In fact, this was the case.
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The reaction of anti-head serum with the structures present
in a wild-type lysate, shown in Figure 19, is very much like that
obtained using anti-phage serum as shown in Figure 17. Precipi-
tation of a wild-type lysate, in the central antigen well, by whole
anti-head serum, in the lower serum trough, causes a typical double-
humped precipitin arc due to phage and proheads.
The pattern remains essentially the same even after the anti-
head serum has been absorbed with a 5~ lysate, as is present in the
upper serum trough. Therefore, anti-capsid antibodies are most
likely responsible for the precipitation of phage and proheads by anti-
head serum.
C. Immunoelectrophoresis of Soluble P22 Antigens
Immunoelectrophoresis of structure-containing lysates, though in-
formative as to the immunological behavior of P22 structures as a whole,
gives limited information as to the actual number and identity of P22
antigens which may exist in these structures. These may include, in
addition to the major capsid protein and the tail protein, a
number of minor phage proteins which participate in phage assembly
(see Introduction). Antiserum generated against proheads, tail heads,
and phage may contain antibodies against these minor structural proteins.
Only one protein, gp8, the scaffolding protein, was detected in
soluble form in the immunoelectrophoresis of structure-containing lysates.
Results from several immunoelectrophoresis experiments (data not shown)
suggest that a pool of soluble gp8 subunits is present in every P22 amber
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Figure 19
Immunoelectrophoresis of P22 Phage and Proheads Using Anti-
head Serum
Anti-head serum from series 7 was absorbed with a 5~ lysate
as described in the legend to Figure 17b, except that 0.1 ml 5~
lysate was added to 1.0 ml anti-head serum. Whole anti-head serum
has been diluted 1:10. The serum precipitated only the phage and
prohead particles present in the wild-type lysate.
5 lysate
wild-type
lysate
5 lysate
5 lye. -absorbed
anti-head
anti-head
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mutant lysate, which reflects its unique properties as a catalytic
structural protein. The other minor phage structural proteins may not
exist in appreciable concentration in soluble form in lysates contain-
ing structures. As structural components of the phage or prohead cap-
sid, these P22 antigens would be electrophoresed and precipitated as a
single antigenic unit.
In the immunoelectrophoresis experiments to be described, 5~ and
8- amber mutant lysates, which do not accumulate structures, are used as
potential sources of antigens in their soluble form. Not all P22 anti-
gens may be detected by this method. Some P22 antigens may be trapped
in membrane debris or be otherwise insoluble in 5~ or 8- amber mutant
lysates, and remain inside the antigen well. Alternatively, as antibodies
were originally generated against P22 antigens as they existed in
particles, some proteins may not display their mature antigenicity in sol-
uble precursor form. Therefore, immunoelectrophoresis of 5~ and 8- amber
mutant lysates provides a minimum estimate of the number of anti-P22 anti-
body classes that exist in the different anti-P22 antisera.
1. Anti-phage serum
(a) Identification of the gp9 precipitin band
Serum blocking experiments have shown that anti-phage serum
contains anti-gp9 antibodies. These experiments detected antigenically-
active gp9 in 5~ amber mutant lysates which was capable of blocking al-
most all of the phage-neutralizing antibodies in the anti-phage serum.
Therefore, at the least, I expected to detect an anti-gp9: gp9 reaction
in the immunoelectrophoresis of a 5~ lysate against anti-phage serum.
The results of such an experiment are shown in panel a of
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Figure 20. Anti-phage serum filled both antiserum troughs; a 5~ amber
mutant lysate was added to the central antigen well. A single pre-
cipitin arc is detectable. As this band was most likely the result
of the precipitation of soluble gp9 by anti-gp9 antibodies, I con-
structed a double amber mutant phage, carrying amber mutations in
both gene 5 and gene 9, to genetically identify the antigen in this
reaction as gp9. This phage was used to generate a 5~9~ mutant lysate
which was added to the top antigen well and immunoelectrophoresed. No
precipitin band formed. Therefore, these results genetically identify
the antigen responsible for the single, detectable precipitin band as
the gene 9 tail protein.
Results from serum blocking experiments and tailing assays using
wild-type lysate, and 5~ 8~, and 2~ amber mutant lysates (see Table 4)
indicated that gp9 was over-produced in the latter three lysates rela-
tive to wild-type amounts. A 2~ amber mutant lysate has been added to
the lower antigen well in panel a of Figure 20. The 2~ amber mutant ly-
sate shows a precipitin band very similar in character to, and at the
precise electrophoretic position of, the gp9 precipitin band in the 5~
amber mutant lysate. This is in contrast to a wild-type lysate, which
shows no soluble bands against anti-phage serum (see Figure 17a and c).
These data provide additional support for the genetic identification of
gp9 as the antigen involved in these precipitation reactions.
The experiment in panel b of Figure 20 shows that purified gp9, in
the central antigen well, produces a precipitin arc similar in character
and electrophoretic position to the single precipitin band produced by
the 5~ amber mutant lysate in the upper antigen well. No such band was
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Figure 20
Identification of the gp9 Precipitin Arc Using
Anti-phage Serum
(a) Anti-phage serum, undiluted, is from series 7. (b)
Anti-phage serum, undiluted, is from series 15. This serum has
not been absorbed with Salmonella cells, and shows several faint
bands due to Salmonella antigens in the lysates. (c) Sera are as
described in the legend to Figure 17b.
The sharp precipitin arcs represent soluble gp9 tail
subunits. The dense precipitate in the bottom of panel a repre-
sents prohead structures.
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detectable in a 5~9- amber mutant lysate, present in the bottom antigen
well. (The faint bands present in the 5~ and 5~9~ amber mutant lysates
are the result of anti-Salmonella precipitation reactions, present
because the antiserum had not been fully absorbed with bacterial cells).
These results establish conclusively that gp9: anti-gp9 interactions are
responsible for the single precipitin arc which results from immuno-
electrophoresis of a 5~ amber mutant lysate against anti-phage serum.
(b) Absence of a coat subunit precipitin band
An 8- amber mutant lysate provides the best potential source of
soluble gp5, the capsid protein. Previous immunoelectrophoresis
experiments of 5~ lysate-absorbed anti-phage serum against particles
suggested that anti-phage serum contains anti-gp5. Therefore, I ex-
pected that immunoelectrophoresis of an 8~ lysate, would show an
additional band due to the reaction of soluble gp5 with anti-gp5 anti-
bodies. This was not the case as is shown in panel c of Figure 20.
An 8~ lysate, in the central antigen well, has a single precipitin
band against whole anti-phage serum, present in the lower serum trough.
This band is virtually identical in appearance to the gp9 precipitin
band present from a 5- lysate in the lower antigen well. However, it
was possible that the gp5 precipitin band was coincident with the gp9
precipitin band. Therefore, I absorbed the anti-phage serum with a 5~
lysate to remove the anti-gp9 antibodies. The absorbed serum, which
should retain anti-capsid antibodies, was added to the upper antiserum
trough in Figure 20c. All anti-gp9 antibodies were removed from the
serum by the absorption, as is shown by the absence of a precipitin
band against a 5~ amber mutant lysate in the upper antigen well. The
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reaction of the absorbed serum with the 8~ lysate in the central anti-
gen well shows that no precipitin arc was uncovered by the removal of
the anti-gp9 antibodies. These results suggest that gp5 in an 8~
amber mutant lysate does not react with anti-capsid antibodies in the
anti-phage serum. However, electron microscopic experiments described
in Chapter III indicate that there is antigenic coat protein in 8~
lysates. A discussion of the paradoxical behavior of gp5 in an 8~
lysate will be taken up in that chapter. It may be that the coat pro-
tein accumulating in 8~ lysates is too heterogenous in electrophoretic
behavior to give a detectable precipitin band; or, under the experi-
mental conditions involved in immunoelectrophoresis, gp5 may be in-
soluble and remain inside the antigen well.
In summary, immunoelectrophoresis of soluble P22 antigen with
anti-phage serum detected only anti-gp9 antibodies. Anti-capsid anti-
bodies, shown by several other methods to be present in the anti-
phage serum, were not detected by the immunoelectrophoresis of an 8~
amber mutant lysate. Finally, immunoelectrophoresis of 5- and 8~
amber mutant lysates did not provide any evidence for the existence of
antibodies in anti-phage serum against minor P22 structural proteins
other than gp9. Either antibodies against them do not exist, at least
in concentrations high enough to be detected by this assay; or P22
minor structural proteins are not antigenic in soluble form.
2. Anti-prohead serum
Proheads contain, in addition to the gp5 capsid protein, the
scaffolding protein, gp8, and several of the minor proteins present
in phage. If gp8 were exposed in the prohead immunogen preparation,
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at 250 copies per prohead, it may reasonably be expected to have evoked
an antibody response. In addition, some of the minor proteins may be
more suitably disposed to induce antibody formation in proheads than
in phage.
(a) Presence of the gp9 precipitin band
Serum blocking experiments have shown that anti-prohead serum
contains anti-gp9 antibodies. As expected, then, immunoelectro-
phoresis of a 5~ lysate with anti-prohead serum, shown in the cen-
tral portion of Figure 21a, shows a sharp precipitin arc at the
position, and with the appearance, characteristic of the gp9 pre-
cipitin band. The pattern also contains a second, more diffuse pre-
cipitin arc whose identification will be discussed presently. When
this experiment was repeated in the lower portion of Figure 21b, the
two arcs became coincident with one another, although the sharp band
remains somewhat distinguishable. No such precipitin arc is
detectable in the immunoelectrophoretic pattern of a 5~9~ lysate, which
was present in the top antigen well. However, one can generate the
immunoelectrophoretic pattern of a 5~ lysate from a 5~9~ lysate by
adding purified gp9 to the 5-9- lysate and immunoelectrophoresing the
mixture, as is shown in the central portion of Figure 21b. Panel c
shows the reaction of two different pools of anti-prohead serum with
purified gp9. From the serum blocking results, we know that the k
of an antiserum reflects its concentration of anti-gp9 antibodies. Anti-
prohead serum with a high k value, in the upper antiserum trough pre-
cipitates purified gp9 very strongly; anti-prohead serum which contains
approximately one-third the number of anti-gp9 antibodies, as in the
153.
Figure 21
Precipitation of gp9 and a Second Soluble Antigen by
Anti-prohead Serum in Immunoelectrophoresis
(a) Undiluted anti-prohead serum is from series 15. The
lower antiserum trough contains serum which has been only par-
tially absorbed with purified phage from batch 2 (see Materials
and Methods, Table 3). Seven aliquots of 0.2 ml purified wild-
type phage at 7.7 x 1012 phage/ml were added to 16.5 ml of serum
over 4 1/2 hours at 470C. The mixture was stored overnight at
40C. The absorbed serum was centrifuged at 10,000 rev/min for
10 minutes in a Sorvall SS-34 rotor, and the supernatant fraction
used in this experiment. Note that addition of 1.1 x 1013 phage
particles to 16.5 ml of serum diminishes only slightly the inten-
sity of the gp9 precipitin band. This experiment was done
initially to monitor the extent of phage absorption of the serum.
However, this is of no relevance to the conclusions of the pre-
sent experiment as discussed in the text.
(b) Undiluted anti-prohead serum is from series 15.
(c) Anti-prohead serum (k = 1700 min~') is from series 15.
Anti-prohead serum (k = 500 min~') is from series 7.
The fine, sharp precipitin arcs represent soluble tail
protein gp9. The dense precipitin arcs (other than the phage
precipitate in the top of panel a) involve soluble scaffolding
protein, gp8.
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lower serum trough, shows a very faint and diffuse precipitation
reaction with purified gp9. Therefore, immunoelectrophoresis experi-
ments detect the presence of anti-gp9 antibodies in the anti-prohead
serum with a k greater than, or equal to, 500 min~I.
(b) Identification of anti-scaffolding protein antibodies
(anti-gp8)
i. gp8 and its amber fragments show different immuno-
electrophoretic behavior
As noted above, anti-prohead serum contains a second class of
antibodies which reacts with a soluble protein in 5~ lysates to give
a diffuse precipitin reaction. This precipitin arc is also present
in the reaction of anti-prohead serum with a 5~9~ lysate (Figure 21b)
and with a wild-type lysate, as well (Figure 18). In fact, using anti-
prohead serum, this precipitation reaction is present in all the morpho-
genetic mutant lysates (data not shown). Therefore, the antigen invol-
ved must be present in soluble form in fairly high concentrations in all
such P22 lysates. One prime candidate for this antigen is gp8, the
scaffolding protein. As a catalytic structural protein, gp8 is released
from proheads during DNA encapsulation, creating a pool of re-usable
gp8 subunits within the cell. If the precipitin arc is caused by gp8,
it should be missing from the immunoelectrophoretic pattern of an 8~
amber mutant lysate. This is shown in panel a of Figure 22. Immuno-
electrophoresis of a 5~ lysate, in the lower antigen well, gives the
sharp gp9 precipitin band and the second, more diffuse band. The immuno-
electrophoretic pattern of an 8~ amber mutant lysate, in the central
antigen well, contains the gp9 precipitin arc; however, the diffuse band
has virtually disappeared. However, a new band appears at an electro-
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Figure 22
Immunoelectrophoretic Behavior of gp8 and its Amber Fragments
(a) The anti-prohead serum is described in the legend to
Figure 21a. The precipitin arc around the antigen well, present
in the reaction of the 8- 202 lysate, is variably present in this
and other lysate reactions (see Figure 20b, 5~9- lysate). It is
most likely the result of the precipitation of Salmonella antigens
by residual anti-Salmonella antibodies.
(b) The anti-prohead serum, from series 15, was diluted
1:5. The dark reaction around the antigen wells and the very faint
and slowly-diffusion precipitates are probably caused by the re-
action of the aberrant gp5-containing structures (spirals and
shells) in these 8~ lysates.
157.
a)
8 202 lysate
anti-prohead5~ lysate
b)
3~8~14 lysate
3~8~123 lysate
3 8-202 lysate
C-- - -~
anti-probead
anti-prohead
158.
phoretically more negative position. The disappearance of the pre-
cipitin band indicates that the antigen involved is gp8-dependent; the
coincident appearance of a new band suggests that the anti-prohead ser-
um may be precipitating a gp8 amber fragment from the 8 amber mutant
lysate.
In support of this theory, you may observe that the antigen in
the 8~ lysate has precipitated closer to the antiserum trough than the
antigen in the 5~ lysate. As the lysates were prepared similarly, the
relative proximity of the 8~ lysate precipitin arc to the serum trough
is consistent with the antigen's being a fragment of the full gp8 poly-
peptide in the 5~ lysate. According to this model, the fragment lacks
determinants present on the full polypeptide chain; therefore, the
effective concentration of antibodies in the serum against the anti-
gen is decreased, and the antigen diffuses farther before being pre-
cipitated.
The full gp8 polypeptide has a molecular weight of 42,000 daltons.
The 8~amH202 lysate used in Figure 22 contains a gp8 fragment of approxi-
mately 18,000 daltons. To test the idea that the new band represents
an amber fragment, 8~ lysates were prepared with amber mutants at other
sites in gene 8. These were 8~amH1348 lysate which yields a gp8 amber
fragment of about 12,000 daltons; and 8~amN123 lysate, in which an
amber fragment is not detectable by SDS-gel electrophoresis (J. King
and C. Hall, unpublished experiments). Genetic mapping data are con-
sistent with the observations on fragment sizes from SDS-gel electro-
phoresis and they suggest that the amber fragment in an 8~amN123 lysate
would be quite small (F. Winston and D. Botstein, unpublished experi-
ments).
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If the precipitations in question are caused by anti gp8: gp8
interactions, anti-prohead serum may be expected to show a somewhat
weaker reaction with the shorter gp8 fragment, most likely at a new
electrophoretic position, and to show no band against the lysate which
lacks a detectable gp8 fragment by SDS-gel electrophoresis. The re-
sults were as predicted, as shown in Figure 22b. (The lysates in this
experiment are also 3~, but this has no effect on the precipitation
pattern). I mention here two technical points to avoid confusion: in
these experiments, the anti-prohead serum has been diluted to a k of
less than 500 min- so that the gp9: gp9 precipitin band is no longer
detectable. Also, the proteins have not migrated during electrophoresis
as far from the antigen well as they had in the experiments of Figure
22a. Therefore, the precipitin arc from an 8~amH202 lysate, in the
bottom antigen well of Figure 22b, is present very close to the antigen
well. The 8~ lysate, 8~amH1348, which contains the shorter gp8 amber
fragment, has been added to the upper antigen well. Using this lysate
as antigen, a weak band was detectable. The antigen in this reaction
electrophoresed to a more negative position and diffused farther before
being precipitated than the antigen in the 8~amH202 lysate. This is
consistent with the hypothesis that we are seeing the precipitation of
a shorter, more negatively charged, gp8 fragment which carries fewer
determinants than the fragment present in the 8~amH202 lysate.
An 8~amN123 mutant lysate has been added to the central antigen
well of Figure 22b. No new precipitin arc was found with this 8 amber
mutant lysate which lacks a detectable gp8 amber fragment.
The combined results show that not only does the precipitin arc
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present in a 5 lysate disappear from the pattern of an 8~ lysate,
but the presence, position, and intensity of a new precipitin band
in the 8~ lysates depends upon the presence and size of the gp8
amber fragment involved. Thus, I conclude that anti-prohead serum
contains anti-scaffolding protein antibodies.
(ii) gp8 and its amber fragments show reaction of partial
identity
If the precipitin arc in a 5~ lysate is caused by the complete
gp8 molecule, and the precipitin arcs in the 8 lysates by fragments
of gp8, then, in immunoelectrophoresis experiments the antigenic
relatedness of these species may be shown directly by examining mix-
tures of the lysates. These will show reactions of partial identity,
in which precipitin arcs both fuse and show spurs. The arcs fuse
because the antigens involved share common determinants. All anti-
bodies directed against these common determinants are precipitated
at the position of equivalence. Spurs form at the junction of two
precipitin arcs if the antigens involved also possess unique deter-
minants. In this case, a subset of antibodies can pass through the
precipitin network caused by the reactions of the common antigenic
sites, because they do not recognize the shared antigens. These anti-
bodies continue to diffuse until they react with their unique target
antigens and form an immune precipitate within the boundaries of the
fused precipitin arcs. Lysate-mixing experiments are shown in Figure 23.
The set-up of the experiments was as follows: 1:5 diluted anti-prohead
serum was present in every antiserum trough. A sample of a 5~ lysate
was added to the bottom antigen wells, and one of three 8~ amber mutant
lysates to the top antigen wells. The central antigen wells contained
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Figure 23
Reactions of Partial Identity
Between gp8 and its Amber Fragments
(a, b) The central reactions show the fusion of the 8-
amber fragment with the complete gp8 polypeptide. The darkly
staining, central tear-shaped precipitates in the 3~8- ly-
sate samples represent precipitation of the aberrant coat
protein aggregates present in the lysates. (c) No amber
fragment was detected in the 3-8-123 lysate.
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a 1:1 mixture of the 5~ and 8- lysates present in the flanking antigen
wells.
The anti-prohead serum in these experiments was diluted only
1:5 so as to maintain a sufficient concentration of antibodies to detect
spur reactions. Consequently, immunoelectrophoresis of the 5~ lysates
in these experiments shows a very dense diffuse gp8 band. The gp9 band
is detectable as well. The gp9 band is present in every reaction and
will not be discussed further.
Panel a of Figure 23 compares the immunoelectrophoretic pattern
of a 5~ lysate with an 8~amH202 lysate. The 8- lysate shows, as it
had previously in Figure 22, a new band which is somewhat sharper than
the band in a 5- lysate, at an electrophoretically more negative
position. When these two lysates are mixed together, the complete gp8
band and the amber fragment band fuse, showing that they share iden-
tical determinants. It is difficult to assess, because of the density
of the precipitates, whether a spur extends from the inner precipitin
arc, which corresponds to the full gp8 molecule; but, I think a weak,
diffuse spur may be present. The low intensity of the spur reaction
suggests that the full gp8 molecule contains very few unique antigenic
determinants. Therefore, an amber fragment accounting for about 2/5
of the polypeptide chain, appears.to contain almost all of the anti-
genic determinants present on a molecule more than twice its size.
Spur formation is much more clearly seen in the reaction in-
volving the shorter gp8 fragment in an 8~amH1348 lysate, shown in panel b.
As in the preceding reaction, the precipitin arcs fuse. For comparison,
note the crossing of the unrelated gp9 and gp8 fragment bands in the 8~
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lysate alone, in the upper portion of this panel. Also, as com-
pared to the preceding experiment, a more dense spur extends from
the precipitin arc of the full gp8 polypeptide. This is entirely
consistent with the fact that the gp8 fragment in the 8~amH1348 lysate
is shorter than the fragment in the 8~amH202 lysate. From these re-
sults, the shorter fragment appears to contain fewer determinants.
Therefore, more antibodies recognize determinants as unique on the
full gp8 molecule and cause a denser spur-related precipitate.
In panel c of Figure 23, the experiment has been repeated using
an 8~amN123 lysate. As expected from previous experiments (Figure 22),
no reaction against an amber fragment was detected.
In conclusion, these results confirm that the antigens in the 8~
lysates are portions of the larger gp8 molecule present in the 5~
lysate. Therefore, the reactions of partial identity observed in
these experiments are derived from the interaction of anti-scaffolding
protein antibodies with gp8 and its fragments.
The composition of the precipitating antibodies in anti-prohead
serum, as shown by immunoelectrophoresis experiments, may be summarized
as follows: the combined data provide strong evidence that anti-gp8
antibodies are present in anti-prohead serum. As expected from the
serum blocking experiments, anti-prohead serum also contains anti-gp9
antibodies which may be detected immunoelectrophoretically using concen-
trated serum. As with anti-phage serum, anti-gp5: gp5 reactions were
not detected by the immunoelectrophoresis of an 8 lysate, although
experiments in Chapter III suggest that they do occur. Finally, no
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evidence exists for the presence of antibodies in anti-prohead
serum directed against minor structural proteins other than gp8
and gp9.
3, Anti-head serum
Immunoelectrophoresis of a 5~ lysate with undiluted anti-head
serum produced a single, somewhat faint, precipitin arc, as is shown in
the central portion of Figure 24a; immunoelectrophoresis of a 5~9~
lysate produced a similar pattern. When an 8~amH202 lysate was used as
an antigen, however, the original precipitin arc disappeared, and a new
band, electrophoretically more negative took its place. This behavior,
reminiscent of the anti-prohead precipitation patterns obtained using
these lysates, suggested that anti-head serum might contain anti-gp8
antibodies. To test this hypothesis, 8~ amber mutant lysates contain-
ing different-sized amber fragments, were used as antigens. This
experiment is shown in panel b of Figure 24. The results are very simi-
lar to the results of the same experiment with anti-prohead serum in
Figure 22b. An 8~amH202 lysate produced a sharp band; an 8~amH1348
which contains a smaller gp8 fragment produced an electrophoretically
more negative band which diffused farther before being precipitated;
and an 8~amN123 lysate, which does not contain a detectable gp8 frag-
ment, did not produce a precipitin arc specific to this lysate. In
analogy with the identification of anti-scaffolding protein in anti-
prohead serum, these results indicated that anti-head serum contained
anti-gp8 antibodies. Tail-less heads ordinarily do not carry gp8;
however, when the particles used to generate the anti-head serum were
run in SDS-gel electrophoresis, a contaminating gp8 band was barely
detectable by protein staining (data not shown). This probably repre-
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Figure 24
Detection of gp8 and its Amber Fragments in
Immunoelectrophoresis by Anti-head Serum
The anti-head serum is from series 7.
(a) The lightly staining precipitin arcs in the 5~9~
and 5~ lysates represents soluble scaffolding protein, gp8.
This arc is missing from the 8-202 lysate and has been replaced
by a precipitate containing a more negatively changed antigen,
the gp8 amber fragment.
(b) The dense darkly staining central precipitates,
particularly prominent in the 3~8~1348 and 3~8-123 lysates,
represents precipitation of the aberrant coat protein aggregates
present in these lysates. The lengthy precipitin arc just out-
side the dense structure precipitate may also represent precipi-
tation of gp5 in these lysates, but as this was not typically
detected in comparable lysates, their identification is uncertain.
The fast-diffusing precipitin arcs, involving the more negatively
changed antigenic species in the top and central reactions show
precipitation of the gp8 amber fragment. No amber fragment was
detectable in the precipitin pattern of the 3~8-123 lysate.
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sents contamination of the tail~ heads used for immunization with
a small number of proheads. (ca. 6%, see Fig. 3)
As anti-head serum was generated against phage heads which
lacked tails, I had expected that I might find additional bands in
the immunoelectrophoretic pattern corresponding to neck-specific
antigens. If these antigens exist, they were not detectable by
immunoelectrophoresis of soluble P22 antigens with anti-head serum.
D. Cross-reactivity of P22 Structures
1. Common antigens
The precipitin arcs from the immunoelectrophoresis of the
phage and proheads in a wild-type lysate fuse, regardless of the
anti-P22 serum involved (see Figures 17a, 18a and 19). As discussed
previously, this phenomenon shows that these structures share a set
of common antigenic determinants. Absorption of the sera with a 5
lysate, designed to generate anti-capsid antibody, did not perceptibly
affect the reaction of these structures with the sera. These results
suggest, as will be shown directly in ChapterIII, that proheads and
phage share many gp5 determinants. Therefore, it appears that the
transition from the prohead precursor structure to the mature phage
particle does not involve a gross rearrangement of the capsid subunits.
2. Unique antigens
(a) Capsid determinants unique to phage as shown by spur
formation
Anti-P22 sera appear to recognize unique antigenic determinants
on phage and proheads, as shown by spur formation between the phage and
prohead precipitin arcs. At high antiserum concentration, however, it
is often difficult to see the spurs. Because P22 structures are so large,
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they do not freely diffuse in this system so they remain localized
in high concentration. In addition, not all unreacted structures
are removed by washing. Even in the absence of serum, structures
are stained, although the stained areas lack the sharp edges of
structure immunoprecipitates (data not shown). Consequently, when
structures are diffusing from the central antigen track against very
concentrated antisera, the mirror-image precipitin arcs are very close
together and very dense, making detection of spur formation nearly
impossible. With more dilute antisera, however, spurs are more
clearly either present or absent, depending on the nature of the
antibody-antigen reaction.
These effects are illustrated in the experiments of Figure 17a
and c in which I attempted to examine, using spur formation, whether
anti-phage serum recognized a set of determinants unique to the phage
capsid. As shown in Figure 17a, phage structures form such a dense,
almost solid sphere of precipitate against concentrated anti-phage
serum that it is extremely difficult to assess whether a spur actually
extends from the phage precipitin arc. Presumably, one does because
anti-gp9 antibodies in the anti-phage serum react with phage tails and
not with proheads. However, in the experiment of 17c, when the anti-
serum is 10-fold more dilute, even whole serum does not seem to form a
spur extending from the phage precipitate. As will be discussed in
section f of this Chapter, the k of the anti-phage serum, about 500 min~I
in this experiment, is such that soluble gp9 would give only a faint
reaction with the serum. Apparently, in this situation, the k of the
anti-prohead serum is, nevertheless, too low to detect the expected spur
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formation. It seems unlikely, then, that a substantial additional
class of determinants could be contributing to spur-related pre-
cipitation reactions. Thus, I conclude from these results that anti-
bodies generated against phage capsids probably recognize the outer
shells of the proheads as identical. Results from experiments using
electron microscopy support this conclusion and will be discussed in
Chapter III.
The reaction of concentrated anti-prohead serum with P22
phage and proheads, as in Figure 18a, produces a precipitin pattern
very similar to that produced by concentrated anti-phage serum. How-
ever, as shown in Figure 18b, 10-fold dilution of the whole anti-
prohead serum results in the definition of a faint precipitin arc
extending from the phage precipitate. The k of the anti-prohead serum,
about 50 min-1 in this reaction, would be much too low to see gp9-
related spur formation, given the previous result that anti-phage serum
at a k of 500 min~1 did not produce such a spur. Thus, these results
suggest that there may be a significant number of determinants on phage,
other than gp9 determinants, which anti-prohead serum recognizes as
different from proheads.
This possibility may be tested by removing the anti-gp9 antibodies
from the serum by absorbing with a 5~ lysate. If a spur reaction per-
sists, the precipitation may be most reasonably attributed to antibodies
specific for the phage capsid. This experiment was done and the results
are shown in Figure 18b. Despite absorption, the spur appears to persist.
If the spur is real, then the experiments suggest that anti-prohead serum
recognizes a class of capsid determinants as present on phage but not on
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proheads. These phage-specific anti-capsid antibodies must have
been generated against contaminating empty phage heads in the original
prohead immunogen preparation, or some breakdown product of proheads
which was antigenically similar to phage.
Will serum made against phage heads which lack gp9 recognize
determinants as present on phage but absent on proheads? Results
from immunoelectrophoresis confirm that anti-head serum lacks anti-
gp9 antibodies (Figure 19). In the absence of anti-gp9 antibodies,
phage-related spurs show directly that phage and proheads are different
in some way other than that proheads lack tails. In the experiment of
Figure 19, the reaction of anti-head serum with the phage and proheads
in a wild-type lysate produced such a spur. Absorption of the serum
with a 5- lysate has little effect on the spur, as shown in the same
figure; this is not particularly meaningful, however, because anti-
head serum did not show a positive precipitation reaction in the first
place with the 5~ lysate. If phage-specific antigens do indeed exist,
they may include a special class of capsid subunits or some minor
structural proteins of the phage which are either not present or not
antigenic in proheads. However, these phage-specific antigens cannot
be present in a part of the neck which is covered by the phage tails
because they are detectable on phage particles.
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(b) Capsid determinants specific to proheads as shown by spur
formation
One might expect that antibodies made against phage would
not recognize prohead-specific determinants. Indeed, as is shown in
Figure 17a, no spur is detectable extending from the prohead precipi-
tin arc.
Perhaps a more intriguing question is: does anti-prohead serum
recognize antigenic determinants unique to proheads? Proheads con-
tain approximately 250 copies of gp8, the scaffolding protein, which
are not present in the mature phage. The exact location of gp8 with-
in the prohead structure has not been determined, but Earnshaw, et al.
(1976) have concluded from the results of electron microscopy and
X-ray diffraction studies on proheads that gp8 is part of an inner
shell structure within the prohead capsid. However, localization of
all of the gp8 molecules to the inner shell of the proheads makes it
difficult to explain how the gp8 protein is able to exit from the pro-
head shell during DNA encapsulation, fully intact, ready to be recycled
in further prohead assembly reactions. Perhaps the gp8 molecule pro-
trudes through the outer capsid shell. If gp8 molecules are exposed
on the capsid of proheads, and if they elicited an antibody response
during immunization of the rabbit, they may be expected to give rise
to a class of prohead-specific antibodies which react exclusively with
proheads and not with structures which do not contain gp8.
In fact, in contrast to the behavior of anti-phage serum, immuno-
electrophoresis with anti-prohead serum of a wild-type lysate produced
a spur extending from the prohead precipitin arc. This is shown in
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Figure 18a. Therefore, antibodies exist in anti-prohead serum which
do not recognize targets on phage but which do precipitate proheads.
In the upper portion of Figure 18b, the anti-prohead serum has
been fully absorbed with a 5~ lysate; it no longer reacts with the sol-
uble gp8 in either the 5~ or the wild-type lysate. If gp8 is the only
antigen unique to proheads, the prohead spur should be removed by this
absorption. However, a spur extending from the prohead precipitin
band persists. Therefore, these results suggest that, unless there are
structure-dependent determinants, gp8 antigens cannot be solely
responsible for the antigenic difference between proheads and phage. In
the simplest interpretation of the data, proheads probably carry gp5-
determinants which are not present in the capsid shell of phage particles.
This hypothesis is supported by experiments involving electron microscopy
in Chapter III.
It is difficult to be absolutely sure because of the density of the
structure precipitates, but anti-head serum does not seem to form prohead-
related spurs. Thus, anti-head serum probably does not recognize deter-
minants on proheads which it does not also detect in phage.
3. Investigation of prohead-specific antibodies by phage-absorp-
tion of the anti-prohead serum
(a) Residual activity of phage-absorbed anti-prohead serum against
proheads
The existence of a prohead-specific class of antibodies in
anti-prohead serum has been suggested by the formation of spurs in
immunoelectrophoresis of a mixture of phage and prohead structures (see
Figure 18). To establish this more clearly, I absorbed anti-prohead
serum exhaustively with purified phage. The object of this absorption
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process was to isolate the reactions of prohead-specific antibodies
from the high background of antibody reactions directed against
determinants shared by proheads and phage. Once isolated, the re-
sidual activity of phage-absorbed anti-prohead serum could be
examined by immunoelectrophoresis. The phage-absorbed sera should
contain anti-scaffolding protein antibodies. In addition, the pro-
head-specific sera may include prohead-specific anti-capsid antibodies.
These antibodies recognize gp5 as antigenic only in the particular
structural conformation it assumes in proheads, and not as it exists
in phage. Finally, phage-absorbed anti-prohead serum may contain
antibodies against minor proteins of the prohead, if these proteins
are not available in antigenic form on the phage structure during
absorption.
The residual activity of phage-absorbed anti-prohead serum
against proheads is examined in Figure 25a. Purified wild-type phage
have been added to the outer antigen wells. Whole anti-prohead serum,
present in the upper antiserum trough, precipitates the phage particles.
Anti-prohead serum, after absorption with wild-type phage, present in
the lower antiserum trough no longer precipitates wild-type phage, and
thus has been fully absorbed. Whole anti-prohead serum precipitates
phage, proheads and soluble gp8 from a wild-type lysate, present in the
central antigen well. Phage-absorbed anti-prohead serum no longer pro-
duces the inner of the two structure-related precipitin arcs. This
provides additional evidence that the anti-prohead serum is fully
absorbed with phage. As expected phage-absorbed serum continues to pre-
cipitate the soluble gp8 in the wild-type lysate.
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Figure 25
Residual Activity of Phage-absorbed Anti-prohead
Serum Against Proheads in Immunoelectrophoresis
(a) Anti-prohead serum from series 7 was absorbed as in the
legend to Figure 17b except that purified phage from batch 1 were
added. Complete absorption of the serum required several additions
of phage. Whole anti-prohead serum from series 7 was diluted 1:15
to match the concentration of the phage-absorbed serum. (b) and
(c). Anti-prohead serum was absorbed sequentially with phage six
times as described in Materials and Methods, Section j. Whole anti-
prohead serum was diluted 1:22.5 to match the dilution of the ab-
sorbed anti-prohead serum. Note the soluble gp8 precipitin band
present in the reaction of the serum with the prohead preparation
added to the central well.
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Will phage-absorbed anti-prohead serum precipitate proheads?
The central precipitation reaction in Figure 25a shows that anti-
prohead serum which has been exhaustively absorbed with phage parti-
cles continues to react, though more weakly, with prohead structures.
A definite precipitin arc exists at the prohead position. This result
yields two important pieces of information about the antigenic-
relatedness of phage and proheads. First, the amount of precipitate
formed against proheads by phage-absorbed anti-prohead serum is signi-
ficantly less than that formed by whole anti-prohead serum. In
addition, the antigen travels closer to the antiserum trough before
being precipitated. The substantial diminution in the response of
phage-absorbed anti-prohead serum to the proheads indicates that
anti-prohead serum recognize a large number of determinants on phage
and proheads as identical. Secondly, a low level of residual
activity in the anti-prohead serum persists against proheads even
after exhaustive absorption of the serum with phage. This result
establishes the existence of a class of antigenic determinants on pro-
heads which are absent from phage.
It is informative to compare spur formation in this experiment
with that in the experiment shown in Figure 18b. In Figure 18b,
spurs extended from both phage and prohead precipitin arcs after
reaction with anti-prohead serum, suggesting that antigenic deter-
minants exist on both phage and prohead structures which are not
shared between them. In the actual experimental data of Figure 25,
although it may be difficult to detect in the photographic reproduction
of the data, a spur is again detectable extending from the prohead pre-
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cipitin arc. Thus, the immunological phenomenon of spur formation
serves to confirm the result of the cross-absorption experiment;
that is, prohead-specific determinants exist which are not present
on phage.
As expected, phage-absorbed anti-prohead serum also precipitates
proheads from a 3~ amber mutant lysate, which accumulates only pro-
heads. This is shown in Figure 25b. Whole anti-prohead serum, pre-
sent in the upper antiserum trough, shows a strong precipitation
reaction with the proheads in a 3~ lysate. Phage-absorbed anti-
prohead serum in the lower antiserum trough, produces a very much
weaker, but perceptible, response to the proheads. Both whole and
absorbed anti-prohead serum precipitate soluble gp8 from the 5~ and
3- lysate. Therefore, the results from this experiment are in agree-
ment with the results of the preceding experiments: anti-prohead
serum which had been fully absorbed with phage retained a small
fraction of prohead-specific antibodies which continued to react with
proheads. The proheads in the 3~13- amber mutant lysate of Figure 25b
appear to be electrophoretically heterogeneous. This effect, seen in
several structure-containing lysates, is variable and may merely be
indicative of the effectiveness of the DNase treatment of the concen-
trated lysates. Often, low-speed centrifugation of the lysate reduces
considerably the electrophoretic variability of the structure and re-
moves completely the precipitation reaction around the antigen well,
as will be shown in Chapter III. The residual precipitating activity
of phage-absorbed anti-prohead serum against proheads present in ly-
sates is observed even more clearly when concentrated, purified pro-
heads are used as antigens, as shown in panel c. These proheads are
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roughly ten times more concentrated than the proheads in the wild-
type lysate of panel a. After exhaustive phage absorption, anti-
prohead serum continues to precipitate purified proheads, which
have been added to the central antigen well. The residual re-
sponse of the phage-absorbed serum is stronger here than in panels
a and b because the proheads are more concentrated. Nevertheless,
the precipitin arc caused by the phage-absorbed serum is signifi-
cantly weaker than that caused by the whole anti-prohead serum.
Therefore, in every instance, the experimental results indicate
that proheads contain a limited number of determinants not pre-
sent on phage.
In the experiment in panel c, I was surprised to find that
the preparation of purified proheads contained appreciable
amounts of a soluble antigen. This antigen, precipitated by both
whole and phage-absorbed anti-prohead serum, was very similar in
its immunoelectrophoretic behavior to gp8. Using anti-prohead
serum as the precipitating antiserum, this band appeared in the
immunoelectrophoretic patterns of several older preparations of
proheads; however, the antigen was not precipitated by anti-phage
serum. These results suggest that proheads progressively release
gp8 from their capsid shells during storage, and that immuno-
electrophoresis may be used to detect this release. This assay
for released gp8 serves as an important control in immunoelectro-
phoresis experiments to follow which use prohead-absorbed anti-
prohead serum absorption.
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(b) Absence of prohead-specific determinants on the necks of
tail-less phage
Particles which lack gp9 are morphologically very similar
to phage except that they are missing a baseplate or tail structure.
In the absence of a tail structure, a short cylindrical neck becomes
visible protruding from the icosahedrial head of the particle. Attached
to the distal end of the neck is a single, fiber-like appendage, which
is also partially visible on phage as a fiber extending downward from
the tail structure (see Figure 34 ). Therefore, several sites become
more accessible in the absence of a tail structure. This suggests the
possibility that anti-prohead serum, generated in response to prohead
determinants, may contain antibodies against these same determinants
in the neck region of gp9~ particles which cannot be absorbed out by
phage which carry tails.
An experiment designed to detect neck-specific antibodies in
the anti-prohead serum is shown in Figure 26a. Whole anti-prohead
serum, in the lower trough, precipitates both phage and tail~ heads.
Phage-absorbed anti-prohead serum, in the upper antiserum trough, no
longer precipitates either phage or tail~ heads. These results
suggest that there are no antigenic determinants on gp9- particles
which are not also recognized as being present on phage by anti-
prohead serum; hence, absorption of anti-prohead serum by phage removes
all precipitating activity against tail-less heads. Therefore, anti-
bodies against proteins as they exist in the neck structure of tail-
less phage have not been generated in response to the determinants
present on proheads.
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Figure 26
Absence of Prohead-specific Determinants
on Tail-less Phage and Empty Heads
(a) Sera are as described in the legend to Figure 25a.
(b) Sera are as described in the legend to Figure 25b.
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(c) Absence of prohead-specific determinants on empty heads
Several amber mutant lysates, including 4~, 10~, and 26~ lysates,
produce phage heads in which the DNA is unstably packaged. A large
number of these heads appear to contain DNA when they are present in-
side the bacterial cell, as observed in thin-section electron micro-
scopy experiments (Lenk, et al., 1975); however, the particles lose
their DNA very rapidly at cell lysis (Botstein, et al., 1973). The
resultant empty head structures have been purified from a 10~ 13~
amber mutant lysate (W. Earnshaw, et al., 1976). The experiment in
Figure 26b examines the immunoelectrophoretic behavior of these empty
head structures against whole and phage-absorbed anti-prohead serum.
Whole anti-prohead serum, in the upper antiserum trough, precipitates
the empty heads; phage-absorbed anti-prohead serum, in the lower anti-
serum trough, does not. Perhaps not surprisingly, these experimental
results indicate that the process by which the mutant particles eject their
DNA does not expose prohead-related determinants that are not also pre-
sent on DNA-containing phage.
(d) Antigenicity of aberrant aggregates of gp5
Thus far, the phage-absorption experiments have established that
a class of prohead-specific antibodies exists in anti-prohead serum,
although their target proteins on the prohead have not yet been identi-
fied. One possibility is that these antibodies are anti-gp8 antibodies
reacting with exposed gp8 on proheads; however, if the phage-absorbed
anti-prohead serum can be shown to react with structures which do not
contain gp8, then the presence of additional antibodies other than anti-
gp8 antibodies is clearly indicated. These antibody classes may include
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Figure 27
Residual Activity of Phage-absorbed Anti-
prohead Serum Against Organized P22 Coat Protein
(a) and (b) Sera are as described in the legend to
Figure 25b. (c) The anti-prohead serum has gone through an
additional cycle of phage absorption as compared to the phage-
absorbed serum in panels a and b (see Materials and Methods,
Section , 07). The central reaction in panel a shows the
precipitation of purified spirals. The upperdsymmetrical
smudge is the result of spillover of the antigen during its
addition to the well. The central reactions in panel b and c
show the precipitation of the mixture of aberrant gp5 aggregates
present in these lysates, which includes spirals and two size
classes of closed shell structures.
16G.
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effect often produced by antibody dilution.
Regardless of the fine points, the basic result of this experiment
is clear: phage-absorbed serum continues to precipitate a class of gp5-
containing structures which do not contain gp8. Therefore, the prohead-
specific antibodies in the anti-prohead serum include antibodies against
the coat protein as well as against the scaffolding protein.
The preceding experiment established that anti-capsid antibodies
remained in the anti-prohead serum after phage absorption. However,
the spirals used in the previous experiment were purified from an 8-amH202
lysate which contains a substantial amber fragment. If this gp8 amber
fragment assembled onto some of the spirals, then the positive precipi-
tation of spirals could have been produced, not by anti-capsid anti-
bodies, but by anti-gp8 antibodies reacting with the gp8 amber fragment
present on some of the structures. Therefore, I examined the reaction
of phage-absorbed anti-prohead serum with the structures present in an
8~amN123 lysate, which does not contain a detectable gp8 amber fragment.
The aberrant gp5-containing structures present in the lysate have been
characterized (W. Earnshaw, unpublished experiments). They fall into
one of three morphological classes: either the spiral structures which
have been described, or, into one of two discrete size classes of shells.
These shells have diameters either like that of the proheads or con-
siderably smaller.
Panel b of Figure 27 examines the reaction of whole anti-prohead
serum with these structures; an 8-amN123 lysate has been added to the
central antigen well. (These lysates are also 3~ but that is irrelevant
to this discussion). Precipitation of the structures in this lysate
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results in a single, dense precipitin arc. As expected, this precipi-
tation reaction is gp5-dependent; when a 5~ lysate is used as an anti-
gen, as in the bottom antigen well, only the soluble gp8 band is de-
tectable. When a lysate which lacks both gp5 and gp8 serves as the
antigen, as in the upper antigen well, no precipitin bands are formed.
This same experiment has been repeated in panel c of Figure 27,
except that the anti-prohead serum in both troughs has been fully ab-
sorbed with phage. Phage absorption of the serum significantly reduces
the reaction of the gp5-containing structures from an 8~ lysate; how-
ever, a definite precipitin band persists which is much lighter and closer
to the antiserum trough. Therefore, even in the absence of an antigenic
gp8 amber fragment, phage-absorbed anti-prohead serum continues to react
with structures principally composed of gp5. This result strengthens
the conclusion from the previous experiment: after exhaustive phage
absorptions, anti-prohead serum retains a class of anti-capsid anti-
bodies.
4. Can proheads absorb anti-scaffolding protein antibody?
The immunoelectrophoresis experiments of this section focus
directly on the question: is gp8 in proheads accessible to the environ-
ment? if so, absorption of anti-prohead serum with intact prohead
structures would remove antibodies in the serum directed against the
scaffolding protein. As a consequence, prohead-absorbed anti-prohead
serum would no longer show a precipitin arc against the soluble gp8
present in P22 lysates. Alternatively, if gp8 were not accessible,
absorption of anti-prohead serum with proheads would not affect
its precipitation of soluble gp8. Although this scheme is theoretically
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straightforward, it was technically difficult to prepare the large
amounts of very concentrated proheads necessary to fully absorb the
anti-prohead serum. As a result of this limitation in the availability
of proheads, the sera in these experiments were not fully absorbed and
they continued to precipitate prohead structures. However, as these
experiments will show, even partial absorption of anti-prohead serum with
proheads reduces the anti-gp8 titer sufficiently so that soluble gp8 is
no longer precipitated from lysates.
Proheads were purified from a 1~16~20~13~ amber mutant lysate
(W. Earnshaw, et al., 1976) and used as antigens in the experiment shown
in Figure 28a. These proheads are missing the minor prohead structural
proteins, gpl, gpl6, and gp20, and are composed of only gp5, gp8, and a
minor protein, gp7. In the lower portion of panel a, whole anti-prohead
serum precipitates these proheads. It is important to note that there is
no evidence of soluble gp8 being present in the prohead preparation.
Whole anti-prohead serum precipitates soluble gp8 from a wild-type lysate,
which was present in the central antigen well. The anti-prohead serum
in the upper trough of this panel has been absorbed with 1 16~20~ pro-
heads, although the absorption is far from complete, as evidenced by the
strong, residual precipitation reaction by the absorbed serum against the
proheads. Despite incomplete prohead absorption, the partially absorbed
serum no longer precipitates the soluble gp8 from the wild-type lysate.
These results indicate that prohead structures are very efficient in
absorbing anti-gp8 antibodies from the anti-prohead serum. Therefore,
the conclusion is that gp8 is accessible to the environment. Also, because
of the complete lack of residual activity of the prohead-absorbed serum
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Figure 28
Absorption of Anti-scaffolding Protein Antibodies
From Anti-prohead Serum by Proheads
(a) and (b) Anti-prohead serum from series 7 was absorbed
with an equal volume of 1~16~20~ proheads and incubated for 90
minutes at 380C. The suspension was stored overnight in the
cold to promote precipitate formation. The absorbed serum was
centrifuged at 10,000 rev/min for 10 minutes in a Sorvall SS-34
rotor. Whole anti-prohead serum from series 7 was diluted 1:2.
a)
b)
8'"202 lysate
84 348 lysate
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Ci 162OC prhd.-abs'danti-prohead
anti-prohead
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I anti-prohead
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against soluble gp8, every determinant present on the soluble gp8
molecule appears to be accessible on the proheads.
The experiment in Figure 28b provides an additional check that
anti-gp8 antibodies have been removed from the anti-prohead serum by
prohead absorption. While whole anti-prohead serum, in the lower
trough, precipitates the gp8 amber fragment from an 8-amH202 lysate,
which was present in the outer antigen wells, absorption of this
serum with 1-16-20- proheads causes the gp8 fragment precipitin arc
to disappear, as shown in the upper portion of panel b. Once again,
intact prohead structures have been able to absorb anti-gp8 antibodies
from the serum. Thus, the determinants present on the gp8 amber
fragment are also available in the prohead.
The accessibility of gp8 in 1~16-20- proheads is not a
result of the absence of several minor proteins from the structure.
When 2 proheads, which contain a wild-type complement of prohead
proteins, are used to absorb anti-prohead serum, they also absorb
anti-gp8 antibodies. Figure 29 has been included to show that the
2~ prohead preparation used to absorb the anti-prohead serum does
not contain soluble gp8. Though the anti-prohead sera in both
troughs (one has been only partially absorbed with 2~ proheads) pre-
cipitate soluble gp8 from a wild-type lysate, present in the central
antigen well, neither serum shows a reaction against soluble gp8
when reacted with the proheads. gp8
The possibility existed that the availability of in 1~16~20~
A
proheads was a direct consequence of the absence of several of the
minor proteins from the prohead shell. Therefore, in the following
experiment, I examined the absorbing activity of 2~ proheads, which
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Figure 29
Absence of Soluble Scaffolding Protein in 2 Prohead
Preparation
Anti-prohead serum was absorbed with 2 proheads as
described in the legend to Figure 28. The absorbed serum was
diluted with buffer to yield a final dilution of 1:5. Whole
anti-prohead serum was also diluted 1:5.
2 prohMs
wildt t
2 prohead
2" hea-abs'd
ant -rhead
anti--rohead
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contain a wild-type complement of prohead proteins. In a control
experiment, presented in Figure 30, I showed that the 2~ prohead
preparation did not contain soluble gp8. There is no soluble gp8
precipitin arc present in the reaction of the whole anti-prohead
serum present in the lower serum trough, and the prohead prepara-
tion, added to the outer antigen wells; however, this same serum
precipitates the soluble gp8 in the wild-type control lysate,
present in the central antigen well. This result establishes that
the absorption of anti-scaffolding antibodies by this preparation
must be accomplished by gp8 which is present as a structural com-
ponent of the prohead.
The upper antiserum trough of Figure 30 contains anti-prohead
serum which has been incubated with the 2~ prohead preparation.
The strong residual precipitation of the proheads by the absorbed
serum shows that the absorption was very incomplete. In fact, at
this relatively high concentration of antiserum, the prohead-
absorbed serum appears to precipitate soluble gp8 from the wild-
type lysate, as if the proheads had not removed anti-gp8 antibodies
from the serum. However, appropriate dilution of the serum reveals
that absorption of the serum with 2~ proheads actually does deplete
the serum of its anti-scaffolding antibodies.
In this experiment, whole anti-prohead serum in the upper
troughs, and 2~ prohead-absorbed anti-prohead serum in the lower
troughs, have been 2-fold serially diluted. In each panel, the sera
are reacted with an 8~amH202 mutant lysate in the outer antigen wells
and a 3~ lysate in the central antigen well.
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Figure 30
Absorption of Anti-scaffolding Antibodies by Proheads
Containing a Wild-type Complement of Proteins
Sera are dilutions, as indicated, of sera used in Figure
29.
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I direct your attention to the immunoelectrophoretic patterns
involving more dilute sera, presented in panels d, e, and f. At
these serum dilutions, whole serum precipitates gp8 very efficiently
from a 3 lysate. At the same concentrations, however, prohead-
absorbed serum displays a considerably weaker, and with increasing
dilution, almost undetectable, reaction with the gp8 in the lysate.
Thus, even proheads which contain all of the proteins normally found
in wild-type proheads can absorb the anti-scaffolding protein anti-
bodies from anti-prohead serum. The most likely conclusion from these
accessible
results, then, is that gp8 is A in all prohead structures.
Because the serum was incompletely absorbed by the proheads,
anti-gp8 antibodies, though diminished, were still present in substantial
numbers. Thus, at high antiserum concentration, as in panels a and b,
large numbers of residual anti-gp8 antibodies give a precipitation
reaction with the soluble gp8 of the 3~ lysate which is indistinguish-
able from that of whole serum. It is also only at high antiserum
concentration, as in panel a, that the reaction of the anti-gp8 anti-
bodies with the gp8 fragment is detectable. Both whole and prohead-
absorbed sera produce a precipitin arc against the gp8 fragment; but,
the band resulting from the reaction of the absorbed serum, which we
expect to contain many fewer anti-gp8 antibodies, is indeed substantially
weaker.
In retrospect, it is interesting to think that an experiment
originally conceived of as a control experiment - prohead absorption
of anti-prohead serum - would yield such important information on the
structure of the prohead. In the simplest interpretation of the
results of these experiments, the ability of proheads to absorb anti-
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scaffolding protein antibodies from the serum indicates that gp8
determinants in the prohead are available for reaction with anti-
bodies in the environment. I did not expect this result, in light
of previous conclusions reached in studies using electron microscopy
and X-ray diffraction (J. King et al., 1973; Earnshaw et al., 1976).
Thus, I was eager to substantiate this finding using another approach.
A set of experiments which lead to the same conclusion using electron
microscopy are described in Chapter III.
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E. Sensitivity of the Immunoelectrophoretic Assay
1. Effects of antigen dilution
Insoluble antibody antigen complexes appear in immuno-
electrophoresis only if the antibody and antigen encounter each
other in precise proportions corresponding to equivalence (Grabar,
1964). Too low a concentration of antigen may cause the precipitate
to be located in the antigen well, and too high a concentration may
push the position of equivalence into the antibody trough (J. Clausen,
1971).
The effect of antigen dilution on the immunoelectrophoretic
patterns of P22 wild-type and 8~ lysates is examined in Figure 31
In each panel, wild-type lysate filled the central antigen well, and
8~ lysate, the outer antigen wells. The lower antiserum troughs con-
tained whole anti-prohead serum. The upper antiserum troughs contained
anti-prohead serum which had been incompletely absorbed with 2 proheads.
This absorption seems mainly to have decreased the intensity of the
reactions and will not be discussed separately.
Decreasing concentration of the antigen in Figure 31 has two
obvious effects: the intensities of the precipitin reactions decrease
and the extent to which the antigens diffuse before being precipitated
also decreases. For example, the double-humped structure precipitin
arcs become fainter and more localized with decreasing structure con-
centration. At dilutions greater than 10-fold, the precipitate becomes too
faint to be of analytical use. At 10-fold lysate dilution, the phage titer
in the lysate is approximately 1012 phage/ml. Thus, a high concentration
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Figure 31
Effects of Antigen Dilution on Immunoelectrophoretic
Patterns Using Anti-Prohead Sera
The serum is described in the legend to Figure 29.
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of particles is required for immunoelectrophoretic analysis-
Precipitins of soluble antigens appear to be even more sensitive
to dilution. For example, the precipitation of soluble gp8 from the
wild-type lysate in Figure 31 disappears when the lysate is diluted
5-fold. In comparison, the gp8 amber fragment from the 8- lysate
shows a somewhat stronger precipitation reaction with the serum. Pre-
sumbly, it is present in soluble form in higher concentrations than
the gp8 in the wild-type lysate, some portion of which has assembled
into prohead structures. Even so, at 10-fold dilution of the lysate,
the precipitation reaction of the gp8 amber fragment disappeared.
Precipitation of gp9 from the 8~ lysate in Figure 31 provides
the single instance in which dilution of the antigen appears to in-
crease its precipitation. The gp9 precipitin arc was barely detect-
able when the lysate was concentrated. At 2.5-fold dilution of the
lysate, the band is slightly stronger; and, at 5-fold lysate dilution,
it reaches its maximum density. The precipitation optimum is very
sharp. The reaction becomes barely detectable at 10-fold dilution
of the lysate, and disappears entirely at 20-fold lysate dilution.
This series of observations may be explained if gp9 is present in anti-
gen excess in the undiluted lysate. Because antibody antigen complexes
are typically soluble in antigen excess (Eisen, 1974) gp9 is not vis-
ibly precipitated at high lysate concentration. Lysate dilution re-
duces the concentration of gp9 to equivalence and a precipitate form.
This precipitation falls off rapidly, however, with decreasing anti-
gen concentration. The gp8 present in the lysate did not seem to be in
excess of the number of anti-gp8 antibodies in the serum. There-
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fore, I conclude that the concentration of anti-gp9 antibodies in the
anti-prohead serum is lower than that of the anti-gp8 antibodies. This
seems reasonable as anti-gp9 antibodies were presumably generated in
response to contaminating tails in the prohead preparation, while
anti-gp8 antibodies were produced against large numbers of gp8 sub-
units exposed on the prohead structure.
In general, the results indicated that only very narrow ranges
of antigen concentrations produced visible precipitates, particularly
in the case of the soluble antigens. Perhaps this explains why I have
never detected soluble gp9 in immunoelectrophoresis of wild-type
lysates (see, for example, Figure 17 and 18). The immunoelectrophoresis
results seem to contradict the data presented in Table 5, which had
shown that a wild-type lysate contained a considerable amount of soluble
tailing activity. The results of the antigen dilution experiment
suggest an explanation: the concentration of soluble gp9 in the wild-
type lysate may be too low to yield detectable precipitation. Apparently,
a 5-10-fold increase in the concentration of gp9, as occurs in 5~, 8~
and 2~ lysates which overproduce gp9, is sufficient to produce a visible
precipitation reaction (compare Figures 20a and 17a for anti-phage serum,
and see Figure 31 for anti-prohead serum).
2. Effects of antiserum dilution
Serum blocking experiments have shown that almost all of the phage-
killing titer of anti-phage and anti-prohead serum results from the bind-
ing of anti-gp9 antibodies to the phage tail. Thus, for anti-gp9: gp9
precipitation reactions, the sensitivity of the system to antibody dilu-
tion may be expressed in terms of k equivalents. The experiment in
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Figure 21c defines a lower limit for the k value of serum which will
show visible precipitation of gp9. Soluble gp9, at a concentration
of 6 x 1014 phage equivalents/ml, was precipitated strongly by a
serum with a k of 1700 min-1 but shows only a very faint diffuse
precipitation reaction with serum from an earlier bleeding, with a k
of 500 min-1 . Similar limits of detection were found using dilutions
from a single antiserum pool against the gp9 in 5~, 8- and 2~ lysates.
The concentration of gp9 in these lysates, probably about 1015 phage
equivalents/ml, is similar to that of the purified gp9 preparation of
Figure 21c, discussed above. In Figure 17c, for example, anti-phage
serum with a k of about 500 min~I just barely precipitated gp9 from a
5~ lysate. In contrast to this weak precipitation behavior, anti-
phage serum with a k about ten times higher precipitated purified gp9
and gp9 from 5~, 8~ and 2~ lysates (Figure 20) very efficiently. Anti-
prohead serum at a k of 50 min-1 (Figure 18b) or even 100 min-1 (Figure
32) did not precipitate gp9; anti-prohead serum with a k of about 500
min~ precipitates gp9 (Figure 22); and anti-prohead serum with a k of
about 1700 min~1 did so effectively (Figure 21).
The precipitation of structures appears to be somewhat less
sensitive to antiserum dilution. In Figure 30, anti-prohead serum
which is 160-fold diluted still precipitated structures quite strongly.
The relative insensitivity of structure precipitation to antiserum
dilution may simply reflect the high concentration of antibodies against
proheads in the anti-prohead serum; however, the large size of P22
structures may also be a contributing factor. Molecules with molecular
weight greater than about 200,000 daltons are too large to diffuse
freely through the micelle structure of the agarose matrix (J. Clausen,
1971).
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DISCUSSION
Considering that proheads contain six species of phage proteins,
tail heads contain eight, and phage contain nine, the antisera made
against each of these particle types contained relatively few classes
of antibodies. Proheads induced antibodies against gp5 and gp8, the
major prohead proteins; phage induced antibodies against gp5 and gp9,
the major proteins of the phage; and tail~ heads induced antibodies
against gp5, the major head protein.
It is difficult to ascertain whether the sera contain antibodies
against the minor proteins and that these were not detected, or whether
such antibodies were not induced in the rabbits in the first place.
The sensitivity of the assay indicated that high concentrations of
both antigen and antibody are needed to form detectable precipitin
arcs in immunoelectrophoresis. Thus, minor antibody species would not
be detected. On the other hand, the three antigens are also displayed
as repeating arrays on the immunogenic particles, and may have been
more effective immunogens than the minor proteins.
I originally started characterizing the antisera using
Ouchlerlony double-diffusion techniques (J. Clausen, 1971). However,
I quickly switched to immunoelectrophoresis experiments because the
interpretation of the data was made considerably easier by the extra
dimension of separation given by electrophoresis of the antigens prior
to their diffusion. In addition, the information obtained regarding
the relative electrophoretic mobilities of gp8 and its amber fragments
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greatly facilitated the identification of anti-scaffolding antibodies
in the anti-prohead serum. Because immunoelectrophoresis also involves
double diffusion, information as to the antigenic-relatedness of species
by analyzing their fusion and spur formation behavior is also available.
It is only in the area of the relative sensitivities of the two methods
that immunodiffusion may have a slight advantage in that 10-30 times the
volume of antigen is routinely used in immunodiffusion. Thus, given
the sensitivity of the precipitation reaction to antigen concentration,
immunodiffusion may be useful in detecting antibody-antigen reactions
in which the antigen concentration would be too low for detection by
immunoelectrophoresis.
Infection with P22 elicits a new somatic antigen on the infected
cell surface (Levine, 1972). Antibody induced in the rabbit by con-
taminating cell envelope fragments would not be absorbed out by unin-
fected Salmonella cells. However, it is unclear whether this induced
host antigen would be expected to yield a precipitin band.
The potency of the tail and the scaffolding proteinsas
immunogens is evidenced by the level of antibody against them induced
by low levels of particles. Thus, the empty phage particles contamin-
ating the prohead preparation represented only a few % of the total
prohead particles injected, and yet they elicited a very substantial
antibody response. Similarly, the tail-less heads were contaminated
with only a few % proheads, yet they elicited a substantial concentra-
tion of anti-gp8 antibodies. In hindsight, I realize that the proheads
should have been induced from a lysogen, to avoid contamination from in-
put particles, and the tail-less heads should have been further purified.
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However, at the time of the experiment, I was not aware of the potency
of these particles as immunogens.
Phage heads without a tail show clearly a short neck structure
with a thin projecting fiber. I had expected that antibodies would
be induced against the proteins in this structure. Apparently either
the antibodies are induced in too low a concentration to be identified,
or the constituent proteins are not immunogenic. I tend to favor the
latter model for the following reason. Reactions which involve the
precipitation of whole phage are easily detected, because even a low
concentration of antibodies, reacting with only a few determinants on
the particle, still precipitates a high concentration of protein. In
the experiment in which anti-head serum was absorbed with whole phage,
the residual activity of the serum against tail-less heads was tested.
As discussed above, this should have been a relatively sensitive test
for the existence of neck-specific antibodies. The negative results
indicate that the serum did not contain anti-neck antibodies, unless
these are also available in mature phage particles.
The absence of a precipitin band in 8 lysates corresponding
to the reaction of gp5 coat subunits and anti-gp5 antibodies was unex-
pected. However, similar results had been found by Yanagida with
phage T4 (1972). There is some evidence of a free pool of gp5 sub-
units in 8~ lysates, but this comes from labelling experiments (Casjens
and King, 1974). The gp5 subunits might aggregate or precipitate in
the concentrated lysates used under conditions for immunoelectrophoresis.
The induction of antibodies directed against scaffolding protein
by proheads was somewhat of a surprise. However, the identification
of these antibodies as anti-gp8 antibodies follows directly from the
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immunoelectrophoretic patterns of the 8~ amber mutants in which the
normal precipitin band disappeared and a new one appeared. Mixing
experiments in which the new band fused with the old band confirms
that the new band represents an amber fragment. The fact that at
least two amber fragments of the scaffolding protein were antigenic
and gave a discrete precipitin arc indicates that they are in a con-
formation similar to the mature protein. This is also consistent
with in vivo experiments which indicate that these fragments still
have the autoregulatory functions of the mature protein (King, Hall,
and Casjens, personal communication).
It is not clear why amber fragments of gene 9 weren't detected.
They may be unstable within the cell, or may not be antigenic. The
gene 5 amber fragments are unstable and are degraded within the cell
(King and Casjens, unpublished results).
Though the lysate experiments showed conclusively that anti-
prohead serum contained anti-gp8 antibodies, it was possible that
this was due to induction by scaffolding protein released from the
proheads during preparation, or in the rabbit. The ability of pro-
heads to remove anti-gp8 from the serum rules this out. Either gp8
is normally accessible in proheads, or it becomes accessible upon
incubation with antiserum. The latter is not unreasonable, since
detergent binding releases scaffolding protein (Casjens and King, 1974)
and since the release must occur in the normal processes of morpho-
genesis. It is not clear whether such release takes place at a par-
ticular site on the prohead, for example, a site of DNA entry, or
whether the scaffolding protein projects through the entire lattice.
This question is taken up in the next chapter.
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APPENDIX
Calculation of Relative Surface Changes of P22 Structures from
their Relative Electrophoretic Mobilities
1. Comparative immunoelectrophoretic behavior of P22 structures
In previous immunoelectrophoresis experiments, P22 structures
migrated different distances from their points of origin during
electrophoresis. The migration behavior of several P22 structures
are systematically compared in Figure 32. In panels a-c, purified
wild-type phage have been added to the outer antigen wells to serve
as electrophoretic standards. Whole anti-prohead serum has been added
to each of the upper antiserum troughs, and 5~ lysate-absorbed anti-
prohead serum, previously shown in Figure 18b to be fully absorbed,
filled each of the lower antiserum troughs.
In panel a, a sample of tail-less heads has been added to the
central antigen well. These tail-less heads electrophorese slightly
faster than phage, a phenomenon also apparent in a comparison of the
relative positions of phage and heads in Figure 26b. In panel b, the
central antigen has been filled with purified proheads, which migrate
considerably faster than either phage or tail-less heads. In panel c,
purified 10~ empty heads (provided by W. Earnshaw) were added to the
central antigen well. These particles, which characteristically lack
tails, migrate more slowly than proheads, slightly faster than phage,
and with approximately the same mobility as tail~ heads.
In panel d, the electrophoretic mobilities of empty heads, phage,
and proheads are compared directly using whole anti-prohead serum.
The actual measured distances which these particles have migrated from
the center of the antigen well are shown in Table 6.
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Figure 32
Comparative Immunoelectrophoretic
Behavior of P22 Structures
(a) - (c) Sera are as described in the legend to Figure
18b. (d) Anti-prohead serum is from series 7.
ph.ge - ,1L
tail heads
hage
b)
proheade
anti-prohead
5 lys. absorbed
an-. absorbed
astlmrba
C)
emPty heads
phage .
empty heads
phage
anti-.rohead
5' lye, absorbed
anti- Rohead
anti-prohead
anti-prohead
proheads
a)
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Table 6
Relative Electrophoretic Mobilities of P22 Structures
Distance Migratd (Relative Electrophoretic MobilityFigure itneMgaed (cm) (Distance Ratios)
Proheads Empty heads Tail~ heads Phage PH/0 EH/0 PH/EH HD/0
(PH) (EH) (HD) (0)
31d 1.9 1.6 1.5 1.27 1.07 1.19
31a 1.1 1.0,1.05 1.08
31b 1.45 1.1,1.1 1.32
31c 1.5 1.25,1.3 1.18
26b 1.35 1.25 1.08
1.15
Average Relative Electrophoretic Mobility: > 1.3 1.13 1.17 1.08
PH/EH = 1.3/1.13 = 1.15
To measure the distance migrated, I dropped a perpendicular from the summit of the arc of the struc-
ture precipitate to a line parallel to the axis of migration. I measured the distance from this
perpendicular to a perpendicular dropped from the center of the antigen well. (In general, one
measures the distance which the protein has migrated from the point of zero mobility, but an elec-
trically neutral species was not included in the runs).
As indicated, PH/EH ratios calculated from average PH/0 and EH/0.
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2. Relationship between electrophoretic mobility and surface
charge
I wondered whether the differences in the electrophoretic
mobilities of the P22 structures was simply a result of differences
in their frictional co-efficients, or whether differences in their
net surface charges might also be contributing. These variables are
related in the following way (J. Cann, 1968): during electrophoresis,
a uniform electric field of intensity E exerts a force qE on an
isolated particle of charge q, assuming it is suspended in a perfect
insulator. The particle is accelerated until the opposing frictional
force, f, exerted by the surrounding viscous medium just equals the
electrical force, after which time the particle moves with constant
velocity, v, according to the relationship:
qE = fv
Therefore, the theoretical electrophoretic mobility, y, of a particle
of arbitrary shape is:
y = v =
E_ f
This calculation assumes that the electrophoresing particle
exists in a perfect insulator. In reality, particles surround them-
selves with an ion cloud of opposite charge which tends to decrease
their electrophoretic mobility. The perfect insulator assumption may
be particularly inadequate in the following calculations which attempt
to describe the relative electrical states of virus structures. These
particles carry multiple charges dispersed over complex surfaces; thus,
charge differences between two particle surfaces may affect the compo-
sition and distribution of their ion clouds, and so, their apparent
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electrophoretic mobilities, in extremely complicated ways. Therefore,
the theoretical calculations presented below provide only an approxi-
mation of the relative surface charges on the virus structures.
3. Experimental limitations: measurements of the relative
electrophoretic mobilities
Had I designed the experiments to measure the absolute electro-
phoretic mobilities of the particles, I could have gotten an estimate
for the absolute charge on the particles, which may have been of
interest. However, the determination of absolute electrophoretic
mobility depends upon experimental conditions such as the strength
of the electric field, the duration of the run, the pH and ionic
strength of the buffer, and the temperature (J. Uriel, 1964). At
the time I did these immunoelectrophoresis experiments, I did not
monitor or control these variables with the kind of precision which
would be required to obtain meaningful data. Furthermore, the
measurement of the absolute electrophoretic mobility of a particle
requires knowing the point of zero mobility in the system. This
defines the position to which an electrically neutral substance would
migrate during the run. It is often different from the point of
application because of the electro-osmotic flow of the liquid phase
relative to the supporting medium (Grabar, 1964). As I did not include
material known to be electrically neutral in the runs, such as glucose
or dextrans, this variable could not be determined.
However, the electrophoretic mobilities may be expressed in
relative values as well; and, in fact, they often are because of the
difficulties involved in establishing and maintaining reproducible
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conditions (J. Uriel, 1964). Ifjpr is the mobility of a standard
reference protein, and p , the mobility of the protein under study,
then the ratio m,/pr should be constant, regardless of the particular
electrophoretic conditions, as long as the migration velocity of the
proteins is constant. This is true for proteins in agar for the
first 4-5 hours of electrophoresis (J. Uriel, 1958).
Values for the distances migrated by various P22 structures,
taken from Table 6, were used to calculate relative electrophoretic
mobilities for empty heads, proheads and tail-less heads, using
mature phage as reference structures. The calculated values, and
their averages are also presented in Table 6.
4. Calculation of the frictional co-efficients of P22 proheads
and empty heads
(a) Calculations assuming proheads and empty heads are
solid spheres
In order to determine the relative surface charges of proheads
and empty heads (this choice of particles will be explained presently),
I needed to know their frictional co-efficients. I estimated the
frictional co-efficients in two ways. Each had its limitations, and I
was interested in the range in values the two methods would generate.
First, I treated proheads and empty heads as solid spheres of
known radius. Although we know from X-ray diffraction work (Earnshaw,
et al., 1976) that empty heads and proheads are not solid spheres, the
same data provides us with an accurate measure of their radii. With
these measurements, we can calculate the frictional co-efficients of the
particles from the equation:
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f = 6iY r r
where q is the density of water (0.01 centipoise), and r is the
radius in cm (J. Cann, 1968). Values for the radii of the particles
and their calculated frictional co-efficients are shown in Table 7,
Method I. The accuracy of these values depends upon the extent to
which proheads and empty heads deviate from the behavior of solid
spheres.
(b) Calculations using sedimentation behavior of proheads
and empty heads
Perhaps a better estimate for the relative frictional co-
efficients of the particles can be obtained from their relative
sedimentation co-efficients as these are based on experimental
measurements of the behavior of the particles during sedimentation.
The relevant equation for the relationship between the frictional
co-efficients of proheads (PH) and empty heads (EH) and their sedi-
mentation behavior is (K.E. Van Holde, 1971):
S20, w (_H) M (PH) (1-vp) f (EH)
S20, w (EH) f (PH) M (EH) (1-9p)
Because the partial specific volume, v, for proteins is typically 0.73
(K.E. Van Holde, 1971), and because proheads and empty heads are com-
posed of only protein, I am assuming that the term (1-vp) cancels out.
That is also why I am restricting this set of calculations to particles
which do not contain DNA. Therefore:
f (PH) M (PH) S20, w (LH)
f (EH) M (EH) S20, w (.)
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Table 7
Calculation of Relative Frictional Co-efficients
for Proheads and Empty Heads
Method I: assumes proheads and empty heads to be solid spheres
f = 6 fr q r = density of water =
0.01 centipoise
r = radius in cm
PH
295
EH
0
335 A
f 5.56 x 10~7 6.32 x 10~7
r PH 295
- = 0.88
r EH 335
Method II: data from sedimentation behavior
Equation2: f PH S EH
= x
f EH
f PH
f EH
S PH
170
M PH
M EH
3.7
- x - = 1.02
240 2.6
1 Radii were taken from curves of Figure 7 in Earnshaw, et al.,
1976, as the points at which the curves crossed zero dinsty.
A correction of 5A was added to this number to adjust for a
possible sphere of hydration about the particle.
2 Molecular weights of the particles are taken from Table 8.
Equation:
radius
f PH
f EH
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Values for the S20 , w of P22 phage have been determined by
a comparison of their sedimentation behavior in a 5-20% linear sucrose
gradient with that of T7 phage (Botstein, et al., 1973), for which a
precise value of S20, w has been determined. Because the gradient is
linear, a direct linear relationship exists between the distance
traveled by one particle relative to another of the same density, and
their sedimentation co-efficients. The values of 170S for empty heads
and 240S for proheads (Botstein, et al., 1973) have been calculated
by comparison of their sedimentation behavior with that of P22 phage.
This estimation assumes equivalent densities, although phage contain
DNA and empty heads and proheads do not; thus, the absolute values for
the S20, w of empty heads may be different from 170S and 240S. However,
the difference in the sedimentation co-efficients calculated in this
manner is an accurate measure of the difference between their true
S20, w valuesbecause the particles being compared in this instance are
of the same density. In this particular set of calculations, accuracy
in the relative sedimentation co-efficients is sufficient because we
are mainly interested in the relative frictional co-efficients of the
particles.
The uncertainties in the calculation of the frictional co-
efficients from sedimentation behavior derive mainly from uncertainties
in the molecular weights of the particles, which may be substantial. I
estimated the molecular weights for the proheads and empty heads by
multiplying the molecular weight of the known structural components by
the number of copies believed to be present in each structure (S. Casiens
and J. King, 1974). The computation and its result are shown in Table 8.
Table 8
Molecular Weights of Proheads and Empty
HHeads
Gene Product2  No. of Copies Monomer Molecular Weight Contributed
Molecular Weight by Gene Products in the
(dal tons) Structure (daltons)
(2) (1) x (2)
5 420 420 55,000 2.3 x 107 2.3 x 107
8 250 - 42,000 1.1 x 10 -
1 10 9 94,000 9.4 x 105  8.5 x 105
16 10 7 67,000 6.7 x 105 4.7 x 105
20 18 14 50,000 9 x 105 7 x 105
7 20 20 18,000 3.6 x 105 3.6 x 105
4 - 10 15,000 - .5 x 105
Sums: 3.7 x 107 2.6 x 10
Values for monomer molecular weights and the
taken from S. Casiens and J. King, 1974.
number of copies of gene product in the structure
Table 8 (Contd.)
Molecular Weights of Proheads and Empty Heads
2 These calculations leave out figures for gplO (MW = 50,000 daltons), (MW = approximately 10,000
daltons), believed to be minor components of the phage. Gene product 9 is not a component or
10 empty heads.
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Using the relative molecular weights and relative sedimentation
co-efficients thus obtained, the relative frictional co-efficients of
proheads and empty heads were calculated. The computation and its
result are shown in Table 7, Method II.
According to this calculation, the frictional co-efficients of
proheads and empty heads are very similar, differing only by a factor
of 1.02. In the previous calculation, assuming proheads and empty
heads were solid spheres, the frictional co-efficients differed by a
factor of 0.88.
5. Calculation of the relative surface charges of proheads and
empty heads
We have obtained a value for the relative electrophoretic
mobilities of proheads and empty heads, and two estimates for their
frictional co-efficients. Therefore, we can determine the relative
surface charges of proheads and empty heads according to the equation:
Values for the relative surface charges of the particles using
the two methods outlined above are shown in Table 9. They vary from
1.03 to 1.19. Therefore, if we assume that empty heads and phage heads
which contain DNA have the same surface charge, then these calculations
suggest that there is no gross change in the relative surface charges
of the capsid shells in the transformation from prohead to phage.
How good an assumption is it, though, that empty heads and phage
have the same surface charge? The data in Table 6 actually suggest that
empty heads migrate faster than phage by a factor of 1.08. However,
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Table 9
Calculation of the Relative Surface Charges
of Proheads and Empty Heads
Equation: q PH
q EH
Method I : q PH
q EH
Method 22: q PH
q EH
u PH
y EH
1.17
f PH
f EH
0.88
q = surface charge
= electrophoretic
mobility
f = frictional co-
efficient
= 1.03
1.17 1.02
x - = 1.19
Relative frictional co-efficients taken from Table 7, Method I,
assuming proheads and empty heads to be solid spheres.
2 Relative frictional co-efficients taken from Table 7, Method II,
using data from the sedimentation behavior of proheads and empty
heads, and particle molecular weights as calculated in Table 8.
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this difference may well be caused by the lack of gp9 in these 10~
empty heads, rather than some surface charge difference in the
capsids. This is suggested by the fact that tail heads, which con-
tain DNA but lack tails, electrophorese faster than phage by about
the same amount as the tail-less empty heads.
Therefore, insofar as I can tell at this level of computation
and with these data, the maturation of a P22 phage from a prohead
precursor occurs without major changes in the surface potential of
the capsid shell.
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Chapter III: Electron Microscopy of Antibody-coated P22
Structures
Previous experiments have shown that injection of P22 phage into
rabbits induced the synthesis of antibody against the gene 5 major coat
protein and the gene 9 tail protein. Injection of proheads pri-
marily generated antibodies to the coat protein and also to the gene 8
scaffolding protein. A question arises, however, as to whether the in-
duction of antibodies by these antigens actually indicates that the
antigenic determinants are exposed at the particle surface. The
possibility exists, for example, that internal proteins were released
as a result of structure degradation either prior to injection, during
mixture of the structures with the adjuvant, or afterwards, in the
tissues of the rabbit. This question is particularly relevant in
relation to the scaffolding protein. X-ray and electron microscopic
investigations (Lenk, et al., 1975; Earnshaw, et al., 1976) had suggested
that the scaffolding protein was primarily located within the particle.
Yet, results from immunoelectrophoresis experiments have indicated that
determinants on the scaffolding protein are available to the environ-
ment for reaction with anti-scaffolding protein antibodies. Thus, I
felt it was important to pursue this question further. Secondly, although
immunoelectrophoresis experiments showed that the antigenicity of the coat
protein in the phage and its prohead precursor particle was very similar,
there was also evidence for a set of unique gp5 determinants on proheads.
These apparently became unavailable during maturation of the virus capsid.
I was interested to see whether these unique capsid determinants might be
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located at a limited number of sites on the prohead, such as those
which give rise to the vertices of the viral icosahedral head, for
example.
Using high resolution transmission electron microscopy and
simple negative staining techniques, antibodies bound to phage struc-
tures can be visualized directly as fine, hair-like projections extend-
ing from the positions of the target antigens (M. Yanagida and C. Ahmad-
Zadeh, 1970; S. Casiens and R. Hendrix, 1974; M. Tosi and Anderson,
1973). Thus, once the antisera have been characterized, electron
microscopy of antibody-coated particles provides a method for deter-
mining the location of known antigenic proteins on the structures.
A. Experimental Approach
Rather than examining the binding of antibody molecules to each
of the various classes of purified phage structures separately, I pre-
pared a mixture of P22 proheads, phage, tail-less heads, and spirals
(from 8~ infections provided by W. Earnshaw). The mixture also con-
tained purified T4 phage (provided by Dr. P. Berget) as a negative con-
trol. This allowed me to examine on the same sample grid the specificity
of antibody binding to several particle types at once. Electron micro-
graphs of these mixtures are shown in Figure 33. Two phage are present
in the upper right-hand corner of panel a. The phage carry small tail
structures and the phage on the left shows a short, fine tail fiber pro-
jecting from the center of the tail. (The tail fiber, only occasionally
visible, can be seen more clearly in the higher magnification electron
micrograph of Figure 34.) A tail-less head is present in the center of
the upper panel, showing the short neck and,vaguely, the projecting single
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Figure 33
Morphology of the Unreacted Antigen Mixture
(a) Electron micrograph of the negatively stained mixture
of particles before incubation with antiserum. This antigen
preparation, described in Materials and Methods, Section j, i
and vi, includes P22 phage, proheads, and a tail-less head in
the center of the micrograph. T4 phage are also present. The
tail fibers of the T4 phage are in close proximity to the sheath
in these experiments. The length of the T4 head, 100 nm, serves
as an internal standard of measurement. Magnification is about
110,000 x.
(b) Electron micrograph of the negatively stained mixture
as in (a), except that spiral structures are also present. The
upper left aggregate of particles contains an empty shell struc-
ture which may represent one of the two aberrant shell classes
contained in 8~ lysates. Note that the proheads in this figure
exhibit inner dense material. Magnification about 110,000 x.
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Figure 34
Morphology of the Tail and Neck Structures of P22 Phage
Electron micrograph of P22 phage which includes a tail-
less head. The morphology of the phage tail and neck structure
and fiber are particularly clear in the phage and tail-less heads
which are in contact in the central area of the figure. Prepara-
tion and purification of the phage are described in Materials and
Methods, Section j, i, 1.
'31.
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fiber. Proheads are easily distinguishable by the partial penetration
of stain which defines the outer shell and the inner stain-excluding
scaffolding protein. The lower panel (b) shows a field with a number
of spiral structures, also clearly distinguishable from both proheads
and phage.
The experimental protocol in these experiments was as follows:
First, the structures in the mixture were absorbed to electron micro-
scope grids prior to their incubation with the antisera. Unabsorbed
particles were washed off. Particles were incubated with antiserum by
simply inverting the grids onto a drop of antiserum for 15 minutes or
more at room temperature. Incubation was terminated by washing off the
unreacted antiserum. Finally, the samples were stained according to
standard negative staining procedures.
There are several advantages and disadvantages to this method.
First, it is simple and efficient. By using a mixture of particles, one
obtains many pieces of data from a single grid. Furthermore, the pre-
sence of experimental and control particles on the same grid facilitates
their direct comparison. Of course, using this procedure, one must be
able to identify the particles according to their morphology even after
antiserum incubation. Pilot experiments showed that this was not a pro-
blem except, perhaps, in distinguishing antibody-coated empty heads from
coated proheads. However, empty heads were not intentionally added to
antigen mixture and would have been present only as contaminants of the
prohead preparation or as phage breakdown products. Therefore, they
represented only a small source of error. A second advantage is that a
large number of antibodies can bind to the particles without causing their
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aggregation because the particles have been previously absorbed to the
electron micrscope grid. However, in this procedure, unreacted anti-
body molecules also bind to the grid. Thus, all detail must be viewed
against a protein saturated background, which actually appears granu-
lar. In addition, I found that particles in the mixture would desorb
from the grid during incubation on the antiserum drop, unless the anti-
serum involved was specifically directed against that sort of particle.
In fact, this actually worked to my advantage as this became a sort of
assay for residual antibody activity. This effect is illustrated in
the following experiments.
B. Coating of Particles by Anti-phage Serum
1. Whole serum
Immunoelectrophoresis experiments showed that anti-phage serum
precipitated phage and proheads. Figure 35 shows the appearance in the
electron microscope of these particles after reaction with anti-phage
serum. The stain-excluding P22 phage particles are coated with fine
hair-like appendages having the dimensions and appearance typical of
bound antibodies (Yanagida and Ahmad-Zadeh, 1970; Casjens and Hendrix,
1974). Proheads appear as dark spheres and are also antibody-coated.
The coated proheads do not seem to exclude the stain as strongly as
uncoated proheads, as if there is some rearrangement of the inner pro-
teins. The outside surfaces of spiral structures also appear coated.
The edges of all these particles are easily distinguished from the well-
defined boundaries of the corresponding uncoated particles in Figure 33
or the sharp edges of the T4 phage on the same grid. The T4 phage
served as a negative control and showed that the antiserum was specific
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Figure 35
Specific Coating of P22 Particles by Anti-P22 Phage
Serum
Electron micrograph of the antigen mixture after incubation
with anti-P22 phage serum showing antibody coating of the P22
particles. Note the fine, hair-like extensions at the edges of
the P22 phage, proheads and spirals which are missing from the T4
phage. The large, round dense object in the left central portion
of the figure probably represents a membrane component.
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for P22 phage.
The coating of phage tails by anti-gp9 antibodies is not obvious.
However, the phage tail protrudes from the capsid only by about the
length of the antibody molecules themselves. The reaction of phage tails
with anti-gp9 antibodies does become visible in the absence of anti-
capsid antibodies as shown in the following experiment.
2. Prohead-absorbed anti-phage serum
The immunoelectrophoresis results using anti-phage serum suggested
that all of the coat protein determinants on phage were also present on
proheads. To test this, I absorbed anti-phage serum with proheads. I
expected that this absorption would eliminate coating of both the phage
and prohead shells but leave the phage tails specifically coated. The
results of such an experiment are shown in Figures 36 and 37.
I was surprised to find that, in general, only phage particles
were present on the grids even though I applied the identical mixture
of structures as used in Figure 35. Occasionally, proheads and spirals
were present, as in the rarer fields shown in Figure 37, but there were
virtually no T4 phage. According to the rationale previously discussed,
I have interpreted these observations to mean that all the antibodies
reactive with proheads and spirals have been absorbed. As expected, on
the other hand, prohead absorption apparently has left behind anti-gp9
antibodies which bind to the phage tail and aid its adherence to the grid.
As shown in Figures 36 and 37, the antibody-coated phage tails appear
as rather indefinite but substantial extensions of the phage capsids (see
arrows). Although phage tails which have not been incubated with serum
may occasionally have a somewhat disordered character, in general, they
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Figure 36
Absence of Coating Other than of Phage Tails
by Prohead-absorbed Anti-phage Serum
Electron micrograph of the antigen mixture after incubation
with prohead-absorbed anti-phage serum. Note that the field con-
tains almost exclusively phage particles. Arrows point to phage
tails whose morphology have been visibly altered by antiserum in-
cubation. The phage (top) and prohead (bottom) capsids at the
extreme right of the figure show some evidence of coating, indi-
cating that the serum may not be fully absorbed. Most of the
capsids of the phage, however, appear antibody-free. Magnifica-
tion about 110,000 x.
2 ~'.
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Figure 37
Absence of Coating of P22 Spirals and Proheads
by Prohead-absorbed Anti-phage Serum
(a) Electron micrograph of antigen mixture in the prohead-
absorbed anti-phage serum showing absence of antibody coating of
the P22 spiral. Arrow points to phage tail amplified by antibody
coating. Magnification about 110,000 x.
(b) Electron micrograph of antigen mixture as in (a)
showing the absence of antibody coating of the proheads by prohead-
absorbed anti-phage serum, showing that the serum is, at least, sub-
stantially absorbed. Arrows point to representative examples of
antibody-coated tails. Magnification about 110,000 x.
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are almost always shorter, denser, and more resolved than tails treated
with prohead-absorbed anti-phage serum. Note that antibody-coated tails
are difficult to see even in the absence of anti-capsid antibodies;
this explains, in Figure 35 for example, why antibody-coated tails were
not more obvious in the reaction of phage with whole serum.
The most significant feature of these experimental results is the
absence of coating on the shells of the phage particles. Thus, prohead
absorption removes all anti-gp5 antibodies from the serum. This con-
firms the earlier result that all gp5 antigenic determinants present in
the capsid of the phage are also present in the precursor prohead shell.
C. Coating of Particles by Anti-prohead Serum
1. Whole serum
Results from immunoelectrophoresis experiments showed that anti-
prohead serum precipitated proheads and phage. Reaction of the particle
mixture with anti-prohead serum as seen in the electron microscope is
shown in Figure 38. The appearance of the particle is basically the
same as particles which had been reacted with anti-phage serum (Figure
35). P22 proheads, phage and spirals are coated with antibody; T4 phage
are not. The antibody-coated proheads in this experiment appear fully
penetrated by stain.
Thus, antibodies made against proheads specifically coat P22 phage,
proheads and spirals. The specificity of these reactions is investi-
gated in the following experiments.
2. Phage-absorbed serum
Exhaustive absorption of anti-prohead serum by phage should remove
most of the anti-coat protein antibodies from the serum. From the
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Figure 38
Specific Coating of P22 Particles by Anti-P22 Prohead Serum
(a) Electron micrograph of the antigen mixture after reaction
with anti-P22 prohead serum. Phage, proheads and the spirals are
coated with antibodies. Magnification about 110,000 x. (b) Elec-
tron micrograph of antigen mixture as in (a) except that the absence
of T4 phage coating by the antibody shows the P22 specificity of the
serum.
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immunoelectrophoretic results the remaining antibody should be pri-
marily anti-scaffolding protein, and antibody directed against coat
protein determinants only found on proheads. The standard mixture
was treated with phage-absorbed anti-prohead serum, and the results
are shown in Figure 39.
Again in this experiment, the number of particles present on
the grids was substantially lower in the case of particle-absorbed
serum than with whole serum. In this experiment, T4 phage could be
found on the grids, though few in number. Wherever possible, these
fields containing T4 phage were used for electron micrographs, which
is why T4 phage appear in each micrograph in Figure 39. A few P22
phage were also present on the grids. Relative to T4 and P22 phage,
spirals were present in significant numbers. Proheads formed the
largest class of particles on the grids. This distribution of
particles is consistent with the expected levels of residual antibody
activity, given that the more that antibodies are present against a
particular particle class, the more likely these particles are to
stick to the grid.
As shown in Figure 39, the phage particles are not coated, as
expected since the serum is fully phage-absorbed. Antibody coating
of the proheads is substantially reduced, compared to the amount of
coating produced by whole anti-prohead serum at the same dilution
(see Figure 38). The reduced amount of coating is significant, however,
when compared with the relatively antibody-free T4 and P22 control phage
in the same field. The coating was increased specifically by incubation
with more concentrated serum (see Figure 40, for example). Therefore,
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Figure 39
Coating of Proheads by Phage-absorbed Anti-
Prohead Serum
(a) Electron micrograph of antigen mixture after reaction
with phage-absorbed anti-prohead serum. Note that P22 phage is
uncoated showing that the serum has been fully absorbed with
phage. The proheads in this panel are clearly antibody-coated.
(b) Electron micrograph of antigen mixture as in (a)
except for the presence of a spiral structure. This spiral
appears to be coated with antibody on its upper edge. As such,
it is representative of a minority class of the spirals which
reacts with the residual antibodies of the phage-absorbed anti-
prohead serum. The prohead in this panel clearly shows anti-
body binding.
(c) Electron micrographs as in (a) and (b). The spirals
in this panel appear antibody-free and these are representative
of the antibody-binding characteristics of the majority of the
spirals. The proheads are not so clearly coated with antibody as
in panel (a) and (b) but for some their edges do appear somewhat
more indefinite than in unreacted proheads.
(d) Electron micrograph as in (a) - (c). The level of
coating of these proheads in this panel is detectable but lower
than in panels (a) and (b).
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these results show that, as predicted, absorption of anti-prohead serum
with phage removed a large fraction of the prohead-coating antibodies.
A smaller residual antibody fraction continued to coat proheads after
absorption and this presumably included anti-gp8 antibodies.
The coating of the spirals in this experiment is rather inter-
esting. Most of the spirals examined did not show detectable antibody
binding. However, there seemed to be a smaller population of spirals
(roughly 15%) which were coated by a small but significant number of
antibodies. The coating of the spiral in panel b is representative of
the appearance of this fraction. Indications that there might be two
populations of spirals were also present in previous immunoelectro-
phoresis experiments (see Figure 27a). One class of spirals appears
to be antigenically identical to phage; a second, smaller class seems
to be antigenically related to proheads in a way that phage are not.
As the spirals in both the immunoelectrophoresis and the electron
microscopy experiments were made from an 8~amH202 lysate, it's possible
that a small number of spirals carried an antigenic gp8 fragment. Thus,
such spirals would be precipitated by the prohead-specific antibodies
in the anti-prohead serum. However, immunoelectrophoresis experiments
suggested that anti-prohead serum contained a fraction of anti-gp5 anti-
bodies that recognized capsid determinants unique to proheads (see
Figure 18b). It may be, then, that gp5 in spirals is in one of two
states: in one form, representing the major class, gp5 resembles the
mature form found in the phage capsid; in the other, gp5 displays an
additional set of sites such as those found on proheads. In this model,
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it is these prohead-specific gp5 determinants which lead to coating
of spirals by phage-absorbed anti-prohead serum.
In summary, the antibodies in phage-absorbed anti-prohead serum
which coat proheads are likely to be, in large part, directed against
the scaffolding protein. However, it is not possible from this experi-
ment alone to exclude the possibility that these antibody molecules
are directed against gp5 capsid determinants which are found only in
proheads. Coating of a fraction of the spirals by the phage-absorbed
serum may also be explained by either model. To sort out these
possibilities, I further absorbed the phage-absorbed anti-prohead
serum with amber mutant lysates. This experiment is presented in
detail below.
3. Lysate-absorbed serum
In these experiments, I attempted to genetically identify the
antibody classes responsible for the coating of proheads by phage-
absorbed serum. Results from previous immunoelectrophoresis experi-
ments suggest that the prohead coating observed in the electron
microscope is probably caused by the reaction of residual antibody
fractions with accessible gp8 subunits (see Figures 28 and 30) and
prohead-specific gp5 capsid determinants (see Figure 18b). To
separate the anti-gp8 and prohead-specific anti-gp5 classes from one
another, I further absorbed the phage-absorbed anti-prohead serum with
phage amber mutant lysates. The protocol and rationale used for the
serum absorption are outlined in Diagram 3.
First, I used several aliquots of purified phage to completely
absorb a large pool of anti-prohead serum. This supplied the starting
material, phage-absorbed anti-prohead serum. The phage-absorbed serum
Diagram 3:
Anti-prohead serum
Phage absorption
Phaqe-absorbed anti-prohead serum
Absorbing lysate
Relevant components
accumulating
Residual antibodies
313
Proheads
None
3~5~13-
Soluble gp8
Anti -gp5(Anti -gp8
structure-
dependent)
3~8-13-
gp5-containing
spirals and
shells
Anti-gp8
(Anti-gp5
structure-
dependent)
Expected resul ts1
1
No coating Coating Coating
From previous immunoelectrophoresis experiments.
35133~5~8~13-
None
Anti -gp5
Anti -gp8
Coating
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was divided into four aliquots to be absorbed with four different,
concentrated lysate preparations: 3~13~, 3~5~13~, 3~8~13~, and 3~5~8l13~
lysates. (The 13~ mutation is not relevant to these discussions and I
will no longer refer to it).
(a) Immunoelectrophoresis of absorbing lysates
The antigenic composition of these lysates was analyzed by
immunoelectrophoresis and the results are shown in Figure 40. Panels
a and d show, using whole anti-prohead serum, the immunoelectrophoretic
patterns of the starting lysates, which were 200-fold concentrated
serum. The 3~ lysate, in the central section of panel a, contains both
soluble gp8, which results in the dense, outer precipitin arc, and pro-
heads, which yield the inner, very dense precipitates (see Chapter II
for the identification of precipitin arcs). When gp5 is effectively
deleted from this lysate by mutation, as in the 3~5 lysate in the
lower section of panel a, the structure-related precipitin arcs disappear
while the soluble gp8 continues to be precipitated. Deletion of gp8
from a 3~ lysate by mutation removes the soluble gp8 band, but the dense
arcs caused by the aberrant gp5 aggregates present in the lysate persist,
as shown in the central section of panel d. No gp8 amber fragment
band is detectable, as expected, because the lysate was made by an in-
fecting phage carrying the 8 amN123 allele.
Prior to serum absorption, the lysates were centrifuged to remove
rapidly sedimenting material which would contribute to background inter-
ference in the electron microscopic observation of the serum-containing
samples. The effect of centrifugation on the antigenic components was
examined in panels b and c. Centrifugation mainly removed gp5-dependent
reactions from directly around the antigen wells. Presumably, either the
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Figure 40
Immunoelectrophoresis of Lysates Used for
Absorption in Electron Microscopy Experiments
Antisera and lysates have been described in Materials and
Methods, Section j, ii, 1, and iv, and Section j, iii, respec-
tively. Immunoelectrophoresis was as described in the figure
lengend to Figure 17 and in Materials and Methods, Section i,
iii.
(a) and (d) Immunoelectrophoresis using whole anti-prohead
serum of the absorbing lysates and a wild-type control lysate be-
fore lysate centrifugation. (b) and (e) Immunoelectrophoresis
using whole anti-prohead serum of the absorbing lysates and wild-
type lysate after lysate centrifugation. Note that reactions
immediately around the antigen well are removed by lysate centri-
fugation. (c) and (f) Immunoelectrophoresis of centrifuged,
absorbing lysates and wild-type lysate using the phage-absorbed
serum used in the electron microscopy experiments. Of particular
interest is the fact that the aberrant aggregates of gp5 contained
in the 3-8- lysate in the central section of panel f continue to
be precipitated by the serum after phage-absorption.
a)
wildmpe
3lysate
3'S5' lysate -
b)
3lysate (cent'd)
3-5 lysate (cent'd>l
C)
3lysate (cent'd)
3 lysate (cent'd)
d )
3-58F lysate
308 lysate
3f5 lysate
a-W
-. anti-prohed
..nti-prohead
ant.Iampw head
- *.luIL'ohead
~~gP~orwaborbod
antl-pzoh~ad
anti-prohead
e)
3-5-8 lys. (centld)
anti-pirohead
383 lys. (cent'd)
anti-pirohead
3 5 Vys. (cent'd)
37--lYs. (cent'd)
3-8- lys. (cent'd)
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phaveoatord
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gp5 itself was removed through association with rapidly sedimenting
material, or the sedimentation of large lysate components released
the gp5-containing structures from some complex which was electro-
phoretically retarded. The latter seems to be the case for the
structures in the 3~8~ lysate in panel e where some of the density
around the antigen well seems to have shifted to the typical struc-
ture position as a result of lysate centrifugation.
Finally, the lysates were immunoelectrophoresed against phage-
absorbed serum to reconstruct the actual conditions which existed
during lysate absorption of the serum for the electron microscopy
experiments. As expected, the precipitation of gp8 is relatively
unaffected by the absorption of the serum with phage, as shown in
panel c and the bottom of panel f. The proheads in the 3~ lysate in
panel c also continue to be precipitated; however, phage-absorption
has obviously reduced the number of anti-capsid antibodies which are
reactive because the prohead structures travel considerably farther
before being precipitated. Perhaps the most important information
from this set of experiments is shown in the central reaction of panel
f. The aberrant aggregates of gp5 present in the 3~8~ lysate are
precipitated by the phage-absorbed serum, although the number of anti-
bodies participating in the reaction has been considerably reduced by
the prior phage absorption. Thus, this absorption depletes the serum
of at least a portion of the prohead-specific anti-gp5 antibodies.
This experiment will be of importance in showing absorption of phage-
absorbed serum with this 3~8~ lysate for the electron microscopy experi-
ments reduced the concentration of the anti-capsid antibodies in the
serum.
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(b) Rationale of the lysate absorptions
Having characterized the antigenicity of the lysate components
in reaction with phage-absorbed anti-prohead serum, we can predict
the residual antibody activity which should remain after lysate-
absorption, as illustrated in Diagram 3. One aliquot of the serum,
absorbed with a 3 13 lysate, served as the negative control. The
prohead structures in this lysate which have been shown to react with
the phage-absorbed serum (Figure 40c) should remove all of the anti-
bodies directed against proheads. Thus, proheads reacted with this
absorbed serum should not appear coated when examined in the electron
microscope.
Another aliquot of phage-absorbed serum was incubated with a
3~5~8~ lysate to serve as the positive control. The lysates were
centrifuged prior to their use as absorbing antigens, and SDS-gel
electrophoresis experiments have shown that, typically, the gp5
amber fragment pellets quantitatively with the debris (data not shown).
In addition, no gp8 amber fragment was detected in this lysate by
immunoelectrophoresis (see Figure 40f). Therefore, absorption of
phage-absorbed serum with a 3~5~8~ lysate should leave all anti-gp5
and anti-gp8 antibodies active; prohead coating by this serum should
approximate that of the starting material, phage-absorbed serum.
The absorptions of prime interest involved the 3~5~ and 3-8~
lysates. As discussed for the 3~5~8~ lysate above, the 3~5~ lysate
totally lacks gp5; however, it contains soluble antigenic gp8, as shown
in Figure 40c and f. Therefore, incubation of the serum with a 3~5~
lysate should remove the anti-gp8 antibodies, but leave behind prohead-
specific anti-capsid antibodies as shown in Diagram 3.
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In the converse experiment, I absorbed the serum with a 3~8~
lysate. As shown by immunoelectrophoresis, (see Figure 40 d-f) the
lysate did not contain a detectable gp8 fragment. However, the gp5-
containing structures in this lysate do react with the phage-absorbed
serum. Thus, absorption of phage-absorbed anti-prohead serum with a
3~8~ lysate should remove anti-capsid antibodies, but leave behind
anti-gp8 antibodies.
I have described the absorption of phage-absorbed anti-prohead
serum with a 3~8- lysate and a 3~5~ lysate as a means of separating
anti-gp8 antibodies from prohead-specific anti-gp5 antibodies. The
discussion has been somewhat oversimplified, however. As always in
using mutant lysate absorptions to generate mono-specific sera, there
is the assumption that the form of the antigen in the lysate can remove
all of the antibodies which were generated against the protein when
it existed in the structure. To the degree to which this is not true,
absorption of the serum with a lysate will leave behind structure-
specific antibodies. These are indicated in parentheses in Diagram 3.
For example, the absorption of anti-gp8 antibodies by the soluble gp8 in
the 3~5~ lysate may leave behind a fraction of anti-gp8 antibodies which
can be absorbed only by gp8 as it exists in the prohead structure.
Thus, in this instance, binding of the unabsorbed structure-dependent
anti-gp8 antibodies would contribute to the coating of proheads.
(c) Technical difficulties
Substantial technical difficulties were encountered with the
experiment just described. First, it required large amounts of absorbing
antigen. For example, to generate fully phage-absorbed serum required
about 7 x 1014 phage/ml serum. To generate enough serum to divide up
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into separate aliquots for lysate absorptions required almost 2 x 1015
phage total. Second, in adding equal volumes of concentrated lysates
to the phage-absorbed serum at the lysate absorption step, I was
also adding a complex mixture of heterogeneous material which contri-
buted significantly to the background material against which the binding
of very small, fine antibodies had to be distinguished. Even though
I clarified the sera of particles of about the size of ribosomes by
high speed centrifugation, there remained substantial particulate
matter in the backgrounds. Third, the levels of coating that I obtained
in the positive control samples after lysate absorption were always
lower than I expected given the results of pilot experiments in which I
simply diluted the phage-absorbed serum with buffer. This was presum-
ably caused by non-specific precipitation occurring under the
highly concentrated conditions of the absorptions. I was not able to
directly compensate totally for this reduced antibody recovery by
concentration of the absorbed serum, since this concentrated the
background material as well. In the experiment presented here, a
satisfactory belance was reached by concentrating the absorbed serum
10-fold. However, in a second larger experiment not shown, working
with greater quantities of material, a 10-fold concentration of the
serum increased the background material to unsatisfactory levels.
(d) Coating of particles by lysate-absorbed serum
1. Control sera
A gallery of particles from the antigen mixture as they appear
after incubation with the four classes of absorbed sera are shown in
Figure 41. Phage are presented in the left-most column. As the start-
ing serum is fully phage-absorbed, these phage images serve as a
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Figure 41
Coating of Proheads by Lysate-absorbed,
Phage-absorbed Anti-prohead Sera
Electron micrograph of prohead coating by phage-absorbed
anti-prohead sera which have been further absorbed with lysates
as described in the text. The first column contains phage as
negative controls. Spirals, in the second column, are also
not coated. Column 3-8 contain proheads which have, in rows
a-c, been roughly arranged in decreasing order of antibody coat-
ing.
Row (a) Phage-absorbed serum containing anti-coat protein
and anti-scaffolding protein coats proheads. The third panel con-
tains both a spiral (top, uncoated) and a prohead (lower, coated).
Row (b) Coating of proheads by anti-scaffolding protein
antibodies as discussed in the text.
Row (c) Coating of proheads by prohead-specific anti-
coat protein antibodies, as described in the text.
Row (d) Absence of prohead coating by phage-absorbed
serum which has been absorbed with proheads.
a.)
b)
c)
d)
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negative control for coating. Spiral structures are shown in the
second column. In general, these also were uncoated. This is to
be expected as the sample population was small and previous electron
microscopy experiments showed that about 15% of the spirals were
coated by phage-absorbed serum. Finally, in columns 3-8, I show a
progression of prohead structures arranged very roughly in order of
my estimation of decreasing amounts of antibody coating.
The positive and negative controls for prohead coating, as
discussed previously, are shown in the upper and lower rows, a and
d. Although there is considerable background material, I think the
difference in prohead coating between these two rows is clear and in
the direction expected. The top row shows the coating of proheads
which have been incubated with 3~5~8~ lysate-absorbed, phage-absorbed
anti-prohead serum. Anti-gp5 and anti-gp8 antibodies should remain
active after this absorption, as indicated in Diagram 3. As expected,
then, the proheads from this antiserum incubation show a considerable
amount of coating. The edges of the proheads show diffuse projections
all about their surfaces. The coated proheads also display more
internal stain indicating some rearrangement of the inner proteins.
In contrast to these proheads, the appearance of the proheads in
the bottom row is much more nearly that typical of unreacted proheads.
The proheads in the bottom row have been incubated with phage-absorbed
serum that had been absorbed with a 3~ lysate. As this lysate accumulates
proheads, all of the antibodies reactive against proheads have
apparently been removed by absorption and thus, these proheads appear
antibody-free. The edges of these particles are more clearly defined
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and no rougher than those of untreated proheads. Only rarely are
protrusions evident, and they are probably the result of the super-
position of the particle edge over dense background material. Note
also that these proheads resemble untreated proheads in that they
are not penetrated by stain. Thus, despite the numerous technical
difficulties described previously, antisera incubated with control
lysates coated proheads in the expected manner.
2. 3-5~ lysate absorbed serum
Now we ask: does phage-absorbed serum contain a prohead-
specific class of anti-gp5 antibodies which will coat proheads? As
illustrated in Diagram 3, the serum used as a probe in this experi-
ment has been absorbed with a 3~5~ lysate so that prohead-specific
anti-capsid antibodies should be left behind. Structure-specific
antibodies may be present as well. The residual coating activity
of this serum against proheads is shown in row c. Although it is
difficult to see small amounts of antibody coating against the
rather granular background, after examining a number of proheads.
I estimated that the level of prohead coating by this absorbed serum
ranged from little to none at all. I have tried to arrange the pro-
heads in a series which is representative of this range of coating,
from a prohead on the left typical of the most coated particles in
the preparation to ones on the right which appear antibody-free.
3. 3~8~ lysate-absorbed serum
Immunoelectrophoresis experiments had suggested a most inter-
esting result, that is, that scaffolding protein was accessible
in proheads (see Figure 29). The experiment in row b shows
accessible
the results of asking whether gp8 is using electron micro-
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scopy. As illustrated in Diagram 3, absorption of phage-absorbed anti-
prohead serum with 3~8~ lysate should leave behind anti-gp8 antibodies
and possibly, structure-dependent anti-capsid antibodies as well. As
shown in row b the proheads show a range of appearances from what I
consider fairly well coated to sparsely coated. There were not any
proheads which seemed to be totally antibody free and the general
level of coating in this experiment was higher than that of the most
coated proheads in the experiment of row c. The internal morphology
of these particles was mixed, but the majority were fully penetrated
by the stain.
4. Discussion
One question of primary importance which I wished to answer
in this experiment was whether gp8 determinants were accessiblein the
prohead structure. This problem is best approached through a com-
parison of the results of the absorption of the serum by the 3-5-
and 3~8- lysates. Absorption of the serum with a 3-5~ lysate
established the maximal level of coating which can be produced by
the binding of prohead-specific anti-gp5 antibodies. Immunoelectro-
phoresis experiments showed that at least some of these anti-capsid
antibodies could be removed by the gp5 aggregates in the 3~8- lysate.
Therefore, since the level of prohead coating was greater using
serum that had been absorbed with a 3~8~ lysate as opposed to a 3-5-
lysate, another set of antibodies must be involved. Given the genetic
constitutions of the absorbing lysates, the observed prohead coating
by 3~8~ lysate-absorbed, phage-absorbed serum is most probably the
result of anti-gp8: gp8 interactions. At the leastprohead coating
by this serum is caused by a combination of anti-gp8 and structure-
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dependent anti-capsid antibodies. Thus, this experiment leads to
same conclusion as did several immunoelectrophoresis experiments;
that is, gp8 as it exists in the prohead structure is accessible
to reaction with anti-gp8 antibodies in the environment.
There are two interpretations of these data possible at the
molecular level. The first and simpler hypothesis is that gp8
is normally exposed at the surface of the prohead. Clearly, there
must be direct interaction of the gp8 molecule with the capsid sub-
units to direct the assembly of gp5 subunits into a shell of the
proper dimensions. Perhaps the capsid and scaffolding proteins
retain their association at the surface of the completed shell.
Such extensions of the gp8 molecule into the outer capsid shell may
facilitate its exit during DNA packaging.
Alternatively, in a more complicated scheme, binding of anti-
capsid antibodies to the outer shell may cause a rearrangement of
the capsid subunits. In analogy to the in vivo situation, these
changes in gp5 may trigger the movement of gp8 out of the capsid
shell where upon it becomes trapped at the surface. According to
this hypothesis, then, gp8 exits through the coat proteins lattice
during virus maturation, and we are observing an intermediate
stage in this process. For this hypothesis to be true, absorption
of the phage-absorbed serum with 3~8- lysate must leave behind a
sufficient population of anti-capsid antibodies to induce this con-
formational change, which is possible. Also the model predicts
that the internal material visible in proheads by electron microscopy,
the scaffolding protein, will be disrupted by the antibody binding.
Proheads which have been reacted with antiserum always appeared emptier
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than control proheads. This re-arrangement seemed to require a certain
minimal number of antibodies. For example, in Figure 38, reaction of
the proheads with whole anti-prohead serum seems to result in very
empty-looking proheads. After absorption of this serum with phage,
proheads coated by the residual antibodies, present in lower concen-
tration, appear somewhat fuller, as in Figure 39. However, ten-fold
concentration of this phage-absorbed serum, which is effectively the
case in the positive control series in Figure 41 (row a) seems to ren-
der the prohead again relatively empty-looking. The proheads in row b
of Figure 41 also appear mostly empty, that is until the level of coat-
ing drops to that shown by 3~5~ lysate-absorbed phage-absorbed anti-
prohead serum. From this point on, the proheads maintain a somewhat
full appearance. The question of the appearance of proheads reacted
with the anti-capsid antibodies of anti-phage serum is interesting.
Although it was possible that only prohead-specific anti-capsid anti-
bodies would release gp8, in fact, a number of proheads which have been
reacted with anti-phage serum also appear empty (see Figure 35).
Either interpretation leads to an interesting conclusion about
prohead structure. Either the scaffolding protein is normally
exposed on the prohead; or, reaction of the coat protein with anti-
body induces release of the scaffolding protein through the capsid
lattice, presumably reflecting its passage out of the capsid shell
in vivo.
The second general question addressed by these experiments was
the existence and location of prohead-specific coat protein deter-
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minants. These were detected by absorption of phage-absorbed
anti-prohead serum with a 3~5~ lysate. This serum absorption
left behind a fraction of antibodies which coated the prohead
surface indicating that prohead-specific gp5 determinants did
indeed exist. Although the low resolution of the data precludes
any statements about the precise location of the antibodies,
they appeared to be distributed over the entire capsid shell.
Thus, a set of coat protein determinants appears to be
exposed uniformly at the surface of the proheads but unavailable
on the phage. In the simplest interpretation of these results,
one can assume that the capsid subunits change their conformation
during the prohead-to-phage transition in such a way that the
prohead-specific gp5 determinants become buried. X-ray diffraction
studies of proheads and phage have showed that the prohead precursor
shell expands during phage maturation, but without radical alter-
ation of coat protein subunit clustering (Earnshaw, et al., 1976).
Nevertheless, these studies using highly specific antibodies have
succeeded in detecting what is probably a very slight configurational
rearrangement of the coat protein molecules during capsid expansion.
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GENERAL DISCUSSION
The analysis of the neutralizing activity of serum directed
against P22 phage showed clearly that the primary target for dir-
ect inactivation of phage was the tail protein. The kinetics
of inactivation indicated that one antibody molecule is sufficient
to inactivate the phage. Further experiments are required to
determine whether the inactivated phages are incapable of absorb-
ing to Salmonella cells, or whether the antibody blocks a later
step in the infection process.
Serum generated against precursor proheads was about as
effective in precipitating mature phage as was the anti-phage
serum. The serum also contained neutralizing anti-tail antibodies
at about 20% of the level in anti-phage serum. This activity was
not blocked by proheads themselves and must have been induced by
contaminants in the prohead preparation. The contaminating ghosts
were present at about the 1% level (Figure 3), and contaminating
soluble gp9 was less than could be detected by SDS-gel electro-
phoresis. This result is of interest in regard to the general
question of the immunogenicity of proteins. First, P22 tail pro-
tein must represent a highly immunogenic protein. Tail protein
could only have accounted for a very small fraction of the total
protein in the prohead immunogen preparation, yet it induced a
significant antibody response. Although the factors contributing
to its high immunogenicity were not investigated, the observed
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dominance of the tail protein in antigenic competition has practical
ramifications. Its behavior illustrates how minor impurities in
vaccine preparation may induce disproportionate antibody responses.
Secondly, the results suggest that had the prohead preparation been
highly pure, the precursor to the mature virus would probably not
have induced a direct neutralizing antibody species. Though not
necessarily of a general nature, these results may be relevant to the
question of whether precursor particles may be of prophylactic value
in immunization against the mature virion. In terms of the actual
immune defense against viruses, it has not been established whether
only the direct neutralizing antibody species function in the pro-
tection of the organism, or whether non-neutralizing antibodies are
also important. In a study of foot-and-mouth disease virus, immuni-
zation with the purified target of the virus neutralizing anitbodies
provided protection against the disease in field tests (Bachrach et
al., 1975). The question of protection by non-neutralizing antibodies
was not addressed.
Naively, one might have expected that extensive coating of the
phage capsid, as was seen in the electron microscopy experiments, would
have led to phage inactivation. The results of the serum blocking
experiments suggested that this was not the case. Although a portion
of the neutralizing antibodies were probably anti-coat protein anti-
bodies, they did not constitute a major fraction of the neutralizing
antibodies, nor were they highly effective in neutralizing the phage,
showing as they did, multi-hit kinetics. These results suggest that,
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sults suggest thst, once the DNA is stably packaged, the capsid shell
may relinquish its role as a dynamic organelle and become a relatively
passive protective shell. In this interpretation, the effective trans-
fer of the DNA from the virus to the host would be mediated almost ex-
clusively by the tail apparatus. Addition of the tail to the capsid
may even result in a final change in the capsid conformation to achieve
maximum stability. Binding of antibodies to the tail parts seems to be
the general mechanism by which antisera neutralize phage. This is true
for phage X in which the phage-neutralizing antibodies are directed
against the adsorption organelle, the gene J tail fiber (Buchwald and
Siminovitch, 1969). Similarly, the neutralizing antibodies against T4
phage are directed against the T4 tail fibers (Edgar and Lielausis,
1965) and baseplate spikes (Berget and King, unpublished experiments).
As the experiments in Chapter I of this thesis and earlier experiments
show (Israel et al., 1967), the virus neutralizing antibodies against
phage P22 are also directed against the tail structure.
The presence in anti-prohead serum of one antibody class, which
inhibited phage neutralization by another, generated serum blocking
curves quite different from those produced in situations where
neutralizing antibody classes act independently. In addition, the
existence of inhibiting antibodies implied that the multi-hit in-
activation of the phage was the result of direct neutralization. If
the loss in phage titer were simply the result of particle agglutina-
tion, then an inhibiting class of antibodies could not exist because
all antibodies precipitate their antigen.
Two of the amber fragments of scaffolding protein gave
positive precipitin reactions in immunoelectrophoresis with anti-
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bodies generated against the whole protein. The identification of
antibodies in the serum directed against the scaffolding protein was
considerably facilitated by the characteristic immunoelectrophoretic
behavior of these amber fragments. This was expressed in both
their altered electrophoretic mobilities and diffusion behavior,
as well as in reactions of partial identity with the complete poly-
peptide chain. This type of analysis may provide a general method
for the identification of antigens whose amber fragments retain anti-
genicity.
Originally, I hoped to use antibodies to locate several of
the minor proteins on the phage structures. In fact, injection of
phage and phage precursor structures into rabbits generated antibodies
against only two minor proteins, the tail and scaffolding proteins.
In the process of characterizing the anti-prohead serum, I unexpectedly
discovered that, in the presence of antibodies, scaffolding protein
is accessible in proheads. This constitutes the major finding in
this thesis and is supported by several lines of evidence.
First, the very fact that injection of prohead structures
into a rabbit induced antibodies against the scaffolding protein is
consistent with its being accessible to the environment. Although
arguments have been made that protein denaturation occurs during
emulsification of the antigen in adjuvant (Sela, 1972), recent studies
have shown that hemoglobin and myoglobin remain undenatured after
mixture with adjuvant (Berkofsky, et al., 1976; Smith, et al., 1977).
Third, even proheads which have experienced only mild conditions
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bind anti-scaffolding protein antibodies: In immunoelectrophoresis
experiments, proheads were able to absorb anti-scaffolding protein
antibodies from the serum. Direct observation in the electron
microscope of antibody-coated proheads showed that anti-scaffolding
protein antibodies bound over the entire prohead surface.
The binding of anti-gp8 all over the prohead shows that the
scaffolding molecules either are normally accessible or become
available (through antibody incubation) over the entire surface of
the shell. This suggests that the exit of the scaffolding protein
might take place through the lattice of the coat protein. In fact,
the prohead shell expands about 10% in the overall transition
(Earnshaw et al., 1976) making this a plausible hypothesis. The fact
that there are coat protein antigens present on the prohead, but absent
from the mature shell indicates that in this transition there is suf-
ficient movement of the subunits so that an antigenic site can be
buried or rendered unavailable. In fact, it is clear from micrographs
of negatively stained P22 proheads that the precursor shell is ser-
rated or much rougher than the mature shell. The easiest way to pic-
ture this is to assume an open lattice for the prohead with perhaps the
scaffolding protein penetrating through. In the expansion of the coat
lattice and exit of the scaffolding protein molecules, the coat sub-
units may reorient or change conformation so as to close up the lattice
holes.
It is also possible that antibodies to the capsid protein trigger
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a change in the conformation of the capsid shell so that gp8 becomes
available for reaction with the anti-scaffolding antibodies in the
environment. From the electron micrographs of antibody-coated pro-
heads, it is clear that the binding reaction results in a rearrangement
of the prohead structure, at least with respect to the scaffolding
molecules. The occupation of the center of the particle by the stain
suggests that the gp8 molecules have moved out to the shell. It is
possible that the antibody-coated proheads represent proheads in
transition, intermediate structures trapped in the process of releasing
their scaffolding protein. Proheads coated with anti-phage serum, which
lack antibodies against gp8, had the same appearance. This suggests that
this transition may be triggered by anti-capsid protein. All of these
observations can be accounted for by the following model:
The majority of the mass of the scaffolding protein is situated
within the prohead as suggested by electron microscopic studies (Casjens
and King, 1974; Lenk et al., 1975) and X-ray diffraction studies
(Earnshaw et al., 1976). However, a part of the chain protrudes through
the capsid lattice and is exposed. Thus, on injection into a rabbit,
anti-scaffolding protein and anti-capsid protein are produced. When
these antibodies are reacted with proheads, they bind to the exposed de-
terminants. The binding of anti-coat antibodies to the prohead trig-
gers the rearrangement of the coat from the prohead to the mature shell,
or to an intermediate stage in the transition. In this process, gp8
moves through the coat protein lattice to the surface leaving the inside
of the particle empty. Antibodies directed against gp8 bind to the ex-
posed scaffolding protein, probably before and after the transition. In
a certain sense the antibody reaction may mimic the SDS treatment of
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proheads which results in the expansion of the shell and the release
of the scaffolding protein. Earnshaw (personal communication) has
recently found that 8~ shells which lack the scaffolding protein,
will expand to the mature size when treated with SDS. Thus, the
expansion is a property of the coat protein alone, and does not
require gp8. In the absence of the coat protein, the scaffolding
protein accumulates as soluble subunits (Casjens and King, 1974),
and does not self-associate. People have generally thought that
gp8 was specifically aggregated into an inner shell with the capsid.
However, it may be that though gp8 molecules are close together in-
side the capsid, they are not tightly bound to each other, but rather
are bound to the capsid lattice. When this lattice rearranges they
are released. In this model, I envision the scaffolding protein as
copolymerizing with the coat protein providing the extra information
to give the coat lattice its proper curvature. Once the prohead is
completed, a further reaction, presumably involving DNA binding,
triggers the rearrangement of coat protein, which then releases gp8,
through the expanded coat protein lattice.
272.
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